Sentence,class,file
"177 https://doi.org/10.3349/ymj.2017.58.1.174Kyu Yeun Kim, et al.",OADS,/arxiv_data1/oa_pdf/1e/fe/ymj-58-174.PMC5122634.pdf
https://doi.org/10.3349/ymj.2017.58.1.174 178Human Coronavirus in the 2014 Winter Season 2013 (positive rate of HCoV 8.3% vs. 14.0%).,Non-OADS,/arxiv_data1/oa_pdf/1e/fe/ymj-58-174.PMC5122634.pdf
"179 https://doi.org/10.3349/ymj.2017.58.1.174Kyu Yeun Kim, et al.",OADS,/arxiv_data1/oa_pdf/1e/fe/ymj-58-174.PMC5122634.pdf
"Key Words:  Pneumonia, nursing home, antimicrobial resistance, mortalityYonsei Med J 2017 Jan;58(1):180-186 https://doi.org/10.3349/ymj.2017.58.1.180Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: December 4, 2015   Revised: July 15, 2016 Accepted: July 22, 2016Corresponding author: Dr. Young-Soon Yoon, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongguk University Ilsan Hospi-tal, Dongguk University College of Medicine, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326, Korea.Tel: 82-31-961-7151, Fax: 82-31-961-9309, E-mail: ysyoonmd@gmail.com •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"181 https://doi.org/10.3349/ymj.2017.58.1.180Yun-Seong Kang, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
https://doi.org/10.3349/ymj.2017.58.1.180 182Nursing Home-Acquired Pneumonia in Elderly RESULTS Patient characteristics A total of 317 patients with pneumonia aged 65 years or more  were analyzed.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"183 https://doi.org/10.3349/ymj.2017.58.1.180Yun-Seong Kang, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
https://doi.org/10.3349/ymj.2017.58.1.180 184Nursing Home-Acquired Pneumonia in Elderly ures of initial antibiotics are presented in Table 4.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"185 https://doi.org/10.3349/ymj.2017.58.1.180Yun-Seong Kang, et al.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"https://doi.org/10.3349/ymj.2017.58.1.180 186Nursing Home-Acquired Pneumonia in Elderly ies, such as blood culture and urinary antigen.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
Available at: http://kostat.go.kr/portal/ eng/pressReleases/1/index.board?bmode=read&aSeq=331389.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/ymj-58-180.PMC5122635.pdf
"Key Words:  Asthma, obesity, treatment costs, productivity loss costs, attributable costsYonsei Med J 2017 Jan;58(1):187-194 https://doi.org/10.3349/ymj.2017.58.1.187Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 19, 2016   Revised:  June 22, 2016 Accepted:  June 29, 2016    Corresponding author:  Dr. Dong-Churl Suh , College of Pharmacy, Chung-Ang  University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"https://doi.org/10.3349/ymj.2017.58.1.187 188Costs Attributable to Overweight and Obesity in Asthma Body mass index (BMI) has been shown to be negatively as - sociated with various lung volume measures, and obesity has  been correlated with lower lung function and more comorbid - ities among asthma patients.14 Increasing BMI has been found  to be significantly associated with worsening asthma severity,15  greater asthma symptoms, poorer asthma control,16,17 more ac - tivity limitations, worse general physical health status, more  missed workdays, and more medication use and hospitaliza - tion.15,18,19 Compared to normal-weight patients with asthma,  overweight or obese patients tend to have more asthma-related  hospitalizations, more emergency department visits, and more  unscheduled urgent care visits, regularly scheduled visits, and  follow-up visits for an asthma episode.19,20 Studies conducted  among non-elderly and elderly asthma patient cohorts have  demonstrated a significant impact of obesity on healthcare  costs.10,21 Although previous studies have consistently shown the sig - nificant economic impact of asthma or obesity on medical  costs and lost productivity, the total incremental costs of obesity  among patients with asthma have not been estimated.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"189 https://doi.org/10.3349/ymj.2017.58.1.187Chongwon Chang, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
https://doi.org/10.3349/ymj.2017.58.1.187 190Costs Attributable to Overweight and Obesity in Asthma age groups.,Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"191 https://doi.org/10.3349/ymj.2017.58.1.187Chongwon Chang, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"https://doi.org/10.3349/ymj.2017.58.1.187 192Costs Attributable to Overweight and Obesity in Asthma were normal weight, total all-cause healthcare expenditures  (including prescription medications) would be expected to be  decreased by $2066 (2015 US dollars) and $4378 (2015 US dol - lars) respectively.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"193 https://doi.org/10.3349/ymj.2017.58.1.187Chongwon Chang, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
Available  at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_258.pdf.,OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
Available  at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_260.pdf.,OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
https://doi.org/10.3349/ymj.2017.58.1.187 194Costs Attributable to Overweight and Obesity in Asthma 9.,Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
Available at: http://meps.ahrq.gov/mepsweb/data_stats/ download_data/pufs/h163/h163doc.pdf.,OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
Available at: http://www.bls.gov/oes/ current/oes_nat.htm.,OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
Available at: http://www.bls.gov/cpi/ 35.,Non-OADS,/arxiv_data1/oa_pdf/2c/aa/ymj-58-187.PMC5122636.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):19-26 https://doi.org/10.3349/ymj.2017.58.1.19",Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
"20Detection of CTCs in Breast Cancer Patients https://doi.org/10.3349/ymj.2017.58.1.19as shorter disease-free and overall survival.2-4 Furthermore,  checking CTC levels may be valuable for follow-up evaluation  and to monitor therapeutic efficacy.1,5-7 Immunocytochemistry using antibodies against proteins,  which are not expressed in mesenchymal cells, but in epithe - lial cells, is commonly used for the detection of CTCs.",Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
https://doi.org/10.3349/ymj.2017.58.1.19at the end of each annealing step for 0.25 second.,Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
"22Detection of CTCs in Breast Cancer Patients https://doi.org/10.3349/ymj.2017.58.1.19100% specificity, because none of the 30 blood samples from  healthy donors had detectable CK-19 mRNA positive cells.",Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
https://doi.org/10.3349/ymj.2017.58.1.19Table 3 shows the detection rates of CK-19 mRNA-positive  cells according to metastatic sites in patients with distant me - tastasis.,Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
"24Detection of CTCs in Breast Cancer Patients https://doi.org/10.3349/ymj.2017.58.1.19ny).1,10,26 CellSearch is the only technology for CTC detection  that has been admitted by the Food and Drug Administration  as an aid in monitoring patients with metastatic breast, colorec - tal, and prostate cancers.",Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
https://doi.org/10.3349/ymj.2017.58.1.19study to clinical settings.,Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
26Detection of CTCs in Breast Cancer Patients https://doi.org/10.3349/ymj.2017.58.1.1914.,Non-OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
http://dx.doi.org/10.1093/jnci/dju066.,OADS,/arxiv_data1/oa_pdf/35/57/ymj-58-19.PMC5122637.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):195-205 https://doi.org/10.3349/ymj.2017.58.1.195",Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
"196Efficacy Evaluation of SurgiGuard® https://doi.org/10.3349/ymj.2017.58.1.195agents, oxidized regenerated cellulose (ORC) has been in use  for several decades.",Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
https://doi.org/10.3349/ymj.2017.58.1.195period.,OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
198Efficacy Evaluation of SurgiGuard® https://doi.org/10.3349/ymj.2017.58.1.195Surgicel® SurgiGuard®Spleen Liver Fabric Fibril Fabric Fibril Resected organ  weight (mg)p=0.436 p=0.218 p=0.853 p=0.436  102 vs.  111  80 vs.  91  264 vs.  272  205 vs.  280 1st period (0–5 min) 2nd period  (5–7 min) 3rd period  (7–9 min) Total (0–9 min)10 8 6 4 2 0* (g)p=0.739 p=0.971 p=0.579 p=0.780 5 4 3 2 1 0(g)p=0.436 p=0.853 p=0.739 p=0.720 5 4 3 2 1 0(g)p=0.043 p=0.912 p=0.971 p=0.780 15 12 9 6 3 0p=0.436 p=0.971 p=0.796 p=0.905 (g) Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
https://doi.org/10.3349/ymj.2017.58.1.195Table 1.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
200Efficacy Evaluation of SurgiGuard® https://doi.org/10.3349/ymj.2017.58.1.195Inflammation Fibrosis Foreign body reaction HemorrhageSurgicel® Nu-Knit SurgiGuard® Fabric Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
https://doi.org/10.3349/ymj.2017.58.1.195Inflammation Fibrosis Foreign body reaction HemorrhageSurgicel® Fibrillar SurgiGuard® Fibrillar Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
202Efficacy Evaluation of SurgiGuard® https://doi.org/10.3349/ymj.2017.58.1.195Inflammation Fibrosis Foreign body reaction HemorrhageSurgicel® Nu-Knit SurgiGuard® Fabric Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
https://doi.org/10.3349/ymj.2017.58.1.195Inflammation Fibrosis Foreign body reaction HemorrhageSurgicel® Fibrillar SurgiGuard® Fibrillar Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
"204Efficacy Evaluation of SurgiGuard® https://doi.org/10.3349/ymj.2017.58.1.195ORC is also occasionally used in breast cancer surgery to pre - vent minor bleeding for aesthetic reasons.22 In our study, we  found no significant difference in preoperative and postopera - tive Hb values, and no gross hematoma was detected at necrop - sy.",Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
https://doi.org/10.3349/ymj.2017.58.1.19513.,Non-OADS,/arxiv_data1/oa_pdf/30/9a/ymj-58-195.PMC5122638.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):206-216 https://doi.org/10.3349/ymj.2017.58.1.206",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"https://doi.org/10.3349/ymj.2017.58.1.206diseases, including traumatic brain injury.5 Mei, et al.1 infused  MSCs intravenously thirty minutes after intra-tracheal LPS and  reported a significant reduction in bronchoalveolar lavage fluid  (BALF) total cell and neutrophil counts three days later in sev - eral lung diseases.",OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
208UC-Derived MSCs Carrying Ang1 Gene Therapy for the Treatment of ALI https://doi.org/10.3349/ymj.2017.58.1.206Ang1 plasmid or empty vector plasmid at a multiplicity of infec - tion of 8.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"https://doi.org/10.3349/ymj.2017.58.1.206ry up to 25% of the field; 2=injury up to 50% of the field; 3=inju - ry up to 75% of the field; and 4=diffuse injury.9 Cell count and measurement of myeloperoxidase  (MPO) activity The trachea was isolated firstly, and then, the right bronchial  tube was ligated after the rat was euthanized.",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
210UC-Derived MSCs Carrying Ang1 Gene Therapy for the Treatment of ALI https://doi.org/10.3349/ymj.2017.58.1.206Transfected MSCs-Ang1 in survival in the lungs after  transplantation The lung tissues were cut into 5-μm thick sections and then ob - served by Laser confocal microscope.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"https://doi.org/10.3349/ymj.2017.58.1.206osteogenesis, and cartilaginous, respectively, under a given  medium culture.UCMSCs transduction efficiency with lentivirus vector After obtaining enriched UCMSCs (P4), the cells were trans - duced with lentivirus vector carrying the GFP report gene and  Fig.",OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
212UC-Derived MSCs Carrying Ang1 Gene Therapy for the Treatment of ALI https://doi.org/10.3349/ymj.2017.58.1.206the Ang1  gene.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"https://doi.org/10.3349/ymj.2017.58.1.206Lung wet-dry ratio LPS challenge produced obvious lung edema in the LPS group,  as shown by increased lung wet-dry ratio.",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
214UC-Derived MSCs Carrying Ang1 Gene Therapy for the Treatment of ALI https://doi.org/10.3349/ymj.2017.58.1.206UCMSCs and UCMSCs-Ang1 groups.,OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"https://doi.org/10.3349/ymj.2017.58.1.206tor cells are reported to restore function of damaged tissue in  various preclinical disease models.13,14 Based on our previously  study by Li, et al.6 intravenous injection of UCMSCs clearly in - creased the survival rate of rats suffering from LPS-induced  lung injuries and reduced systemic and pulmonary inflamma - tion, and a study by Xu, et al.8 reported that lung injury induced  by LPS was alleviated by treatment with MSCs (from bone mar - row) carrying Ang1 (BM-MSCs-Ang1), while the UCMSCs car - rying Ang1 was uncertain.",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
216UC-Derived MSCs Carrying Ang1 Gene Therapy for the Treatment of ALI https://doi.org/10.3349/ymj.2017.58.1.2067.,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/ymj-58-206.PMC5122639.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):217-225 https://doi.org/10.3349/ymj.2017.58.1.217",Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
"218Enteric-Coated Mycophenolate Sodium and Cyclosporine https://doi.org/10.3349/ymj.2017.58.1.217are almost universal at ten years, and can exacerbate CAI.4 To  alleviate CNI nephrotoxicity, reduction and/or withdrawal of  CNI may be necessary.",Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
https://doi.org/10.3349/ymj.2017.58.1.217all adverse events (AEs) and serious adverse events (SAEs) were  documented.,OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
"220Enteric-Coated Mycophenolate Sodium and Cyclosporine https://doi.org/10.3349/ymj.2017.58.1.217All categorical values were expressed as a percentage of the  group from which they were derived, and their p-values were  calculated using Fisher’s exact test.",OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
"https://doi.org/10.3349/ymj.2017.58.1.217Cyclosporine exposure and study drug compliance The mean blood trough levels and doses of CsA at one, two,  four, and six months post-transplantation are shown in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
"222Enteric-Coated Mycophenolate Sodium and Cyclosporine https://doi.org/10.3349/ymj.2017.58.1.217gational group, compared to 60.0±17.5 mL/min/1.73 m2 in the  control group ( p=0.148).",Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
https://doi.org/10.3349/ymj.2017.58.1.217DISCUSSION Our experience with using standard dose EC-MPS in combi - nation with reduced-exposure CsA and steroids in de novo  KT  provides additional strong evidence that this strategy is safe  and efficacious.,Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
224Enteric-Coated Mycophenolate Sodium and Cyclosporine https://doi.org/10.3349/ymj.2017.58.1.217excellent efficacy in both de novo  and maintenance patients.,Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
https://doi.org/10.3349/ymj.2017.58.1.217in Australian de novo kidney transplant patients.,Non-OADS,/arxiv_data1/oa_pdf/1b/fd/ymj-58-217.PMC5122640.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):226-233 https://doi.org/10.3349/ymj.2017.58.1.226",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"https://doi.org/10.3349/ymj.2017.58.1.226sidered to be an etiological or at least a contributing factor.3,6-11 In addition to traumatic events defined in the DSM, there is a  growing body of evidence that more broadly defined trauma,  including adverse life experiences that can cause or contribute  to later development of mental disorders and even physical ill - nesses.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
228Korean Version of the Lifetime Stressor Checklist-Revised https://doi.org/10.3349/ymj.2017.58.1.226may happen to the respondent and one item asking if any of  these 29 events ever happened to someone close (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"https://doi.org/10.3349/ymj.2017.58.1.226ue of 0.84 and test-retest correlation of 0.82 within a five-week  interval.31 Zung self-rating anxiety scale The Zung Self-Rating Anxiety Scales consists of 20 questions  covering different aspects of anxiety, including emotional and  somatic anxiety, on a scale with four responses ranging from 1  (almost never) to 4 (all the time) and a total score ranging from  20–80.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"230Korean Version of the Lifetime Stressor Checklist-Revised https://doi.org/10.3349/ymj.2017.58.1.226RESULTS Prevalence of lifetime stressors For college students, the death of someone close was the most  commonly endorsed event (48.0%), followed by the sudden  death of someone close (24.0%), witnessing family violence  (24.0%), witnessing a serious accident (22.0%), and serious di - saster (20.0%).",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
https://doi.org/10.3349/ymj.2017.58.1.226Eigen-value being larger than one.,OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"232Korean Version of the Lifetime Stressor Checklist-Revised https://doi.org/10.3349/ymj.2017.58.1.226DISCUSSION In this study, the Korean version of the LSC-R showed sound  psychometric properties among outpatients with anxiety or de - pressive disorders.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
http://dx.doi.org/10.3402/ejpt.v4i0.22482.,Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"https://doi.org/10.3349/ymj.2017.58.1.226personal trauma, and family functioning in patients with somati - zation disorder.",Non-OADS,/arxiv_data1/oa_pdf/60/f5/ymj-58-226.PMC5122641.pdf
"Key Words:  Vascular smooth muscle cells, miR-379, cell proliferation, invasion, migration, IGF-1Yonsei Med J 2017 Jan;58(1):234-240 https://doi.org/10.3349/ymj.2017.58.1.234Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: March 10, 2016   Revised: May 29, 2016 Accepted: May 30, 2016Corresponding author: Dr. Yong Wang, Department of Cardiology, The First Af-filiated Hospital of Xi’an Medical University, Xi’an 710077, Shaanxi Province, China.Tel: 86-29-84277356, Fax: 86-29-84277859, E-mail: yong_wang0756@sina.com •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"235 https://doi.org/10.3349/ymj.2017.58.1.234Kai Li, et al.",OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"Using a bioinfor - matic analytic tool (Targetscan; http://www.targetscan.org), the 3’UTR of IGF-1 gene was found to be a target of miR-379.",OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"https://doi.org/10.3349/ymj.2017.58.1.234 236miR-379 and VSMCs plates (5×104 cells/well), cultured for 24 h, and then transfect - ed with miR-379 mimics, miR-379 inhibitor, or their respective  controls.",OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"237 https://doi.org/10.3349/ymj.2017.58.1.234Kai Li, et al.",OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"https://doi.org/10.3349/ymj.2017.58.1.234 238miR-379 and VSMCs transfection with miR-379 mimics increased the cell apoptotic  rate in VSMCs, compared to its respective control, while miR-379 inhibitor treatment caused a decrease in the cell apoptotic rate of VSMCs, compared to its respective control (Fig.",Non-OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"239 https://doi.org/10.3349/ymj.2017.58.1.234Kai Li, et al.",OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"https://doi.org/10.3349/ymj.2017.58.1.234 240miR-379 and VSMCs miRNA may target more than one gene; it is likely that miR-379  targets both IGF-1 and other genes to regulate cell proliferation, invasion, and migration of VSMCs.",Non-OADS,/arxiv_data1/oa_pdf/12/34/ymj-58-234.PMC5122642.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):241-247 https://doi.org/10.3349/ymj.2017.58.1.241",Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
242Three-Dimensional Curved-MPR Images for Sylvian Dissection https://doi.org/10.3349/ymj.2017.58.1.241ing trans-sylvian approach with a pterional craniotomy.,Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
https://doi.org/10.3349/ymj.2017.58.1.241RESULTS Sylvian dissection time using different grouping  parameters The mean dissection time for all patients was 50±9.9 minutes.,OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
244Three-Dimensional Curved-MPR Images for Sylvian Dissection https://doi.org/10.3349/ymj.2017.58.1.241adhesion group ( p<0.05).,Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
https://doi.org/10.3349/ymj.2017.58.1.241DISCUSSION The SF is a gateway to aneurysms around the circle of Willis.,Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
"246Three-Dimensional Curved-MPR Images for Sylvian Dissection https://doi.org/10.3349/ymj.2017.58.1.241operative comlications, such as the formation of brain edema  or ischemic lesions.3 Pre-operative information regarding SF anatomy, nearby  vessels, and aneurysms is of utmost importance in sylvian dis - section and is required for safe microsurgical treatment.",Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
https://doi.org/10.3349/ymj.2017.58.1.2412.,Non-OADS,/arxiv_data1/oa_pdf/62/15/ymj-58-241.PMC5122643.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):248-251 https://doi.org/10.3349/ymj.2017.58.1.248",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/ymj-58-248.PMC5122644.pdf
"https://doi.org/10.3349/ymj.2017.58.1.248tion was also reduced, particularly within the mid to apical seg - ments.",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/ymj-58-248.PMC5122644.pdf
250Cardiac Rupture in Takotsubo Cardiomyopathy https://doi.org/10.3349/ymj.2017.58.1.248sessment after the development of cardiac rupture.,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/ymj-58-248.PMC5122644.pdf
"https://doi.org/10.3349/ymj.2017.58.1.248room, pericardial effusion was not present on echocardiogra - phy and she was hemodynamically stable.",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/ymj-58-248.PMC5122644.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):252-254 https://doi.org/10.3349/ymj.2017.58.1.252",Non-OADS,/arxiv_data1/oa_pdf/be/ab/ymj-58-252.PMC5122645.pdf
"https://doi.org/10.3349/ymj.2017.58.1.252No oral or injectable medication was administered during the  dental treatment, except root canal disinfectants and local an - esthesia.",Non-OADS,/arxiv_data1/oa_pdf/be/ab/ymj-58-252.PMC5122645.pdf
"254Formaldehyde in Root-Canal Disinfectant Causing Recurrent Urticaria https://doi.org/10.3349/ymj.2017.58.1.252by PFA-containing dental materials in Table 25,8,9-17 including  our case.",Non-OADS,/arxiv_data1/oa_pdf/be/ab/ymj-58-252.PMC5122645.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):255-258 https://doi.org/10.3349/ymj.2017.58.1.255",Non-OADS,/arxiv_data1/oa_pdf/fb/c3/ymj-58-255.PMC5122646.pdf
"256EWD-PTC https://doi.org/10.3349/ymj.2017.58.1.255UMP) has been suggested in cases showing that nuclear fea - tures are histologically inadequate for PTC and also clinical  features inadequate for malignancy, thus avoiding overtreat - ment.3,4 We herein report a case showing histologic features  similar to WDT-UMP , but with clinically malignant behavior.",Non-OADS,/arxiv_data1/oa_pdf/fb/c3/ymj-58-255.PMC5122646.pdf
"https://doi.org/10.3349/ymj.2017.58.1.255veloped a mass in the left thyroid, which was diagnosed as en - capsulated FVPTC without capsular or vascular invasion (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fb/c3/ymj-58-255.PMC5122646.pdf
258EWD-PTC https://doi.org/10.3349/ymj.2017.58.1.255LN metastasis was solely based on the metastatic pattern of the  tumor.,OADS,/arxiv_data1/oa_pdf/fb/c3/ymj-58-255.PMC5122646.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):259-260 https://doi.org/10.3349/ymj.2017.58.1.259 Is Human Brucellosis Endemics in Korea?",Non-OADS,/arxiv_data1/oa_pdf/19/b2/ymj-58-259.PMC5122647.pdf
"260Human Brucellosis in Korea https://doi.org/10.3349/ymj.2017.58.1.259in 2006, 11548 heads in 2007, 8416 heads in 2008, 6571 heads  in 2009, 4822 heads in 2010, 4070 heads in 2011, 2287 heads in  2012, 979 heads in 2013, 727 heads in 2014, and 304 heads from  January to October 2015 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/19/b2/ymj-58-259.PMC5122647.pdf
Available at: http://is.cdc.go.kr/dstat/index.jsp.,OADS,/arxiv_data1/oa_pdf/19/b2/ymj-58-259.PMC5122647.pdf
Avail - able at: http://www.kahis.go.kr.Fig.,Non-OADS,/arxiv_data1/oa_pdf/19/b2/ymj-58-259.PMC5122647.pdf
"261 www.eymj.orgYonsei Med J 2017 Jan;58(1):261-261 https://doi.org/10.3349/ymj.2017.58.1.261Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.ACKNOWLEDGEMENTS This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2007 (6-2007-0138) .Erratum to “Clinical Experience with the Bentall   Procedure: 28 Years” by Joo HC, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/29/ymj-58-261.PMC5122648.pdf
"Key Words:  Ovarian cancer, metastasis, mouse xenograft, SLC6A12, DNA methylationYonsei Med J 2017 Jan;58(1):27-34 https://doi.org/10.3349/ymj.2017.58.1.27Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: May 31, 2016   Revised: June 28, 2016 Accepted: June 30, 2016Co-corresponding authors: Dr. Jung-Hyuck Ahn, Department of Biochemistry,  School of Medicine, Ewha Womans University, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea.Tel: 82-2-2650-5712, Fax: 82-2-2652-7846, E-mail: ahnj@ewha.ac.kr andDr.",Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
https://doi.org/10.3349/ymj.2017.58.1.27 28Epigenetic Regulation of SLC6A12  in Ovarian Cancer from the classical patterns of hematogenous metastases.,Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"29 https://doi.org/10.3349/ymj.2017.58.1.27Hye Youn Sung, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"https://doi.org/10.3349/ymj.2017.58.1.27 30Epigenetic Regulation of SLC6A12  in Ovarian Cancer Transwell migration and in vitro  invasion assay After 24 h transfection, complete growth medium was replaced  by serum-free medium.",Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"31 https://doi.org/10.3349/ymj.2017.58.1.27Hye Youn Sung, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
https://doi.org/10.3349/ymj.2017.58.1.27 32Epigenetic Regulation of SLC6A12  in Ovarian Cancer regulatory mechanism of SLC6A12 expression.,Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"33 https://doi.org/10.3349/ymj.2017.58.1.27Hye Youn Sung, et al.",OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
https://doi.org/10.3349/ymj.2017.58.1.27 34Epigenetic Regulation of SLC6A12  in Ovarian Cancer tients.,Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
http://dx.doi.org/10.1158/1078- 0432.CCR-16-1017.,Non-OADS,/arxiv_data1/oa_pdf/84/8d/ymj-58-27.PMC5122649.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):35-42 https://doi.org/10.3349/ymj.2017.58.1.35",Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
"36Decitabine for Older Adults with AML https://doi.org/10.3349/ymj.2017.58.1.35So far, several studies have demonstrated that decitabine is ef - fective against AML and shows tolerable toxicity profiles in pa - tients of older age.10,11 However, the United States Food and Drug  Administration did not approve decitabine for the treatment of  newly diagnosed AML based on the results of a clinical trial re - ported by Kantarjian, et al.12 in 2012.",Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
"https://doi.org/10.3349/ymj.2017.58.1.35RESULTS Patient characteristics A total of 24 patients (12 males and 12 females) diagnosed with  AML received decitabine as a first-line treatment between De - cember 1, 2013 and May 31, 2015 at Severance Hospital, Seoul,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
38Decitabine for Older Adults with AML https://doi.org/10.3349/ymj.2017.58.1.35ond-line therapy.,Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
https://doi.org/10.3349/ymj.2017.58.1.35centage at diagnosis was significantly lower in the responders  than in the non-responders (median 35.5% vs. 71.4%; p=0.027).,OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
"40Decitabine for Older Adults with AML https://doi.org/10.3349/ymj.2017.58.1.35Changes of BM and peripheral blood parameters  according to treatment  The BM blast percentage, WBC count, hemoglobin concen - tration, and platelet count at diagnosis and their numeric  changes according to the treatment cycles in the patients who  kept receiving decitabine treatment are shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
"https://doi.org/10.3349/ymj.2017.58.1.35days, which might not be inferior to the results of other treat - ment modalities reported in previous studies showing a medi - an OS ranging from 7.5 to 10 months after intensive chemo - therapy15-17 and of 5.0 months after supportive care or low-dose  cytarabine.12 During the decitabine therapy, the hemograms of  the patients gradually improved.",Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
42Decitabine for Older Adults with AML https://doi.org/10.3349/ymj.2017.58.1.35ACKNOWLEDGEMENTS This study was supported by a faculty research grant of Yonsei  University College of Medicine for (6-2010-0165).,Non-OADS,/arxiv_data1/oa_pdf/7d/d3/ymj-58-35.PMC5122650.pdf
"Key Words:  HLA-A*33;03, HPV 16 E7, immunotherapy, cervical cancer, epitopesYonsei Med J 2017 Jan;58(1):43-50 https://doi.org/10.3349/ymj.2017.58.1.43Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: May 3, 2016   Revised: July 28, 2016 Accepted: August 22, 2016Corresponding author: Dr. Jong-Baeck Lim, Department of Laboratory Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.Tel: 82-2-2019-3533, Fax: 82-2-2057-8926, E-mail: jlim@yuhs.ac •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"https://doi.org/10.3349/ymj.2017.58.1.43 44HPV 16 E7 50-59 and E7 52-61 as Epitopes for HLA-A*33;03 Therefore, further research on the development of therapeutic  HPV vaccines is required for HPV-associated cancers.",Non-OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"45 https://doi.org/10.3349/ymj.2017.58.1.43Sunghoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"https://doi.org/10.3349/ymj.2017.58.1.43 46HPV 16 E7 50-59 and E7 52-61 as Epitopes for HLA-A*33;03 Cytotoxicity assay A cytotoxicity assay was performed employing the 51Cr release  assay as previously described.11 Briefly, SNU1299 cells were  labeled for 45 min with 51Cr (100 mCi/106 cells, Perkin Elmer,  Waltham, MA, USA), and then washed in PBS, and dispensed  into U-bottom 96-well plates in triplicate (Nunc) at 4×103 cells/ well.",OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"47 https://doi.org/10.3349/ymj.2017.58.1.43Sunghoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
https://doi.org/10.3349/ymj.2017.58.1.43 48HPV 16 E7 50-59 and E7 52-61 as Epitopes for HLA-A*33;03 E7 50-59- and E7 52-61-specific cytotoxicity was  induced by CD8+ CTLs We further examined whether the cytotoxicity of peptide-sen- sitized PBMCs was related to cytolytic activity of CD8+ CTLs in PBMCs.,OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"49 https://doi.org/10.3349/ymj.2017.58.1.43Sunghoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
https://doi.org/10.3349/ymj.2017.58.1.43 50HPV 16 E7 50-59 and E7 52-61 as Epitopes for HLA-A*33;03 advanced cervical cancer (CC) patients.,Non-OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
Available at: https://www.cdc.gov/media/releases/2011/ p0825_hpv_vaccine.htm 7.,Non-OADS,/arxiv_data1/oa_pdf/16/9e/ymj-58-43.PMC5122651.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):51-58 https://doi.org/10.3349/ymj.2017.58.1.51",Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
"52The Effectiveness of Ferritin as a MR Agent https://doi.org/10.3349/ymj.2017.58.1.51and analyses at the molecular or cellular levels to investigate  cellular and pathological phenomena, whereas molecular im - aging provides a more intuitive approach to gaining insight into  disease pathophysiology and cellular mechanisms through in  vivo  real-time imaging.1,2 These types of molecular imaging in - clude magnetic resonance imagining (MRI),3-8 nuclear imag - ing,9 and optical imaging,10 and each has their own benefits and  limitations.",Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
https://doi.org/10.3349/ymj.2017.58.1.51performed at each indicated time point.,OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
54The Effectiveness of Ferritin as a MR Agent https://doi.org/10.3349/ymj.2017.58.1.51taneous cancer.,Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
"https://doi.org/10.3349/ymj.2017.58.1.51contrast agent for MRI, we used the serotype 5 adenoviral ex - pression system of Ad-hFTH.",Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
56The Effectiveness of Ferritin as a MR Agent https://doi.org/10.3349/ymj.2017.58.1.51scribed in the Materials and Methods.,Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
https://doi.org/10.3349/ymj.2017.58.1.51could be a potential candidate for a MR reporter gene in cell  tracking imaging.,Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
58The Effectiveness of Ferritin as a MR Agent https://doi.org/10.3349/ymj.2017.58.1.51gene expression.,Non-OADS,/arxiv_data1/oa_pdf/7b/f3/ymj-58-51.PMC5122652.pdf
"Key Words:  Adenocarcinoma, clear cell; ovarian neoplasms; AT rich interactive domain 1A (SWI- like), human; estrogen receptor  2 (ER beta), human; endometriosis; prognosisYonsei Med J 2017 Jan;58(1):59-66 https://doi.org/10.3349/ymj.2017.58.1.59Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 22, 2016   Revised:  June 3, 2016 Accepted:  June 8, 2016    Corresponding author:  Dr. Nam Hoon Cho , Department of Pathology, Yonsei Uni - versity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"https://doi.org/10.3349/ymj.2017.58.1.59 60ARID1A-Positive Ovarian Clear Cell Carcinoma noted in ovarian cancers,13 which may also be involved in ARI - D1A loss-dependent O-CCC pathophysiology.",Non-OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"61 https://doi.org/10.3349/ymj.2017.58.1.59Jae Yoon Choi, et al.",OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"https://doi.org/10.3349/ymj.2017.58.1.59 62ARID1A-Positive Ovarian Clear Cell Carcinoma Immunohistochemical profiles of O-CCCs We analyzed expressional characteristics of several molecules,  including HNF1 β, ERβ, and E-cadherin, along with ARID1A.",OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"63 https://doi.org/10.3349/ymj.2017.58.1.59Jae Yoon Choi, et al.",OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"https://doi.org/10.3349/ymj.2017.58.1.59 64ARID1A-Positive Ovarian Clear Cell Carcinoma While ARID1A-negative tumors exhibited a homogenous im - munoprofile, the immunoprofiles of ARID1A-positive tumor  were rather heterogeneous: HNF1 β-positive rate was slightly Using readily available clinical samples and immunohisto - chemical tools, we sought to characterize ARID1A-negative O- CCCs in comparison with ARID1A-intact (or positive) O-CCCs.",Non-OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"65 https://doi.org/10.3349/ymj.2017.58.1.59Jae Yoon Choi, et al.",OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"https://doi.org/10.3349/ymj.2017.58.1.59 66ARID1A-Positive Ovarian Clear Cell Carcinoma (KHIDI), funded by the Ministry of Health & Welfare, Republic  of Korea (grant number: HI13C0858).",Non-OADS,/arxiv_data1/oa_pdf/bf/0f/ymj-58-59.PMC5122653.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):67-74 https://doi.org/10.3349/ymj.2017.58.1.67",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"68Early Repolarization and Myocardial Bridging https://doi.org/10.3349/ymj.2017.58.1.67nary arteries that are otherwise angiographically normal and  do not constitute a hazard.7 Occasionally, compression of a  portion of a coronary artery by a MB can be related to clinical  symptoms and signs of myocardial ischemia during strenuous  physical activities, and may even result in myocardial infarction  or initiation of a malignant ventricular arrhythmia.7 We, there - fore, hypothesized that the presence of MB may be associated  with ER.",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"https://doi.org/10.3349/ymj.2017.58.1.67The average heart rate of the 142 patients with ER pattern was  67±14, and the 1161 patients with no ER pattern had a heart  rate of 69±13 ( p=0.096).",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"70Early Repolarization and Myocardial Bridging https://doi.org/10.3349/ymj.2017.58.1.67agnosed with gastric ulcer or gastroesophageal reflux disease,  and four patients (1.6%) had an anxiety disorder with or with - out panic disorder.",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"https://doi.org/10.3349/ymj.2017.58.1.67(1.9%) subjects with and without ER, respectively ( p=0.001).",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"72Early Repolarization and Myocardial Bridging https://doi.org/10.3349/ymj.2017.58.1.67ward currents (principally I Na and I Ca), increases outward potas - sium currents by opening K ATP channels, and intensifies I to, es- pecially in the epicardium.",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"https://doi.org/10.3349/ymj.2017.58.1.67might involve arrhythmogenic potential and consequently,  may be more susceptible to myocardial ischemia caused by  MB.",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"74Early Repolarization and Myocardial Bridging https://doi.org/10.3349/ymj.2017.58.1.67Interian A Jr, et al.",Non-OADS,/arxiv_data1/oa_pdf/21/99/ymj-58-67.PMC5122654.pdf
"Key Words:  End-stage renal disease, diabetes mellitus, target organ damage, coronary artery disease, hypertensionYonsei Med J 2017 Jan;58(1):75-81 https://doi.org/10.3349/ymj.2017.58.1.75Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: November 24, 2015   Revised: July 31, 2016 Accepted: August 16, 2016Co-corresponding authors: Dr. Sungha Park, Division of Cardiology, Severance  Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.Tel: 82-2-2228-8455, Fax: 82-2-393-2041, E-mail: shpark0530@yuhs.ac andDr.",Non-OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"https://doi.org/10.3349/ymj.2017.58.1.75 76Vascular Biomarker in ESRD with DM MATERIALS AND METHODS The current study used the Cardiovascular and Metabolic dis - ease Etiology Research Center-HIgh risk cohort (CMERC-HI)  data, which is a prospective cohort study aimed at developing individual prevention strategies for patients with high risks of CV disease (clinicaltrial.gov NCT02003781).",Non-OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"77 https://doi.org/10.3349/ymj.2017.58.1.75Jeonggeun Moon, et al.",OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
https://doi.org/10.3349/ymj.2017.58.1.75 78Vascular Biomarker in ESRD with DM the non-DM group.,OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"79 https://doi.org/10.3349/ymj.2017.58.1.75Jeonggeun Moon, et al.",OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"https://doi.org/10.3349/ymj.2017.58.1.75 80Vascular Biomarker in ESRD with DM patients had significantly higher central aortic systolic pressure,  which is a robust prognosticator for CV outcomes and is supe - rior to conventional brachial BP .14 One potential explanation  for this finding is more advanced arteriosclerosis in the DM ESRD group.",Non-OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"81 https://doi.org/10.3349/ymj.2017.58.1.75Jeonggeun Moon, et al.",OADS,/arxiv_data1/oa_pdf/05/72/ymj-58-75.PMC5122655.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):82-89 https://doi.org/10.3349/ymj.2017.58.1.82",Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"https://doi.org/10.3349/ymj.2017.58.1.82igibility of patients for statin treatment, they also led to an over - estimation of CVD risk in several particularistic populations.4-6 Coronary artery calcium (CAC) score is determined using  cardiac computed tomography and acts a robust marker of cor - onary artery calcification.",Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"84CAC for Statin Treatment in Asymptomatic Korean https://doi.org/10.3349/ymj.2017.58.1.82mended (SN) (Table 1).3 Specifically, the SR group was defined  as either: 1) those with LDL cholesterol levels ≥190 mg/dL, 2)  those aged 40 to 75 years with diabetes and LDL cholesterol  levels ranging from 70 to 189 mg/dL, or 3) individuals without  diabetes, but with an estimated 10-year ASCVD risk of 7.5% or  higher.",Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"https://doi.org/10.3349/ymj.2017.58.1.82All-cause mortality and CAC across statin  candidate groups During a median follow-up of 5 years (25 –75th percentile: 3 –7  years), 251 mortality events occurred among 31375 subjects.",Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
86CAC for Statin Treatment in Asymptomatic Korean https://doi.org/10.3349/ymj.2017.58.1.82Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"https://doi.org/10.3349/ymj.2017.58.1.82with a lower dose, compared to Western populations, as the  pharmacokinetics and metabolites of statins differ substantially  by ethnicity.26 Moreover, the Management of Elevated Choles - terol in the Primary Prevention Group of Adult Japanese (MEGA)  study reported that the low dosage statin prescribed therein  was half the dose often utilized in European and U.S. popula - tions and could significantly lower the risk of coronary heart  disease in Japanese patients.27 A recent meta-analysis evaluat - ing the effect of statin therapy on coronary plaque also docu - mented a different effect of statins for modifying LDL-choles - terol levels, as well as the regression of coronary atherosclerotic  plaque, among ethnic groups.28 In this study, we employed CAC as a marker for reclassifica - tion of statin treatment.",Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"88CAC for Statin Treatment in Asymptomatic Korean https://doi.org/10.3349/ymj.2017.58.1.82ment guidelines were based on a 10-year risk of ASCVD, infor - mation regarding ASCVD events was unavailable, as only ACM  were ascertained in the KOICA registry.",OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
https://doi.org/10.3349/ymj.2017.58.1.82for trials where the outcome is time to an event.,Non-OADS,/arxiv_data1/oa_pdf/c3/48/ymj-58-82.PMC5122656.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.with the targeting of these proteins by small molecule inhibi - tors, has emerged as an increasingly successful treatment strat - egy for non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"RET is a receptor tyro - sine kinase (RTK) involved in cell proliferation, neuronal navi - gation, cell migration, and cell differentiation.4 The incidence of  RET  fusions ( KIF5B-RET  or CCDC6-RET ) is approximately 1%  in patients with primary lung tumors.5 The oncogenic potential Yonsei Med J 2017 Jan;58(1):9-18 https://doi.org/10.3349/ymj.2017.58.1.9",Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
10EGF Triggers Resistance to RET Inhibition https://doi.org/10.3349/ymj.2017.58.1.9of RET  fusion has been demonstrated in vitro  in transfected NI - H3T3 and Ba/F3 cells.,Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"https://doi.org/10.3349/ymj.2017.58.1.9LC-2/ad cells were incubated with RET inhibitors (sunitinib,  E7080, vandetanib, or sorafenib) for 72 hours.",Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
12EGF Triggers Resistance to RET Inhibition https://doi.org/10.3349/ymj.2017.58.1.9tion).,Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"https://doi.org/10.3349/ymj.2017.58.1.9EGF triggers RET inhibitor resistance by reactivating  AKT and ERK signaling To assess the mechanism by which EGF reduced cell sensitivity  to RET inhibitors, we analyzed the phosphorylation status of  RET, EGFR, and their downstream molecules in LC-2/ad cells  using western blots.",OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
14EGF Triggers Resistance to RET Inhibition https://doi.org/10.3349/ymj.2017.58.1.9and ERK signaling.,Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
https://doi.org/10.3349/ymj.2017.58.1.9by co-culture of LC-2/ad cells was inhibited by anti-EGFR anti - body and a reversible EGFR-TKI (Figs.,Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"16EGF Triggers Resistance to RET Inhibition https://doi.org/10.3349/ymj.2017.58.1.9RET  fusions as drivers in NSCLC, and proposed that RET inhi - bition may represent a new therapeutic paradigm for RET  fu- sion lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
https://doi.org/10.3349/ymj.2017.58.1.9FR-TKI therapy combined with corresponding target drugs.,Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"18EGF Triggers Resistance to RET Inhibition https://doi.org/10.3349/ymj.2017.58.1.9that, for RET inhibitors, HGF had relatively little effect on resis - tance to TKIs.",Non-OADS,/arxiv_data1/oa_pdf/97/c7/ymj-58-9.PMC5122657.pdf
"Key Words:  Diltiazem, nitrate, coronary vasospasmYonsei Med J 2017 Jan;58(1):90-98 https://doi.org/10.3349/ymj.2017.58.1.90Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: April 15, 2016   Revised: July 15, 2016 Accepted: July 18, 2016Co-corresponding authors: Dr. Seung-Woon Rha, Cardiovascular Center, Korea  University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308 Korea.Tel: 82-2-2626-3020, Fax: 82-2-864-3062, E-mail: swrha617@yahoo.co.kr andDr.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"91 https://doi.org/10.3349/ymj.2017.58.1.90Taeshik Park, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"https://doi.org/10.3349/ymj.2017.58.1.90 92Clinical Outcomes of Diltiazem with Nitrate as counts and percentages, and differences were analyzed with  χ2 (or Fisher’s exact) test between groups as appropriate.",OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"93 https://doi.org/10.3349/ymj.2017.58.1.90Taeshik Park, et al.",OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"https://doi.org/10.3349/ymj.2017.58.1.90 94Clinical Outcomes of Diltiazem with Nitrate test, reference vessel diameter after nitroglycerin injection, left  anterior descending spasm, spasm locations, diffuse spasm, ECG changes, and chest pain.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"95 https://doi.org/10.3349/ymj.2017.58.1.90Taeshik Park, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"https://doi.org/10.3349/ymj.2017.58.1.90 96Clinical Outcomes of Diltiazem with Nitrate that a CCB affecting vasoconstriction by reaction of VSMC  should be more important for CAS, as compared with nitrate affecting endothelial dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"97 https://doi.org/10.3349/ymj.2017.58.1.90Taeshik Park, et al.",OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
https://doi.org/10.3349/ymj.2017.58.1.90 98Clinical Outcomes of Diltiazem with Nitrate clinical outcomes in patients with significant coronary artery  spasm: a propensity score-matched analysis.,Non-OADS,/arxiv_data1/oa_pdf/9a/c3/ymj-58-90.PMC5122658.pdf
"© Copyright: Yonsei University College of Medicine 2017 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2017 Jan;58(1):99-104 https://doi.org/10.3349/ymj.2017.58.1.99",Non-OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
"100Paclitaxel-Coated Balloon and Peri-Procedural MI https://doi.org/10.3349/ymj.2017.58.1.99stent dilation, which is performed with high-pressure balloon  inflation.12 In this regard, paclitaxel-coated balloon (PCB) treat - ment is an attractive therapeutic option and may have bene - fits over DES.",Non-OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
https://doi.org/10.3349/ymj.2017.58.1.99RESULTS Patient characteristics  The matched cohort included 104 patients who had been suc - cessfully treated with PCB (n=52 patients) and DES (n=52 pa - tients).,OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
"102Paclitaxel-Coated Balloon and Peri-Procedural MI https://doi.org/10.3349/ymj.2017.58.1.99interval (CI): 1.2–1.8].1 A later meta-analysis showed that any  troponin elevation was associated with a significantly increased  risk of mortality (4.4% vs. 3.3%, p=0.001; odds ratio 1.35, 95%  CI: 1.1–1.6).18 To date, PCI has not been shown to reduce mor - tality in patients with stable coronary artery disease, however,  if PMI can be reduced, these clinical outcomes would be ex - pected to improve.",Non-OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
https://doi.org/10.3349/ymj.2017.58.1.99an increase in the SB ostial lumen area at 9-months follow-up.,OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
104Paclitaxel-Coated Balloon and Peri-Procedural MI https://doi.org/10.3349/ymj.2017.58.1.9985 Suppl 1:696-705.,Non-OADS,/arxiv_data1/oa_pdf/46/2e/ymj-58-99.PMC5122659.pdf
"The Definition of Obesity Soo Young Kim Department of Family Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Koreahttps://doi.org/10.4082/kjfm.2016.37.6.309   Korean J Fam Med 2016;37:309 Editorial eISSN: 2092-6715 The World Health Organization (WHO) Regional Office for the  Western Pacific Region has suggested body mass index (BMI) standards that differ from those used in Europe and North America: normal, 18.5–22.9 kg/m 2; overweight, 23–24.9 kg/m2;  moderate obesity, 25–29.9 kg/m2; and severe obesity, ≥30 kg/ m2.1) The Korean Society for the Study of Obesity has adopted  this definition.2) Recently, there has been controversy over the  definition of obesity, as some medical professionals feel that this standard is too low.",Non-OADS,/arxiv_data1/oa_pdf/4b/ed/kjfm-37-309.PMC5122660.pdf
Available from: http://www.wpro.who.int/nutrition/documents/Redefining_obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/4b/ed/kjfm-37-309.PMC5122660.pdf
"Keywords:  Nephropathy; Analgesics; Renal Insufficiency Received: June 30, 2016, Revised: August 11, 2016, Accepted: August 24, 2016 *Corresponding Author:  Julian Yaxley  Tel: +61-420808049, Fax: +61-738837528, E-mail: julianyaxley@yahoo.com.auhttps://doi.org/10.4082/kjfm.2016.37.6.310   Korean J Fam Med 2016;37:310-316 Review Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
Julian Yaxley   Analgesic Nephropathy https://doi.org/10.4082/kjfm.2016.37.6.310www.kjfm.or.kr   311 INTRODUCTION Analgesic nephropathy (AN) is a form of chronic renal insufficiency  caused by long-term regular ingestion of one or more analgesic medi-cations.,Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
"Julian Yaxley   Analgesic Nephropathy 312  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.310 merular filtration rate (GFR) or albuminuria (OR, 1.21; 95% CI, 0.87 to  1.67 and OR, 1.13; 95% CI, 0.92 to 1.40, respectively).",Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
"Julian Yaxley   Analgesic Nephropathy https://doi.org/10.4082/kjfm.2016.37.6.310www.kjfm.or.kr   313  Mixtures containing both paracetamol and aspirin are associated  with greater renal toxicity than either agent used alone.35,36) This was  confirmed in a Belgian prospective controlled study of 400 primary care patients followed for seven years between 1984–1992.",Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
"Julian Yaxley   Analgesic Nephropathy 314  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.310 95% CI, 1.04 to 1.53).43) Several smaller cohort and case control studies  have supported these findings.44) DISCUSSION The development of renal insufficiency as a consequence of chronic analgesic consumption remains unproven despite a large body of epi-demiologic research.",Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
Julian Yaxley   Analgesic Nephropathy https://doi.org/10.4082/kjfm.2016.37.6.310www.kjfm.or.kr   315 dence.,Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
Julian Yaxley   Analgesic Nephropathy 316  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.310 prevalence of albuminuria and reduced GFR in US adults.,Non-OADS,/arxiv_data1/oa_pdf/3c/04/kjfm-37-310.PMC5122661.pdf
"Keywords:  Body Mass Index; Mortality; Aged; South Korean; Women Received: March 15, 2016, Revised: May 6, 2016, Accepted: May 24, 2016 *Corresponding Author:  Byung Sung Kim  Tel: +82-2-958-8700, Fax: +82-2-958-8699, E-mail: byungskim@naver.com *Corresponding Author:  Chang Won Won  Tel: +82-2-958-8700, Fax: +82-2-958-8699, E-mail: chunwon62@naver.comhttps://doi.org/10.4082/kjfm.2016.37.6.317   Korean J Fam Med 2016;37:317-322 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
"  BMI and Mortality according to Gender in a Community-Dwelling Elderly Population 318  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.317 INTRODUCTION Over the past five decades, obesity has become a major cause of in- creased healthcare costs and decreased quality of life in many coun-tries.",Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
"  BMI and Mortality according to Gender in a Community-Dwelling Elderly Population https://doi.org/10.4082/kjfm.2016.37.6.317www.kjfm.or.kr   319 equivalents [METs] in mL·kg-1·min-1) for light, moderate, and vigorous  intensity activity: 3.3, 4.0, and 8.0 METs, respectively.",OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
  BMI and Mortality according to Gender in a Community-Dwelling Elderly Population 320  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.317 6) Education Education was classified as education for at least 8 years or education  for less than 8 years.,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
"  BMI and Mortality according to Gender in a Community-Dwelling Elderly Population https://doi.org/10.4082/kjfm.2016.37.6.317www.kjfm.or.kr   321 utes per week: 2.6% vs. 6.7%, P<0.001), were more dependent in terms  of instrumental daily activities (K-IADL score ≥11: 45.1% vs. 23.2%, P<0.001), and had the highest score for symptoms of depression (GDS score ≥8, 37.6% vs. 24.6%, P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
  BMI and Mortality according to Gender in a Community-Dwelling Elderly Population 322  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.317 2.,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
Available from: http://www.wpro.who.int/nutrition/documents/Redefining_obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/kjfm-37-317.PMC5122662.pdf
"Keywords:  Alcohol Drinking; Surveys and Questionnaires; Drinkin g; Diagnostic and Statistical Manual of Mental  Disorders, Fifth Edition Received: March 10, 2016, Revised: May 25, 2016, Accepted: May 26, 2016 *Corresponding Author:  Jong Sung Kim  Tel: +82-42-280-8172, Fax: +82-42-280-7879, E-mail: jskim@cnuh.co.krhttps://doi.org/10.4082/kjfm.2016.37.6.323   Korean J Fam Med 2016;37:323-328 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
"  Validity of AUDIT-KR for Screening AUD according to DSM-5 324  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.323 INTRODUCTION Many questionnaires have been designed for the early detection of al- cohol use disorder (AUD), including the Alcohol Use Disorder Identifi-cation Test (AUDIT), developed by the World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
  Validity of AUDIT-KR for Screening AUD according to DSM-5 https://doi.org/10.4082/kjfm.2016.37.6.323www.kjfm.or.kr   325 gard to screening for AUD was 0.884 (0.840−0.920) for male subjects  and 0.962 (0.923−0.985) for female subjects (Figure 1).,OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
  Validity of AUDIT-KR for Screening AUD according to DSM-5 326  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.323 5 diagnostic criteria for classifying the AUD and non-AUD groups.,Non-OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
  Validity of AUDIT-KR for Screening AUD according to DSM-5 https://doi.org/10.4082/kjfm.2016.37.6.323www.kjfm.or.kr   327 ful Alcohol Consumption--II.,Non-OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
  Validity of AUDIT-KR for Screening AUD according to DSM-5 328  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.323 Appendix 2.,Non-OADS,/arxiv_data1/oa_pdf/a0/67/kjfm-37-323.PMC5122663.pdf
"Keywords:  Beers Criteria; Potentially Inappropriate Medication List; Aged; Prescriptions Received: March 8, 2016, Revised: May 18, 2016, Accepted: July 1, 2016 *Corresponding Author:  Jaekyung Choi  Tel: +82-2-2030-7683, Fax: +82-2-2030-7748, E-mail: cjk@kuh.ac.krhttps://doi.org/10.4082/kjfm.2016.37.6.329   Korean J Fam Med 2016;37:329-333 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
"  Potentially Inappropriate Medications by Beers Criteria in Older Outpatients 330  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.329 INTRODUCTION There has been an unprecedented worldwide increase in the number  of elderly individuals, and this has been referred to as ‘a rapidly aging world.",Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
"  Potentially Inappropriate Medications by Beers Criteria in Older Outpatients https://doi.org/10.4082/kjfm.2016.37.6.329www.kjfm.or.kr   331 RESULTS Of the 25,880 total outpatients, 25,810 outpatients were enrolled in the  study after excluding 70 based on the exclusion criteria described in the methods.",Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
"  Potentially Inappropriate Medications by Beers Criteria in Older Outpatients 332  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.329 factors, there is a general consensus on the association between multi- ple medications and PIM use.",Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
  Potentially Inappropriate Medications by Beers Criteria in Older Outpatients https://doi.org/10.4082/kjfm.2016.37.6.329www.kjfm.or.kr   333 medication use by the elderly: an update.,Non-OADS,/arxiv_data1/oa_pdf/23/5a/kjfm-37-329.PMC5122664.pdf
"Keywords:  Leukocytes; Mitochondria; DNA Copy Number; Exercise; Postmenopausal Received: June 16, 2016, Revised: September 20, 2016, Accepted: September 30, 2016 *Corresponding Author:  Jung-Ha Kim  Tel: +82-2-6299-1891, Fax: +82-2-6299-2064, E-mail: girlpower219@cau.ac.krhttps://doi.org/10.4082/kjfm.2016.37.6.334   Korean J Fam Med 2016;37:334-339 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
" Increased Leukocyte Mitochondrial DNA Copy Number in Postmenopausal Women with Regular Exercise https://doi.org/10.4082/kjfm.2016.37.6.334www.kjfm.or.kr   335 INTRODUCTION Mitochondria provide energy for cellular processes by generating ade- nosine 5-triphosphate (ATP) via the electron transport chain.1) Addi- tionally, they are important in the regulation of immune responses to both pathogenic infections and oxidative stress, 2) and they are essen- tial for the maintenance of homeostatic mechanisms such as cell sur-vival, redox signaling, and death.",Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
  Increased Leukocyte Mitochondrial DNA Copy Number in Postmenopausal Women with Regular Exercise 336  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.334 of polymerase chain reaction cycles needed to produce 20 ng of DNA  product.,Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
" Increased Leukocyte Mitochondrial DNA Copy Number in Postmenopausal Women with Regular Exercise https://doi.org/10.4082/kjfm.2016.37.6.334www.kjfm.or.kr   337 sociated with mtDNA copy number ( =0.25, P<0.01) after adjusting for  age, BMI, WHR, systolic and diastolic blood pressure, HDL cholesterol level, triglyceride level, HOMA-IR, and homocysteine level.",Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
"  Increased Leukocyte Mitochondrial DNA Copy Number in Postmenopausal Women with Regular Exercise 338  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.334 ship between regular exercise and leukocyte mtDNA copy number, a  proxy for mitochondrial function, in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
Available from: http://www.cdc.gov/physicalactivity/downloads/pa_fact_sheet_adults.pdf.,OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
https://doi.org/10.18632/oncotarget.10325.,Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
 Increased Leukocyte Mitochondrial DNA Copy Number in Postmenopausal Women with Regular Exercise https://doi.org/10.4082/kjfm.2016.37.6.334www.kjfm.or.kr   339 tochondrial function by adipose triglyceride lipase-mediated lipolysis.,Non-OADS,/arxiv_data1/oa_pdf/38/a0/kjfm-37-334.PMC5122665.pdf
"Keywords:  Medical Students; Clinical Clerkship; Primary Health Care; Community Medicine Received: February 17, 2016, Revised: June 7, 2016, Accepted: June 7, 2016 *Corresponding Author:  Eal Whan Park  Tel: +82-41-550-3997, E-mail: ewpark@dku.eduhttps://doi.org/10.4082/kjfm.2016.37.6.340   Korean J Fam Med 2016;37:340-345 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
Eal Whan Park   Medical Students’ Satisfaction with Family Medicine Clerkship https://doi.org/10.4082/kjfm.2016.37.6.340www.kjfm.or.kr   341 INTRODUCTION Effective teaching of family medicine to medical students requires not  only lecturing on core knowledge b ut also the use of clinical clerkships.,Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
Eal Whan Park   Medical Students’ Satisfaction with Family Medicine Clerkship 342  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.340 RESULTS 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
"Eal Whan Park   Medical Students’ Satisfaction with Family Medicine Clerkship https://doi.org/10.4082/kjfm.2016.37.6.340www.kjfm.or.kr   343 back pain (55.3%), and functional gastrointestinal disorder (52.6%)  (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
"Eal Whan Park   Medical Students’ Satisfaction with Family Medicine Clerkship 344  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.340 for the clerkship was 4.6±0.5, while that for the item concerning stu- dents’ understanding of the clerkship’s evaluation criteria was 3.6±1.0 (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
Eal Whan Park   Medical Students’ Satisfaction with Family Medicine Clerkship https://doi.org/10.4082/kjfm.2016.37.6.340www.kjfm.or.kr   345 relationship.,Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
Med Educ Online 2012;17. http://dx.doi.org/10.3402/meo.v17i0.18899.,Non-OADS,/arxiv_data1/oa_pdf/a9/bc/kjfm-37-340.PMC5122666.pdf
"Keywords:  Osteoporosis; Screening Index; Predictive Index for Osteoporosis; Osteoporosis Self-Assessment Tool  for Asians Received: March 27, 2016, Revised: April 19, 2016, Accepted: April 27, 2016 *Corresponding Author:  Mi Hee Kong  Tel: +82-64-717-8221, Fax: +82-64-717-8220, E-mail: toy827@hanmail.nethttps://doi.org/10.4082/kjfm.2016.37.6.346   Korean J Fam Med 2016;37:346-350 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
"  New Index for Osteoporosis https://doi.org/10.4082/kjfm.2016.37.6.346www.kjfm.or.kr   347 INTRODUCTION Osteoporosis patients have a high risk of fracture, which increases  morbidity and mortality.1) The prevalence of osteoporosis increases  with aging and is especially hi gh in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
  New Index for Osteoporosis 348  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.346 specificity)2} was used to determine the cut-off point for the PIO and  OSTA indices.,OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
"  New Index for Osteoporosis https://doi.org/10.4082/kjfm.2016.37.6.346www.kjfm.or.kr   349 DISCUSSION The results of this study indicated that the easily calculated PIO was a  valid predictive index that can be used in Korean men 50–69 years of age to classify the risk of osteoporosis and to select candidates suitable for DXA.To overcome the single-center, small-sample-size limitations of our previous study, we analyzed data obtained from KNHANES in this study.",Non-OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
  New Index for Osteoporosis 350  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.346 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
Available from: http://nof.org/files/nof/public/content/file/344/upload/139.pdf.,OADS,/arxiv_data1/oa_pdf/43/da/kjfm-37-346.PMC5122667.pdf
"Keywords:  Afatinib; Acute Fatal Pneumonitis; Metastatic Lung Adenocarcinoma Received: January 19, 2016, Revised: February 22, 2016, Accepted: March 3, 2016 *Corresponding Author:  Young Jun Yang  Tel: +82-42-220-9100, Fax: +82-42-220-9037, E-mail: yyj7009@daum.net †These authors contributed equally to this work.https://doi.org/10.4082/kjfm.2016.37.6.351   Korean J Fam Med 2016;37:351-355 Case Report eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/8b/1e/kjfm-37-351.PMC5122668.pdf
  Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma 352  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.351 INTRODUCTION Lung cancer is the leading cause of death due to malignancy.,Non-OADS,/arxiv_data1/oa_pdf/8b/1e/kjfm-37-351.PMC5122668.pdf
  Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma https://doi.org/10.4082/kjfm.2016.37.6.351www.kjfm.or.kr   353 C DA B Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/8b/1e/kjfm-37-351.PMC5122668.pdf
"  Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma 354  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.351 and sputum study tests for pneumocystis pneumonia and viral pneu- monia, which are frequently found in immune-depressed patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/1e/kjfm-37-351.PMC5122668.pdf
  Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma https://doi.org/10.4082/kjfm.2016.37.6.351www.kjfm.or.kr   355 mous cell carcinoma of the lung (LUX-Lung 8): an open-label ran- domised controlled phase 3 trial.,Non-OADS,/arxiv_data1/oa_pdf/8b/1e/kjfm-37-351.PMC5122668.pdf
"Keywords:  Rhabdomyolysis; Stationary Cycling; Acute Kidney Injury Received: March 27, 2016, Revised: March 27, 2016, Accepted: March 28, 2016 *Corresponding Author:  Hyuk-Jung Kweon  Tel: +82-43-840-8660, Fax: +82-43-840-8962, E-mail: fmkhj@korea.comhttps://doi.org/10.4082/kjfm.2016.37.6.356   Korean J Fam Med 2016;37:356-358 Case Report eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/f3/38/kjfm-37-356.PMC5122669.pdf
"  Exertioal Rhabdomyolyis after Spinning https://doi.org/10.4082/kjfm.2016.37.6.356www.kjfm.or.kr   357 INTRODUCTION Rhabdomyolysis may occur when muscles are overworked.1) Although  several cases of exercise-related rhabdomyolysis have been docu-mented, exertional rhabdomyolysis due to stationary cycling is seldom reported.",Non-OADS,/arxiv_data1/oa_pdf/f3/38/kjfm-37-356.PMC5122669.pdf
"  Exertioal Rhabdomyolyis after Spinning 358  www.kjfm.or.kr https://doi.org/10.4082/kjfm.2016.37.6.356 ues that signify a significant risk for renal failure.8) Patients with peak  CPK levels <15,000–20,000 IU on admission are generally at low risk of acute kidney injury, although CPK levels as low as 5,000 IU have been associated with renal failure.",Non-OADS,/arxiv_data1/oa_pdf/f3/38/kjfm-37-356.PMC5122669.pdf
Available from: http://www.clinicaladvis or.com/muscle-soreness-ina- fit-young-woman/article/136126/.,Non-OADS,/arxiv_data1/oa_pdf/f3/38/kjfm-37-356.PMC5122669.pdf
"Long-Term Use of Escitalopram and a  High Level of Carcinoembryonic Antigen Mehmet Emin Ceylan, Alper Evrensel*, Barı ş Önen Ünsalver Department of Psychiatry, Uskudar University, İstanbul, Turkey Received: June 3, 2016, Accepted: June 7, 2016 *Corresponding Author: Alper Evrensel  Tel: +90-2122701292, Fax: +90-2122701719, E-mail: alperevrensel@gmail.comhttps://doi.org/10.4082/kjfm.2016.37.6.359   Korean J Fam Med 2016;37:359 Letter eISSN: 2092-6715 To the Editor Escitalopram is a commonly used antidepressant.",Non-OADS,/arxiv_data1/oa_pdf/24/69/kjfm-37-359.PMC5122670.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/main.PMC5122693.pdf
After  the  cur- http://dx.doi.org/10.1016/j.ejro.2016.10.001 2352-0477/© 2016  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/main.PMC5122693.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/main.PMC5122693.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/62/main.PMC5122695.pdf
http://dx.doi.org/10.1016/j.ejro.2016.11.001 2352-0477/© 2016  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/3b/62/main.PMC5122695.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/62/main.PMC5122695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/25/main.PMC5122699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/25/main.PMC5122699.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.013Urology Case Reports 10 (2017) 26 e29,Non-OADS,/arxiv_data1/oa_pdf/5e/25/main.PMC5122699.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HLAclass I Lak populationAnthropologyImmunology Iran 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/27/main.PMC5122700.pdf
http://dx.doi.org/10.1016/j.gdata.2016.11.012 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ec/27/main.PMC5122700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/27/main.PMC5122700.pdf
9 (2016) 2483 –2486 http://jchps.com/issues/jchps%209(4)%20140%20Seyyed%20Amir% 208%202483-2486.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/27/main.PMC5122700.pdf
(2014) ( https://www.hindawi.com/ journals/jir/2014/565296/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/27/main.PMC5122700.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"A  10-year-old male  with  a  history  of  hydrocephalus  and  3  prior  VP  shunt  place- ments,  presented  to  El  Paso  Children’s  Hospital  emergency  room (an  academic,  tertiary  care  hospital)  with  several  days  of  wors- http://dx.doi.org/10.1016/j.ijscr.2016.11.002 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"140  (2016)  26–32,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"4  (2009)  122–123,  http://dx.doi.org/10.4103/1817-1745.",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"115  (2013)  1918–1919,  http://dx.doi.org/10.1016/j.clineuro.2013.",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"Case Rep.  6c  (2015)  198–202,  http://dx.doi.org/10.1016/j.ijscr.2014.09.032 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"[8]  S.S.  Panda,  A.  Singh,  M.  Bajpai,  N.  Sharma,  Shunt  in  scrotum:  unusual complication in operated cases of hydrocephalus,  BMJ  Case  Rep.  2013  (2013), http://dx.doi.org/10.1136/bcr-2013-201854 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"Julian,  Migration  of  a  fractured ventriculoperitoneal  shunt  into  the  scrotum:  a  rare  complication,  BMJ  Case Rep.  2013  (2013),  http://dx.doi.org/10.1136/bcr-2013-200609 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"40  (2004)  257–258,  http://dx.doi.org/10.1159/ 000082304 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"[16]  A.  Despot,  A.T.  Luetic,  Letter  to  the  editor:  ultrasound  detection  of  the disconnected  distal  catheter  of  a  ventriculoperitoneal  shunt  in  the  pelvic region,  Ultraschall  in  der  Medizin  (Stuttgart,  Germany:  1980)  36  (2015)  393, http://dx.doi.org/10.1055/s-0034-1399720 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"Case  Rep.  20  (2016)  60–62,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"22  (2015) 771–773, http://dx.doi.org/10.1016/j.jocn.2014.10.020 .",OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"8  (2015) 95–97,  http://dx.doi.org/10.1111/ases.12157 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"45 (2009)  78–80,  http://dx.doi.org/10.1159/000204909 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"(2016),  http://dx.doi.org/10.1016/j.wneu.2016.05.024 .",OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"120  (2014)  164–166,  http://dx.doi.org/10.3171/ 2013.6.jns121768 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"Case  Rep.  7 (2013)  1–8,  http://dx.doi.org/10.3941/jrcr.v7i9.1243 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"107  (2007)  156–158,  http://dx.doi.org/10.3171/ ped-07/08/156 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"(London,  England)  27 (2016)  187–189, http://dx.doi.org/10.1016/j.ijsu.2016.01.094 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"50  (2015) 1898–1902, http://dx.doi.org/10.1016/j.jpedsurg.2015.07.001 .",Non-OADS,/arxiv_data1/oa_pdf/d1/75/main.PMC5122702.pdf
"Published by Elsevier Inc. on behalf of Neoplasia Press, Inc..This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ad/89/main.PMC5122704.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.10.001,OADS,/arxiv_data1/oa_pdf/ad/89/main.PMC5122704.pdf
Supplementary Material Supplementary Material to this article can be found online at http://dx.doi.org/10.1016/j.neo.2016.10.001 .,Non-OADS,/arxiv_data1/oa_pdf/ad/89/main.PMC5122704.pdf
"Nat Commun, 4. http://dx.doi.org/10.1038/ncomms.3516 .",Non-OADS,/arxiv_data1/oa_pdf/ad/89/main.PMC5122704.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8, 23–32 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.10.006 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/98/6f/main.PMC5122705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/6f/main.PMC5122705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/98/6f/main.PMC5122705.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.005 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/43/9f/main.PMC5122708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/9f/main.PMC5122708.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/43/9f/main.PMC5122708.pdf
Facts About Physical Activity 2014; http://www.cdc.gov/physicalactivity/data/facts.,OADS,/arxiv_data1/oa_pdf/43/9f/main.PMC5122708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/c1/main.PMC5122709.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.09.004,Non-OADS,/arxiv_data1/oa_pdf/77/c1/main.PMC5122709.pdf
"479© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Primary Follicular Lymphoma of the Duodenum: A Case Report Jin Roh · Jooryung Huh · Chan-Sik Park Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaJournal of Pathology and Translational Medicine 2016; 50: 479-481 https://doi.org/10.4132/jptm.2016.01.27▒ BRIEF CASE REPORT ▒ Follicular lymphoma (FL) is a neoplasm of the germinal center  B-cells and usually involves lymph nodes.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/jptm-2016-01-27.PMC5122722.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.01.27480     •  Roh J, et al.",OADS,/arxiv_data1/oa_pdf/44/d1/jptm-2016-01-27.PMC5122722.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.01.27Primary Follicular Lymphoma of the Duodenum   •     481 tures of duodenal follicular lymphoma and other whitish lesions.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/jptm-2016-01-27.PMC5122722.pdf
"482pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Goblet Cell Carcinoid of the Rectum in a Patient   with Neurofibromatosis Type 1 Youngjin Kang · Jung-Woo Choi · Younghye Kim · Hwa Eun Oh · Ju-Han Lee · Young-Sik Kim Department of Pathology, Korea University Ansan Hospital, Ansan, KoreaJournal of Pathology and Translational Medicine 2016; 50: 482-485 https://doi.org/10.4132/jptm.2016.02.27▒ BRIEF CASE REPORT ▒ Patients with neurofibromatosis type 1 (NF-1) have rarely  been reported to present with intraabdominal tumors including  neuroendocrine tumors (NETs) and gastrointestinal stromal  tumor (GIST), besides diagnostic features of café au lait macules,  axillary or inguinal freckling, optic nerve gliomas, Lisch nodules,  or neurofibromas.1 Specifically, the co-existence of periampullary  NET and GIST has been suggested to be an indirect evidence  for undisclosed NF-1.",Non-OADS,/arxiv_data1/oa_pdf/99/dc/jptm-2016-02-27.PMC5122723.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.02.27Rectal Goblet Cell Carcinoid in NF-1   •     483 whereas NETs initiate from subepithelial neuroendocrine cells  in the mucosa.4 Moreover, the neuroendocrine cells of GCC are  considerably fewer than those of NETs.",Non-OADS,/arxiv_data1/oa_pdf/99/dc/jptm-2016-02-27.PMC5122723.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.02.27484     •  Kang Y, et al.",OADS,/arxiv_data1/oa_pdf/99/dc/jptm-2016-02-27.PMC5122723.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.02.27Rectal Goblet Cell Carcinoid in NF-1   •     485 Pathol 2012; 5: 852-62.,Non-OADS,/arxiv_data1/oa_pdf/99/dc/jptm-2016-02-27.PMC5122723.pdf
"469© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 A Case of Malignant PEComa of the Uterus Associated with Intramural  Leiomyoma and Endometrial Carcinoma Yoo Jin Choi · Jin Hwa Hong1  Aeree Kim · Hankyeom Kim  Hyeyoon Chang Departments of Pathology and 1Obsterics and  Gynecology, Korea University Guro Hospital,   Korea University College of Medicine, Seoul,  KoreaPerivascular epithelioid cell tumors (PEComas) refers to a family of mesenchymal neoplasms  composed of angiomyolipomas, clear cell “sugar” tumors of the lung, and lymphangioleiomyo - matoses.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
"Key Words:  Immunihistochemistry; Perivascular epithelioid cell neoplasms; UterusReceived:  February 12, 2016 Revised:  March 24, 2016 Accepted:  April 20, 2016 Corresponding Author Hyeyoon Chang, MD, PhD Department of Pathology, Korea University Guro  Hospital, Korea University College of Medicine,   148 Gurodong-ro, Guro-gu, Seoul 08308, Korea  Tel: +82-2-2626-3255 Fax: +82-2-2626-1486 E-mail: breakfree83@hanmail.netJournal of Pathology and Translational Medicine 2016; 50: 469-473 https://doi.org/10.4132/jptm.2016.04.20▒ CASE STUDY ▒ Perivascular epithelioid cell tumors (PEComas) have a distinc - tive and common component of perivascular epithelioid cells  that show an association with blood vessel walls and immuno - histochemically display myomelanocytic differentiation.1-4 In this  report, we present a unique case of a malignant uterine PEComa  infiltrating a preexisting intramural leiomyoma with synchro - nous well differentiated endometrial carcinoma and multiple liver  and lung metastases.",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.20470     •  Choi YJ, et al.",OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.20PEComa Infiltrating Myoma with Endometrial Cancer   •     471 The differential diagnosis of uterine PEComa includes uterine  smooth muscle tumor, endometrial stromal tumor, gastrointes - tinal stromal tumor (GIST) with secondary involvement of the  uterus, and other sarcomas such as alveolar soft part sarcoma  (ASPS).",Non-OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.20472     •  Choi YJ, et al.",OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.20PEComa Infiltrating Myoma with Endometrial Cancer   •     473 mor (PEComa) of the uterus with late renal and pulmonary metas - tases: a case report with review of the literature.,Non-OADS,/arxiv_data1/oa_pdf/9e/ae/jptm-2016-04-20.PMC5122724.pdf
"474pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Case of Giant Colonic Muco-submucosal Elongated   Polyps Associated with Intussusception Joo Heon Kim · Seung Yun Lee   Je Ho Jang1 · Hyun Young Han2  Dong Wook Kang Departments of Pathology, 1Surgery, and   2Radiology, Eulji University Hospital, Daejeon,  KoreaColonic muco-submucosal elongated polyp (CMSEP), a newly categorized non-neoplastic  colorectal polyp, is a pedunculated and elongated polyp composed of normal mucosal and sub - mucosal layers without any proper muscle layer.",Non-OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
"Key Words:  Non-neoplastic colorectal polyps; Colonic muco-submucosal elongated polyp; Intus - susceptionReceived:  February 27, 2016 Revised:  April 3, 2016 Accepted:  April 27, 2016 Corresponding Author Dong Wook Kang, MD  Department of Pathology, Eulji University Hospital,  95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea Tel: +82-42-611-3454 Fax: +82-42-611-3459  E-mail: astrias@eulji.ac.krJournal of Pathology and Translational Medicine 2016; 50: 474-478 https://doi.org/10.4132/jptm.2016.04.27▒ CASE STUDY ▒ The term polyp in the gastrointestinal tract is a nonspecific  clinical term, broadly utilized when referring to any localized  elevation above the surrounding mucosa regardless of its histo - logic nature, and can be categorized as neoplastic and non-neo - plastic polyps.",Non-OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.27Colonic Muco-submucosal Elongated Polyp with Intussusception   •     475 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.27476     •  Kim JH, et al.",OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.27Colonic Muco-submucosal Elongated Polyp with Intussusception   •     477 prolapse polyps in patients with mucosal prolapse syndrome  (MPS).,Non-OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.04.27478     •  Kim JH, et al.",OADS,/arxiv_data1/oa_pdf/af/8e/jptm-2016-04-27.PMC5122725.pdf
"419© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 The Predictive Value of Pathologic Features in Pituitary Adenoma and  Correlation with Pituitary Adenoma Recurrence Jee Soon Kim · Youn Soo Lee  Min Jung Jung1 · Yong Kil Hong2 Department of Hospital Pathology,   College of Medicine, The Catholic University  of Korea, Seoul;  1Department of Hospital  Pathology, Soonchunhyang University Hospital,  Bucheon; 2Department of Neurosurgery,   College of Medicine, The Catholic University   of Korea, Seoul, KoreaBackground:  The 2004 World Health Organization classification introduced atypical pituitary ade- noma (aPA), which was equivocally defined as invasion with increased mitotic activity that had a  Ki-67 labeling index (LI) greater than 3%, and extensive p53 immunoreactivity.",Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
"Key Words:  Pituitary neoplasms; Recurrence; Ki-67 antigen; Tumor suppressor protein p53Received: April 29, 2016 Revised: June 10, 2016Accepted: June 30, 2016 Corresponding Author Youn Soo Lee, MD, PhDDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, KoreaTel: +82-2-2258-1626Fax: +82-2-2258-1628E-mail: lys9908@catholic.ac.krJournal of Pathology and Translational Medicine 2016; 50: 419-425 https://doi.org/10.4132/jptm.2016.06.30▒ ORIGINAL ARTICLE ▒ Pituitary adenomas (PAs) are defined as adenomas that are  derived from adenohypophyseal cells in the sella turcica.1 PAs  account for more than 10% of all intracranial tumors2 and are  relatively common.3,4 Clinically, PAs are classified into nonfunc- tioning and functioning.",Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30420     •  Kim JS, et al.",OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30Predictive Value in Pituitary Adenoma   •     421 statistical software ver.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30422     •  Kim JS, et al.",OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30Predictive Value in Pituitary Adenoma   •     423 with other patients.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30424     •  Kim JS, et al.",OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.06.30Predictive Value in Pituitary Adenoma   •     425 of endocrine organs.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
https://doi.org/10.1097/PAI.0000000000000303.,Non-OADS,/arxiv_data1/oa_pdf/56/4d/jptm-2016-06-30.PMC5122726.pdf
"442pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Detection of Human Papillomavirus in Korean Breast Cancer Patients  by Real-Time Polymerase Chain Reaction and Meta-Analysis  of Human Papillomavirus and Breast Cancer Jinhyuk Choi · Chungyeul Kim  Hye Seung Lee · Yoo Jin Choi Ha Yeon Kim · Jinhwan Lee Hyeyoon Chang · Aeree Kim Department of Pathology, Korea University  Guro Hospital, Seoul, KoreaBackground:  Human papillomavirus (HPV) is a well-established oncogenic virus of cervical, ano- genital, and oropharyngeal cancer.",Non-OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"Key Words:  Breast neoplasms; Human papillomavirus; Real-time polymerase chain reaction;   Meta-analysisReceived: April 26, 2016 Revised: June 12, 2016Accepted: July 8, 2016 Corresponding Author Aeree Kim, MD, PhDDepartment of Pathology, Korea University  Guro Hospital, 148 Gurodong-ro, Guro-gu,  Seoul 08308, KoreaTel: +82-2-2626-1741Fax: +82-2-2626-1846E-mail: Ark@korea.ac.krJournal of Pathology and Translational Medicine 2016; 50: 442-450 https://doi.org/10.4132/jptm.2016.07.08▒ ORIGINAL ARTICLE ▒ Human papillomavirus (HPV) is a known oncogenic virus  associated with uterine cervical cancer, anogenital cancer, and  oropharyngeal cancer.",Non-OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08HPV Detection in Breast Cancer by PCR   •     443 MATERIALS AND METHODS Meta-analysis A systematic literature search was conducted in PubMed  (January 1, 1992, to September 30, 2015) with the following  keywords: “breast neoplasm” and “human papillomavirus.” All  potentially relevant studies were reviewed.",Non-OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08444     •  Choi J, et al.",OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08HPV Detection in Breast Cancer by PCR   •     445 Availability of Anyplex II HPV 28 Detection System in FFPE  tissue HPV-16 was detected in the FFPE tissue of uterine cervical squamous cell carcinoma using Anyplex II HPV 28 Detection  System, in concordance with the result of cytology sample using Anyplex II HPV 28 Detection System, proving that Anyplex II  HPV 28 Detection System worked properly for FFPE tissue as  for the cytology specimen.",OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08446     •  Choi J, et al.",OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08HPV Detection in Breast Cancer by PCR   •     447 HPV can play a role in this multistep mammary carcinogenesis.,Non-OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08448     •  Choi J, et al.",OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08HPV Detection in Breast Cancer by PCR   •     449 ise of immunotherapy: a review.,Non-OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.08450     •  Choi J, et al.",OADS,/arxiv_data1/oa_pdf/73/3d/jptm-2016-07-08.PMC5122727.pdf
"436pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Comparison of the FDA and ASCO/CAP Criteria for HER2   Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma Gilhyang Kim1 · Yul Ri Chung1  Bohyun Kim1 · Boram Song1  Kyung Chul Moon1,2 1Department of Pathology,   2Kidney Research Institute, Medical Research  Center, Seoul National University   College of Medicine, Seoul, KoreaBackground:  Human epidermal growth factor receptor 2 (HER2) is one of the known oncogenes  in urothelial carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
"Key Words:  Upper urinary tract urothelial carcinoma; HER2; FDA criteria; ASCO/CAP criteriaReceived:  April 21, 2016 Revised:  July 11, 2016 Accepted:  July 12, 2016 Corresponding Author Kyung Chul Moon, MD Department of Pathology, Kidney Research Institute,  Medical Research Center, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 03080, Korea  Tel: +82-2-740-8380 Fax: +82-2-743-5530 E-mail: blue7270@snu.ac.krJournal of Pathology and Translational Medicine 2016; 50: 436-441 https://doi.org/10.4132/jptm.2016.07.12▒ ORIGINAL ARTICLE ▒ Upper urinary tract urothelial carcinoma (UUTUC), urothelial  carcinoma of the renal pelvis and ureter, is a relatively rare malig - nant tumor, and is known to have a less favorable prognosis because  of its late diagnosis compared with urothelial carcinoma of the  urinary bladder.1-3 Human epidermal growth factor receptor type 2 (HER2) is a  transmembrane receptor tyrosine kinase.4 HER2 protein overex - pression is well known to be associated with poor prognosis in  various cancers, and chemotherapy for HER2 has been established  for breast cancers,5,6 gastric cancers, and gastroesophageal junction  carcinomas.7-9 In HER2 immunohistochemical staining (IHC),  a 3+ HER2 IHC score is regarded as positive, and patients with  breast cancer who have a 3+ HER2 IHC score are eligible for  trastuzumab therapy, but 2+ HER2 IHC score is regarded as an  equivocal result and requires further testing.10,11 Many studies  have attempted to clarify more accurate guidelines for interpreting  HER2 protein expression in various cancers.",Non-OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.12HER2 Expression in UUTCC   •     437 could predict disease progression and disease-related survival in  upper urothelial carcinoma,1,3 but another study could not show  the prognostic significance of HER2 protein expression.2 Further - more, there has been no study comparing the FDA and ASCO/ CAP guidelines in HER2 IHC of UUTUC.",Non-OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.12438     •  Kim G, et al.",OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.12HER2 Expression in UUTCC   •     439 ferent prognostic significance in this study.,Non-OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.12440     •  Kim G, et al.",OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.12HER2 Expression in UUTCC   •     441 UUTUC.,OADS,/arxiv_data1/oa_pdf/43/5e/jptm-2016-07-12.PMC5122728.pdf
"426pISSN 2383-7837 eISSN 2383-7845 © 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Morphological and Functional Changes in the Thyroid Follicles  of the Aged Murine and Humans Junguee Lee · Shinae Yi1  Yea Eun Kang1· Hyeon-Woo Kim1  Kyong Hye Joung1 · Hae Joung Sul  Koon Soon Kim1 · Minho Shong1 Department of Pathology, Daejeon St. Mary’s  Hospital, College of Medicine, The Catholic  University of Korea, Daejeon; 1Division of  Endocrinology, Department of Internal Medicine, Research Center for Endocrine and Metabolic Diseases, Chungnam National University School  of Medicine, Daejeon, KoreaBackground:  Although both thyroid histology and serum concentrations of hormones are known  to change with age, only a few reports exist on the relationship between the age-related structural  and functional changes of the thyroid follicles in both mice and humans.",Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"Key Words:  Aged; Elderly; Thyroid gland; Thyroid hormonesReceived: May 24, 2016 Revised: July 15, 2016Accepted: July 19, 2016 Corresponding Author Junguee Lee, MD, PhDDepartment of Pathology, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, KoreaTel: +82-42-220-9937Fax: +82-42-252-9722E-mail: junguee@catholic.ac.krJournal of Pathology and Translational Medicine 2016; 50: 426-435 https://doi.org/10.4132/jptm.2016.07.19▒ ORIGINAL ARTICLE ▒ The functional unit of the thyroid gland is the thyroid follicle,  which is composed of follicular cells and intrafollicular colloid.",Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19Thyroid Follicles of the Aged Murine and Humans   •     427 MATERIALS AND METHODS Animals and tissue histology Thyroids were excised from C57BL/6 male mice that were  sacrificed at 18 weeks (n = 2), 6 months (n = 2), 15 months (n =  2), or 30 months (n = 2) of age.",Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19428     •  Lee J, et al.",OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19Thyroid Follicles of the Aged Murine and Humans   •     429 with the result of the independent sample t-test.,Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19430     •  Lee J, et al.",OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19Thyroid Follicles of the Aged Murine and Humans   •     431 Fig.,Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19432     •  Lee J, et al.",OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19Thyroid Follicles of the Aged Murine and Humans   •     433 with thyroids from women between 30 and 50 years of age.,Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19434     •  Lee J, et al.",OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.19Thyroid Follicles of the Aged Murine and Humans   •     435 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/03/6e/jptm-2016-07-19.PMC5122729.pdf
"451© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Does Polymerase Chain Reaction of Tissue Specimens Aid  in the Diagnosis of Tuberculosis?",Non-OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"Key Words:  Tuberculosis; Polymerase chain reaction; Mycobacterial culture; Interferon- γ release testsReceived:  May 10, 2016 Revised:  July 25, 2016 Accepted:  August 4, 2016 Corresponding Author Chul Hwan Kim, MD, PhD   Department of Pathology, Korea University Anam  Hospital, 73 Inchon-ro, Seongbuk-gu,  Seoul 02841, Korea  Tel: +82-2-920-5595 Fax: +82-2-920-6576 E-mail: chkap@korea.ac.krJournal of Pathology and Translational Medicine 2016; 50: 451-458 https://doi.org/10.4132/jptm.2016.08.04▒ ORIGINAL ARTICLE ▒ Tuberculosis (TB) is an infectious disease caused by Mycobacterium  tuberculosis  (MTB) that remains one of the world’s most important  health problems due to its high risk of complications, mortality, and  infectivity.",Non-OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04452     •  Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04Detecting TB in Tissue by PCR May Not Be Highly Sensitive, But is a Good Alternative Method   •     453 (к >0.75, excellent agreement; 0.75 ≥ к ≥ 0.40, fair to good  agreement; к< 0.40, poor agreement).",Non-OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04454     •  Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04Detecting TB in Tissue by PCR May Not Be Highly Sensitive, But is a Good Alternative Method   •     455 been included in the section used for PCR.",Non-OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04456     •  Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04Detecting TB in Tissue by PCR May Not Be Highly Sensitive, But is a Good Alternative Method   •     457 diagnosing active TB are 80%–81% and 59%–79%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.04458     •  Lee YJ, et al.",OADS,/arxiv_data1/oa_pdf/7a/41/jptm-2016-08-04.PMC5122730.pdf
"411© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips So-Woon Kim · Jin Roh  Chan-Sik Park Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, KoreaImmunohistochemistry (IHC) is an important auxiliary method for pathologists in routine diagnostic  work as well as in basic and clinical research including exploration of biomarkers, as IHC allows  confirmation of target molecule expressions in the context of microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"Key Words:  Immmunohistochemistry; Antigen-antibody reactions; Immunostain; Auxiliary testReceived: April 18, 2016 Revised: August 5, 2016Accepted: August 8, 2016 Corresponding Author Chan-Sik Park, MDDepartment of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-5838Fax: +82-2-472-7898E-mail: csikpark@amc.seoul.krJournal of Pathology and Translational Medicine 2016; 50: 411-418 https://doi.org/10.4132/jptm.2016.08.08▒ REVIEW ▒ Immunohistochemistry (IHC) is an important auxiliary method  for pathologists as it specifically visualizes distribution and  amount of a certain molecule in the tissue using specific antigen- antibody reaction.",Non-OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08412     •  Kim S-W, et al.",OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08IHC for Pathologists   •     413 cookers, autoclaves, and water baths in varying conditions in- cluding pH 6–10.",Non-OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08414     •  Kim S-W, et al.",OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08IHC for Pathologists   •     415 counterstain should be selected carefully.,Non-OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08416     •  Kim S-W, et al.",OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08IHC for Pathologists   •     417 as provisional cut-offs at first.,Non-OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.08418     •  Kim S-W, et al.",OADS,/arxiv_data1/oa_pdf/80/65/jptm-2016-08-08.PMC5122731.pdf
"405© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Pathogenesis of Focal Segmental Glomerulosclerosis Beom Jin Lim · Jae Won Yang1  Woo Sung Do · Agnes B. Fogo2 Department of Pathology, Yonsei University   College of Medicine, Seoul; 1Department   of Nephrology, Yonsei University Wonju College  of Medicine, Wonju, Korea; 2Department   of Pathology, Microbiology and Immunology,  Vanderbilt University Medical Center, Nashville,  TN, USAFocal segmental glomerulosclerosis (FSGS) is characterized by focal and segmental obliteration  of glomerular capillary tufts with increased matrix.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"Key Words:  Focal segmental glomerulosclerosis; Podocytopathy; Permeability factors; Parietal   epithelial cellsReceived:  August 23, 2016 Accepted:  September 21, 2016 Corresponding Author Agnes B. Fogo, MD MCN C3310, Department of Pathology,  Microbiology and Immunology, Vanderbilt University  Medical Center, Nashville, TN 37232, USA  Tel: +1-615-322-3114 Fax: +1-615-343-7023 E-mail: agnes.fogo@vanderbilt.eduJournal of Pathology and Translational Medicine 2016; 50: 405-410 https://doi.org/10.4132/jptm.2016.09.21▒ REVIEW ▒ Focal segmental glomerulosclerosis (FSGS) typically presents  with nephrotic range proteinuria and, as its name implies, shows  obliteration or collapse of glomerular capillary loops by increased  extracellular matrix in some glomeruli only, and the capillary injury  does not occupy the entire glomerulus involved.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.21406     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.21Pathogenesis of FSGS   •     407 inhibitor.31,32 A phase II clinical trial on therapeutic effect of ga - lactose in patients with steroid-resistant FSGS was performed  with inconclusive results due to small sample size.33,34 This study  design is interesting, considering that CLC-1 has high affinity for  galactose and the CLC-1–galacotse complex can be easily removed  in the liver.30 Though known to be related to minimal change disease rather  than FSGS, angiopoietin-like-4 (Angptl4) is also of interest.35  Angptl4 has different functions according to its sialylation.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.21408     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.21Pathogenesis of FSGS   •     409 adults: course of glomerular lesions and value of the Columbia  classification of histological variants of focal and segmental glo - merulosclerosis (FSGS).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.21410     •  Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/4e/20/jptm-2016-09-21.PMC5122732.pdf
"459© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 CD9 Expression in Colorectal Carcinomas and Its Prognostic Significance Kyung-Ju Kim · Hee Jung Kwon   Min Chong Kim · Young Kyung Bae Department of Pathology, Yeungnam University  College of Medicine, Daegu, KoreaBackground:  CD9, a member of the tetraspanin superfamily, is a tumor suppressor in many  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"Key Words:  Colorectal neoplasms; CD9 antigens; Tetraspanin; PrognosisReceived:  August 8, 2016 Revised:  September 21, 2016 Accepted:  October 2, 2016 Corresponding Author Young Kyung Bae, MD Department of Pathology, Yeungnam University  College of Medicine, 170 Hyeonchung-ro,   Nam-gu, Daegu 42415, Korea  Tel: +82-53-640-6755 Fax: +82-53-622-8432 E-mail: ykbae@ynu.ac.krJournal of Pathology and Translational Medicine 2016; 50: 459-468 https://doi.org/10.4132/jptm.2016.10.02▒ ORIGINAL ARTICLE ▒ Colorectal cancer (CRC) is ranked as the third most common  malignancy by incidence and the fourth most common cause of  cancer-specific death worldwide.1 Although many diagnostic  and therapeutic strategies have been developed recently, the  mortality rate from CRC remains high.2,3 Previous studies have  increased our understanding of genetic alterations involved in  cancer development and molecular subtypes of CRCs, but accurate  prediction of clinical outcomes is still difficult.",Non-OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02460     •  Kim K-J, et al.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02CD9 Expression in Colorectal Cancers   •     461 neoplastic colorectal tissues exhibited strong expression of CD9  throughout the entire samples and were classified as the high  expression group.,Non-OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02462     •  Kim K-J, et al.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02CD9 Expression in Colorectal Cancers   •     463 types, including lung, breast, prostate, stomach, pancreas, and  colon carcinoma.4,20-22 Miyake et al.23 demonstrated that injection  of CD9-transfected melanoma cells suppressed lung metastasis  in a rodent model and Ovalle et al.16 showed that ectopic CD9  expression in a colon cancer cell line resulted in inhibition of cell  growth.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02464     •  Kim K-J, et al.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02CD9 Expression in Colorectal Cancers   •     465Table 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02466     •  Kim K-J, et al.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02CD9 Expression in Colorectal Cancers   •     467 tetraspanin, especially CD9, using monoclonal Abs such as  ALB6 and PAIN13, might be beneficial for cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.10.02468     •  Kim K-J, et al.",OADS,/arxiv_data1/oa_pdf/bd/f1/jptm-2016-10-02.PMC5122733.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ rThe Author(s) 2016 The Supplementary Information that accompanies this paper is available on the Immunology and Cel l Biology website (http://www.nature.com/icb)Defective Rab prenylation in MKD J Jurczyluk et al 999 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/51/bc/icb201658a.PMC5122740.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 269–274 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.001 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/fc/93/main.PMC5122748.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/93/main.PMC5122748.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/fc/93/main.PMC5122748.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 292–298 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.002 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/e2/0f/main.PMC5122749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/0f/main.PMC5122749.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 305–311 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.07.002 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/25/df/main.PMC5122751.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/df/main.PMC5122751.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 248–255 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.09.001 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/79/54/main.PMC5122797.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/54/main.PMC5122797.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 287–291 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.006 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/3b/ee/main.PMC5122799.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/ee/main.PMC5122799.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 312–316 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.003 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/9a/4b/main.PMC5122800.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/4b/main.PMC5122800.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9a/4b/main.PMC5122800.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 299–304 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.09.002 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/5a/26/main.PMC5122801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/26/main.PMC5122801.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 280–286 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.09.005 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/b0/b9/main.PMC5122807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/b9/main.PMC5122807.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 256–261 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.09.003 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/05/94/main.PMC5122808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/94/main.PMC5122808.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 275–279 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.005 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/0b/43/main.PMC5122811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/43/main.PMC5122811.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 262 –268 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.08.004 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/dd/8a/main.PMC5122813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/8a/main.PMC5122813.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 241–247 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.09.004 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC5122814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC5122814.pdf
Methods The SCImago Journal and Country Rank website (http://www.scimagojr.com ) was used to retrieve the list of Scopus /C210indexed Urology journals.,OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC5122814.pdf
Available at: < http://www.scimagojr.com/ > [accessed September 2016].,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC5122814.pdf
Available at: < http://www.icsu.org/publications/ cfrs-statements/bias-in-science-publishing/advisory-note-bias-in-science-publishing > [accessed September 2016].,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC5122814.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Inflammation, a supplement to  Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS779Abstract Background:  We report a case of steroid‑resistant Tolosa–Hunt syndrome (THS)  with recurrent bilateral painful ophthalmoplegia, accompanied with sphenoid  sinusitis, pituitary abscess, and an aneurysm arising from the cavernous portion  of the internal carotid artery.",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/SNI-7-779.PMC5122815.pdf
"http://surgicalneurologyint.com/Steroid-resistant-T olosa-Hunt-syndrome-with-a-de- novo-intracavernous-aneurysm:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/SNI-7-779.PMC5122815.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neurosurgical Developments on the Horizon, a supplement to SNIEditor: Michel Kliot, MD  UCSF Medical Center   San Francisco, CA 94143S801Abstract Background: The recent expansion of three‑dimensional (3D) printing technology  into the field of neurosurgery has prompted a widespread investigation of its utility.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/SNI-7-801.PMC5122816.pdf
"http://surgicalneurologyint.com/3D-printing-in-neurosurgery:-A-systematic-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/SNI-7-801.PMC5122816.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neurosurgical Developments on the Horizon, a supplement to SNIEditor: Michel Kliot, MD  UCSF Medical Center   San Francisco, CA 94143S797Review Article Epigenetic mechanisms drive the progression of neurofibromas  to malignant peripheral nerve sheath tumors Krish Suresh, Tamara Kliot1, Andrea Piunti2, Michel Kliot3  Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA, 1Medical School for International Health, Beersheba, Israel,   Departments of 2Biochemistry and Molecular Genetics, 3Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA E‑mail:  Krish Suresh ‑ krish.suresh@northwestern.edu; Tamara Kliot ‑ tamarakliot@gmail.com; Andrea Piunti ‑ andrea.piunti@northwestern.edu;   *Michel Kliot ‑ michel.kliot@northwestern.edu   *Corresponding author Received: 18 March 16  Accepted: 01 August 16  Published: 14 November 16 Abstract Thinking Outside the Box:  The polycomb repressive complex 2 (PRC2) is a  histone methyltransferase complex known to repress gene expression.",Non-OADS,/arxiv_data1/oa_pdf/07/28/SNI-7-797.PMC5122817.pdf
"http://surgicalneurologyint.com/Epigenetic-mechanisms-drive-the-progression-of- neurofibromas-to-malignant-peripheral-nerve-sheath-tumors/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/07/28/SNI-7-797.PMC5122817.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Socio-Economics, Politics, and Medicine, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS811Recently, I had an experience with one of the negative  manifestations of modern medicine, an event that should  teach us all some important lessons concerning health care.",Non-OADS,/arxiv_data1/oa_pdf/58/b9/SNI-7-811.PMC5122818.pdf
"http://surgicalneurologyint.com/My-experience-with-a-major-hospital-stroke-team- What's-wrong-with-""Modern""-medicine/",Non-OADS,/arxiv_data1/oa_pdf/58/b9/SNI-7-811.PMC5122818.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Epilepsy, a supplement to Surgical Neurology InternationalS775Case Report Cerebral foreign body granuloma in brain triggering generalized  seizures without obvious craniocerebral injury: A  case report and  review of the literature Nina Brawanski1, Peter Baumgarten1,2, Jürgen Konczalla1, Volker Seifert1, Christian Senft1 1Department of Neurosurgery, 2Edinger- Institut of Neuropathology, Goethe-University Hospital, Frankfurt am Main, Germany E-mail: *Nina Brawanski - Nina.Brawanski@kgu.de; Peter Baumgarten - baumgarten.peter2@kgu.de; Jürgen Konczalla - J.Konczalla@med.uni-frankfurt.de;   Volker Seifert - v.seifert@em.uni-frankfurt.de; Christian Senft - c.senft@med.uni-frankfurt.de   *Corresponding author Received: 20 May 16  Accepted: 28 July 16  Published: 11 November 16 Abstract Background:  Intracerebral foreign body granuloma is rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/7b/ba/SNI-7-775.PMC5122819.pdf
"http://surgicalneurologyint.com/Cerebral-foreign-body-granuloma-in-brain- triggering-generalized-seizures-without-obvious-craniocerebral-injury:-A-case- report-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/7b/ba/SNI-7-775.PMC5122819.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Neuromonitoring, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS791Abstract Background:  Intraoperative monitoring of motor evoked potentials by transcranial  electric stimulation is popular in neurosurgery for monitoring motor function  preservation.",Non-OADS,/arxiv_data1/oa_pdf/4a/1c/SNI-7-791.PMC5122820.pdf
"http://surgicalneurologyint.com/Comparison-of-effectiveness-between-cork-screw-and-peg-screw-electrodes-for-transcranial-motor-evoked-potential-monitoring-using-the- finite-element-method/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/4a/1c/SNI-7-791.PMC5122820.pdf
MATERIALS AND METHODS Realistic three‑dimensional head model creation  and electrode placement The realistic 3D head models created in this study were  developed from International Consortium for Brain  Mapping (ICBM) T1‑weighted images obtained from  BrainWeb (http://brainweb.bic.mni.mcgill.ca/).,OADS,/arxiv_data1/oa_pdf/4a/1c/SNI-7-791.PMC5122820.pdf
Available from: http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Flav/Flav3-1.pdf  4.,OADS,/arxiv_data1/oa_pdf/c0/96/RPS-11-355.PMC5122824.pdf
Available at:  http://www.who.int/mediacen tre/factsheets/fs204/en/  2/8/2016.,Non-OADS,/arxiv_data1/oa_pdf/b1/20/RPS-11-366.PMC5122825.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f0/41/10.1177_2325967116672445.PMC5122835.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Neurobiology, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS785Abstract Background:  Ventricular tumors represent a major neurosurgical challenge,  making endoscopic approach an invaluable tool as it gained importance due  to technological advances.",Non-OADS,/arxiv_data1/oa_pdf/27/3a/SNI-7-785.PMC5122836.pdf
"http://surgicalneurologyint.com/Conversion-technique-from-neuroendoscopy-to-microsurgery-in-ventricular-tumors:-T echnical-note/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/27/3a/SNI-7-785.PMC5122836.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/b6/18/srep37810.PMC5122898.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: October 12, 2016 EXTRA  Jaime D. Mondragón, MD   Unidad de Resonancia Magnética   Instituto de Neurobiología, UNAM-Campus Juriquilla   Boulevard Juriquilla 3001, Col Juriquilla, Querétaro 76230 (Mexico)   E-Mail jaimemondragon   @   gmail.com www.karger.com/dee DOI: 10.1159/000449424  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a1/8e/dee-0006-0486.PMC5122988.pdf
"Hospital administrative data combined with physician billing data more than doubled the observed agreement for carotid imaging (k = 0.65) and echocardiography (k = 0.66) compared to hospital administra- Received: November 20, 2016   Accepted after revision: August 4, 2016   Published online: October 18, 2016 EXTRA  Ruth E. Hall   Institute for Clinical Evaluative Sciences   G1 06, 2075 Bayview Avenue    Toronto, ON M4N 3M5 (Canada)   E-Mail Ruth.hall   @   ices.on.ca www.karger.com/cee DOI: 10.1159/000449288  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/7c/5d/cee-0006-0096.PMC5122989.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Received: June 3, 2016   Accepted after revision: August 8, 2016   Published online: Octobre 22, 2016 EXTRA  Andrew Bivard   Department of Neurology, John Hunter Hospital, University of Newcastle   1 Kookaburra Circuit   New Lambton Heights, NSW 2305 (Australia)   E-Mail Andrew.bivard   @   newcastle.edu.au www.karger.com/cee DOI: 10.1159/000450620  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/47/27/cee-0006-0120.PMC5122990.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: October 12, 2016 EXTRA  Inga Strand Thorsen   Department of Internal Medicine   Stavanger University Hospital   PB 8100, NO–4068 Stavanger (Norway)   E-Mail inga.strand   @   gmail.com/ings   @   sus.no www.karger.com/nne DOI: 10.1159/000450621  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/6d/63/nne-0006-0031.PMC5122995.pdf
http://www.nephro.no/nnr/AARSM2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6d/63/nne-0006-0031.PMC5122995.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: October 21, 2016 EXTRA  Giovanna Zamboni, MD, PhD   FMRIB Centre, Nuffield Department of Clinical Neuroscience   University of Oxford, John Radcliffe Hospital   Oxford, OX3 9DU (UK)   E-Mail giovanna.zamboni   @   ndcn.ox.ac.uk www.karger.com/dee DOI: 10.1159/000450546  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1c/f3/dee-0006-0518.PMC5123022.pdf
Padma Srivastava    Department of Neurology   All India Institute of Medical Sciences   New Delhi 110029 (India)   E-Mail vasanthapadma123   @   gmail.com www.karger.com/cee DOI: 10.1159/000446404  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).,Non-OADS,/arxiv_data1/oa_pdf/e3/e3/cee-0006-0107.PMC5123023.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: October 12, 2016 EXTRA  Marlijn H. de Beer, MD    Department of Neurology and Alzheimer Center    VU University Medical Center and Neuroscience Campus Amsterdam    De Boelelaan 1118, NL–1081 HZ Amsterdam (The Netherlands)   E-Mail M.deBeer   @   hagaziekenhuis.nl  www.karger.com/dee DOI: 10.1159/000450547  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/55/55/dee-0006-0500.PMC5123026.pdf
"APT E42   Berkeley, CA 94704 (USA)   E-Mail shai73   @   gmail.com www.karger.com/dee DOI: 10.1159/000449130  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/78/3e/dee-0006-0508.PMC5123027.pdf
2000. http://www.loni.ucla.edu/ ∼ esowell/new_sulcvar.html.,Non-OADS,/arxiv_data1/oa_pdf/78/3e/dee-0006-0508.PMC5123027.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Received: April 6, 2016   Accepted after revision: September 6, 2016   Published online: October 12, 2016 EXTRA  Teruo Kimura, MD, PhD   Department of Neurosurgery, Dohtoh Neurosurgical Hospital    Okhotsk Stroke Medical Center    Miyamacho Higashi 2 68-9, Kitami City, Hokkaido 090-0069 (Japan)   E-Mail tekimura-nsu   @   umin.ac.jp  www.karger.com/cee DOI: 10.1159/000450835  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/36/7f/cee-0006-0084.PMC5123034.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.10.005,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1016/j.oooo.2015.10.031 .,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
"Head Neck 33,7 7–81.http://dx.doi.org/10.1002/hed.21397 .",Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
"Curr Opin Immunol 27,1 6–25.http://dx.doi.org/10.1016/j.coi.2014.",OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1002/cncr.23615 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1002/hed.21607 .,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1002/hed.24406 .,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1093/annonc/mdu450 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1126/science.1129139 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/ 10.1200/JCO.2009.23.7370 .,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-15-1543 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1200/JCO.2008.19.6147 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1158/ 1078-0432.CCR-13-3271 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1038/bjc.2014.446 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1038/nature13954 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-06-0488 .,Non-OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-05-1886 .16 Prognostic Value of TILs in Head and Neck cancer Xu et al.,OADS,/arxiv_data1/oa_pdf/7c/94/main.PMC5123038.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/df/main.PMC5123039.pdf
1936-5233/17 http://dx.doi.org/10.1016/j.tranon.2016.10.004,Non-OADS,/arxiv_data1/oa_pdf/d1/df/main.PMC5123039.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Curriculum doseProcess evaluationAdolescents Fruit and vegetable intake Knowledge of recommendationsTaste preferencesSituational normsSchool-based interventionRCT 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/df/main.PMC5123064.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.009 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/df/main.PMC5123064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/df/main.PMC5123064.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d7/df/main.PMC5123064.pdf
The study has been pre-speci ﬁed as a secondary analysis of Boost intervention data in the trial registry Current Controlled Trials ISRCTN11666034 ( http://www.isrctn.com/ ISRCTN11666034 ).,Non-OADS,/arxiv_data1/oa_pdf/d7/df/main.PMC5123064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/d5/main.PMC5123065.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.11.007 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/aa/d5/main.PMC5123065.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Epiphytic bacteriaLettuceMicrobacterium sp.,Non-OADS,/arxiv_data1/oa_pdf/98/a8/main.PMC5123072.pdf
Direct link to deposited data https://www.ncbi.nlm.nih.gov/nuccore/CP017674 .,OADS,/arxiv_data1/oa_pdf/98/a8/main.PMC5123072.pdf
http://dx.doi.org/10.1016/j.gdata.2016.11.018 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/98/a8/main.PMC5123072.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/a8/main.PMC5123072.pdf
"http://dx.doi.org/10.1016/j.redox.2016.11.010 Received 13 October 2016; Received in revised form 31 October 2016; Accepted 14 November 2016⁎Corresponding authors at: Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Barcelona, Spain.",OADS,/arxiv_data1/oa_pdf/ce/1a/main.PMC5123076.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/main.PMC5123076.pdf
99 (1997) 773– 780. http://dx.doi.org/ 10.1172/JCI119223 .,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/main.PMC5123076.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: miR-15amiR-34cmiR-199bLymph node invasionPerineural invasion 1.,Non-OADS,/arxiv_data1/oa_pdf/53/d0/main.PMC5123084.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.11.001 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/d0/main.PMC5123084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/d0/main.PMC5123084.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2011.02372.x ] [PMID: 22211305 ] [2] Belser UC, Schmid B, Higginbottom F, Buser D. Outcome analysis of implant restorations located in the anterior maxilla: a review of the recent literature.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1999.100301.x ] [PMID: 10522178 ] [6] Fürhauser R, Florescu D, Benesch T, Haas R, Mailath G, Watzek G. Evaluation of soft tissue around single-tooth implant crowns: the pink esthetic score.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2005.01193.x ] [PMID: 16307569 ] [7] Meijer HJ, Stellingsma K, Meijndert L, Raghoebar GM.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2005.01128.x ] [PMID: 16307570 ] [8] Belser UC, Grütter L, Vailati F, Bornstein MM, Weber HP, Buser D. Outcome evaluation of early placed maxillary anterior single-tooth implants using objective esthetic criteria: a cross-sectional, retrospective study in 45 patients with a 2- to 4-year follow-up using pink and white esthetic scores.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1902/jop.2009.080435 ] [PMID: 19228100 ] [9] Vilhjálmsson VH, Klock KS, Størksen K, Bårdsen A. Aesthetics of implant-supported single anterior maxillary crowns evaluated by objective indices and participants perceptions.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2010.02128.x ] [PMID: 21443608 ] [10] Gallucci GO, Grütter L, Nedir R, Bischof M, Belser UC.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2010.01997.x ] [PMID: 21158931 ] [11] den  Hartog  L,  Raghoebar  GM,  Slater  JJ,  Stellingsma  K,  Vissink  A,  Meijer  HJ.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1708-8208.2011.00372.x ] [PMID: 21815991 ] [12] Raes F, Cosyn J, Crommelinck E, Coessens P, De Bruyn H. Immediate and conventional single implant treatment in the anterior maxilla: 1- year results of a case series on hard and soft tissue response and aesthetics.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2010.01687.x ] [PMID: 21272052 ] [13] Cosyn J, Eghbali A, Hanselaer L, et al.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1708-8208.2011.00417.x ] [PMID: 22236111 ] [14] Cosyn J, Eghbali A, De Bruyn H, Dierens M, De Rouck T. Single implant treatment in healing versus healed sites of the anterior maxilla: an aesthetic evaluation.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1708-8208.2010.00300.x ] [PMID: 20662859 ] [15] Noelken R, Kunkel M, Jung BA, Wagner W. Immediate nonfunctional loading of NobelPerfect implants in the anterior dental arch in private practice5-year data.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1708-8208.2012.00449.x ] [PMID: 22376277 ] [16] Evans CD, Chen ST. Esthetic outcomes of immediate implant placements.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.11607/jomi.2560 ] [PMID: 23377074 ] [18] Lai HC, Zhang ZY, Wang F, Zhuang LF, Liu X, Pu YP.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"Long-term Soft Tissue Esthetic Outcomes The Open Dentistry Journal, 2016, Volume 10    609 [http://dx.doi.org/10.1111/j.1600-0501.2008.01522.x ] [PMID: 18474062 ] [19] Cosyn J, Eghbali A, De Bruyn H, Collys K, Cleymaet R, De Rouck T. Immediate single-tooth implants in the anterior maxilla: 3-year results of a case series on hard and soft tissue response and aesthetics.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2011.01748.x ] [PMID: 21752044 ] [20] Felice P, Soardi E, Piattelli M, Pistilli R, Jacotti M, Esposito M. Immediate non-occlusal loading of immediate post-extractive versus  delayed placement  of  single  implants  in  preserved  sockets  of  the  anterior  maxilla:  4-month  post-loading  results  from  a  pragmatic  multicentre randomised controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/jcpe.12049 ] [PMID: 23297745 ] [22] Gu YX, Shi JY, Zhuang LF, Qiao SC, Xu YY, Lai HC.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/clr.12408 ] [PMID: 24750306 ] [23] Nisapakultorn K, Suphanantachat S, Silkosessak O, Rattanamongkolgul S. Factors affecting soft tissue level around anterior maxillary single- tooth implants.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2009.01887.x ] [PMID: 20384705 ] [24] Kan  JY,  Rungcharassaeng  K,  Lozada  JL,  Zimmerman  G.  Facial  gingival  tissue  stability  following  immediate  placement  and provisionalization of maxillary anterior single implants: a 2- to 8-year follow-up.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2012.02486.x ] [PMID: 22540833 ] [26] Small PN, Tarnow DP.",OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
[http://dx.doi.org/10.1097/00008505-200207000-00013 ] [PMID: 12271566 ] © Rokn et al.,OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/39/TODENTJ-10-602.PMC5123127.pdf
"[http://dx.doi.org/10.1902/annals.1996.1.1.816 ] [2] Adell R, Eriksson B, Lekholm U, Brånemark PI, Jemt T. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws.",Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
[http://dx.doi.org/10.1902/jop.2001.72.4.485 ] [PMID: 11338301 ] [5] Isidor F. Loss of osseointegration caused by occlusal load of oral implants.,Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1996.070208.x ] [PMID: 9002833 ] [6] Miyata T, Kobayashi Y, Araki H, Motomura Y, Shin K. The influence of controlled occlusal overload on peri-implant tissue: a histologic study in monkeys.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.2329/perio.39.234 ] [8] Miyata T, Kobayashi Y, Araki H, Ohto T, Shin K. The influence of controlled occlusal overload on peri-implant tissue.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2007.01374.x ] [PMID: 17655715 ] [11] Naert I, Duyck J, Vandamme K. Occlusal overload and bone/implant loss.",Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2012.02550.x ] [PMID: 23062133 ] [12] Kan JP, Judge RB, Palamara JE.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
[http://dx.doi.org/10.1111/clr.12059 ] [PMID: 23067316 ] [13] Merin RL.,OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1111/clr.12009 ] [PMID: 22931471 ] [15] Pihlstrom BL, Anderson KA, Aeppli D, Schaffer EM.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
[http://dx.doi.org/10.1902/jop.1986.57.1.1 ] [PMID: 3484785 ] [16] Tawil G. Peri-implant bone loss caused by occlusal overload: repair of the peri-implant defect following correction of the traumatic occlusion.,Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1992.030302.x ] [PMID: 1290790 ] [19] Escalante Vasquez R. Management of occlusion over implants, Part I: three 10-year case follow-ups and evaluations.",Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2009.01834.x ] [PMID: 20070758 ] [22] Ben-Gal G, Lipovetsky-Adler M, Haramaty O, Sharon E, Smidt A.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2008.00043.x ] [PMID: 18498587 ] [24] Misch CE, Bidez MW.",OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/51/TODENTJ-10-594.PMC5123128.pdf
"[http://dx.doi.org/10.1038/187493a0 ] [2] Verma SK, Maheshwari S, Singh RK, Chaudhari PK.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.4103/0975-5950.111342 ] [PMID: 23833485 ] [3] Lalani N, Foley TF, Voth R, Banting D, Mamandras A. Polymerization with the argon laser: curing time and shear bond strength.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.14219/jada.archive.1971.0267 ] [PMID: 5281161 ] [5] Fuhrmann R, Gutknecht N, Magunski A, Lampert F, Diedrich P. Conditioning of enamel with Nd:YAG and CO2 dental laser systems and with phosphoric acid.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/PL00001943 ] [PMID: 11590826 ] [6] Hibst R, Keller U.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1002/lsm.1900090405 ] [PMID: 2761329 ] [7] Subramaniam P, Pandey A.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.4103/1305-7456.137656 ] [PMID: 25202223 ] [8] Bachmann L, Craievich AF, Zezell DM.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.archoralbio.2004.05.009 ] [PMID: 15353249 ] [9] Hadley J, Young DA, Eversole LR, Gornbein JA.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.14219/jada.archive.2000.0277 ] [PMID: 10860330 ] [10] Ceballos L, Osorio R, Toledano M, Marshall GW.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/S0109-5641(00)00092-0 ] [PMID: 11356211 ] [11] Nair PN, Baltensperger M, Luder HU, Eyrich GK.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-004-0317-7 ] [PMID: 15647971 ] [12] Anderson RR, Parrish JA.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1126/science.6836297 ] [PMID: 6836297 ] [13] Visuri SR, Walsh JT Jr, Wigdor HA.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
[http://dx.doi.org/10.1002/(SICI)1096-9101(1996)18:3<294::AID-LSM11>3.0.CO;2-6 ] [PMID: 8778525 ] [14] Takamori K. A histopathological and immunohistochemical study of dental pulp and pulpal nerve fibers in rats after the cavity preparation using Er:YAG laser.,Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1097/00004770-200002000-00009 ] [PMID: 11194381 ] [15] Nair PN, Baltensperger MM, Luder HU, Eyrich GK.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1002/lsm.10155 ] [PMID: 12605427 ] [16] Chu CH, Lo EC, You DS.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-009-0655-6 ] [PMID: 19259758 ] [17] Kositbowornchai S, Sukanya C, Tidarat T, Chanoggarn T. Caries detection under composite restorations by laser fluorescence and digital radiography.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s00784-012-0908-9 ] [PMID: 23242816 ] [18] Ozturk E, Sinanoglu A. Histological validation of cone-beam computed tomography versus  laser fluorescence and conventional diagnostic methods for occlusal caries detection.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1089/pho.2014.3831 ] [PMID: 25650901 ] [19] Bussaneli DG, Restrepo M, Boldieri T, et al.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-014-1704-3 ] [PMID: 25549960 ] [20] Martínez-Insua A, Da Silva Dominguez L, Rivera FG, Santana-Penín UA.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1067/mpr.2000.108600 ] [PMID: 11005900 ] [21] Esteves-Oliveira M, Pasaporti C, Heussen N, Eduardo CP, Lampert F, Apel C. Prevention of toothbrushing abrasion of acid-softened enamel by CO2 laser irradiation.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.jdent.2011.06.007 ] [PMID: 21741428 ] [22] Mohan  AG,  Ebenezar  AV,  Ghani  MF,  Martina  L,  Narayanan  A,  Mony  B.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.4103/1305-7456.126264 ] [PMID: 24966758 ] [23] Fornaini C, Brulat N, Milia G, Rockl A, Rocca JP.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.5978/islsm.14-OR-13 ] [PMID: 25368443 ] [24] Kita T, Ishii K, Yoshikawa K, Yasuo K, Yamamoto K, Awazu K. In vitro  study on selective removal of bovine demineralized dentin using nanosecond pulsed laser at wavelengths around 5.8 μm for realizing less invasive treatment of dental caries.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-013-1517-9 ] [PMID: 24395343 ] [25] Radatti DA, Baumgartner JC, Marshall JG.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.14219/jada.archive.2006.0384 ] [PMID: 16946431 ] [26] Nguyen D, Chang K, Hedayatollahnajafi S, et al.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1117/1.3603996 ] [PMID: 21806256 ] [27] Ishii K, Kita T, Yoshikawa K, Yasuo K, Yamamoto K, Awazu K. Selective removal of carious human dentin using a nanosecond pulsed laser operating at a wavelength of 5.85 μm.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1117/1.JBO.20.5.051023 ] [PMID: 25594772 ] [28] Toro CV, Derceli JdosR, Faraoni-Romano JJ, Marchi P, Pécora JD, Palma-Dibb RG.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
[http://dx.doi.org/10.1002/jemt.22156 ] [PMID: 23174887 ],Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1002/jemt.20902 ] [PMID: 20623778 ] [30] Neves  AdeA,  Coutinho  E,  De  Munck  J,  Van  Meerbeek  B.  Caries-removal  effectiveness  and  minimal-invasiveness  potential  of  caries- excavation techniques: a micro-CT investigation.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.jdent.2010.11.006 ] [PMID: 21111770 ] [31] Baraba A, Miletic I, Krmek SJ, Perhavec T, Bozic Z, Anic I. Ablative potential of the erbium-doped yttrium aluminium garnet laser and conventional handpieces: a comparative study.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1089/pho.2008.2416 ] [PMID: 19731997 ] [32] Chinelatti MA, Raucci-Neto W, Corona SA, Palma-Dibb RG.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-008-0618-3 ] [PMID: 18982403 ] [33] Bachmann L, Diebolder R, Hibst R, Zezell DM.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.saa.2004.09.026 ] [PMID: 16043057 ] [34] Ferreira LS, Apel C, Francci C, Simoes A, Eduardo CP, Gutknecht N. Influence of etching time on bond strength in dentin irradiated with erbium lasers.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-009-0715-y ] [PMID: 19655225 ] [35] Korkmaz Y, Ozel E, Attar N, Bicer CO, Firatli E. Microleakage and scanning electron microscopy evaluation of all-in-one self-etch adhesives and their respective nanocomposites prepared by erbium:yttrium-aluminum-garnet laser and bur.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-009-0672-5 ] [PMID: 19396579 ] [36] Kimyai S, Ajami AA, Chaharom ME, Oskoee JS.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1089/pho.2009.2562 ] [PMID: 20001320 ] [37] Baghalian A, Nakhjavani YB, Hooshmand T, Motahhary P, Bahramian H. Microleakage of Er:YAG laser and dental bur prepared cavities in primary teeth restored with different adhesive restorative materials.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-012-1222-0 ] [PMID: 23135785 ] [38] Yaman BC, Efes BG, Dörter C, Gömeç Y, Erdilek D, Yazıcıoğlu O. Microleakage of repaired class V silorane and nano-hybrid composite restorations after preparation with erbium:yttrium-aluminum-garnet laser and diamond bur.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-010-0755-3 ] [PMID: 20162317 ] [39] Cagidiaco MC, Ferrari M, Vichi A, Davidson CL.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/S0300-5712(96)00060-7 ] [PMID: 9241956 ] [40] Parhami P, Pourhashemi SJ, Ghandehari M, Mighani G, Chiniforush N. Comparative study of the shear bond strength of flowable composite in permanent teeth treated with conventional bur and contact or non-contact er:YAG laser.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.4103/1119-3077.151044 ] [PMID: 25665995 ] [42] Shirani F, Birang R, Malekipour MR, Hourmehr Z, Kazemi S. Shear bond strength of resin composite bonded with two adhesives: Influence of Er: YAG laser irradiation distance.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s40368-014-0149-5 ] [PMID: 25361608 ] [44] Altunsoy M, Botsali MS, Sari T, Onat H. Effect of different surface treatments on the microtensile bond strength of two self-adhesive flowable composites.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-014-1640-2 ] [PMID: 25118664 ] [45] Dunn WJ, Davis JT, Bush AC.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.dental.2004.11.003 ] [PMID: 15978270 ] [46] Trajtenberg CP, Pereira PN, Powers JM.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
[http://dx.doi.org/10.2341/11-383-L ] [PMID: 23215546 ],Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1089/pho.2007.2044 ] [PMID: 17975950 ] [50] Shahabi S, Chiniforush N, Bahramian H, Monzavi A, Baghalian A, Kharazifard MJ.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-012-1086-3 ] [PMID: 22491942 ] [51] Visuri SR, Gilbert JL, Wright DD, Wigdor HA, Walsh JT Jr. Shear strength of composite bonded to Er:YAG laser-prepared dentin.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1177/00220345960750011401 ] [PMID: 8655766 ] [52] Olivi G, Genovese MD.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.joen.2006.12.013 ] [PMID: 17368330 ] [55] De Coster P, Rajasekharan S, Martens L. Laser-assisted pulpotomy in primary teeth: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1007/s10103-011-0885-2 ] [PMID: 21274733 ] [57] Handa K, Koike T, Hayashi K, Saito T. Application of high-frequency radio waves to direct pulp capping.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/j.joen.2013.06.007 ] [PMID: 23953288 ] [58] Shoji S, Nakamura M, Horiuchi H. Histopathological changes in dental pulps irradiated by CO2 laser: a preliminary report on laser pulpotomy.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1016/S0099-2399(85)80024-8 ] [PMID: 3934314 ] [59] Elliott RD, Roberts MW, Burkes J, Phillips C. Evaluation of the carbon dioxide laser on vital human primary pulp tissue.",OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
[http://dx.doi.org/10.1016/j.joen.2006.01.005 ] [PMID: 16631836 ] © Davoudi et al.,OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/2f/TODENTJ-10-636.PMC5123129.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2010.01298.x ] [PMID: 21564118 ] [2] Dietschi D, Duc O, Krejci I, Sadan A. Biomechanical considerations for the restoration of endodontically treated teeth: a systematic review of the literature, Part II (Evaluation of fatigue behavior, interfaces, and in vivo  studies).",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1177/154405910808700802 ] [PMID: 18650540 ] [5] Yang A, Lamichhane A, Xu C. Remaining coronal dentin and risk of fiber-reinforced composite post-core restoration failure: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.11607/ijp.4157 ] [PMID: 25965640 ] [6] Sornkul E, Stannard JG.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/S0099-2399(06)80845-9 ] [PMID: 9796512 ] [7] Akkayan B, Gülmez T. Resistance to fracture of endodontically treated teeth restored with different post systems.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
[http://dx.doi.org/10.1067/mpr.2002.123227 ] [PMID: 12011860 ],Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.2341/07-86 ] [PMID: 18505227 ] [9] Balbosh A, Kern M. Effect of surface treatment on retention of glass-fiber endodontic posts.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/j.prosdent.2006.01.006 ] [PMID: 16543019 ] [10] Skupien JA, Sarkis-Onofre R, Cenci MS, Moraes RR, Pereira-Cenci T. A systematic review of factors associated with the retention of glass fiber posts.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1590/1807-3107BOR-2015.vol29.0074 ] [PMID: 26083089 ] [11] OKeefe KL, Miller BH, Powers JM.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2002.00025.x ] [PMID: 11203608 ] [12] Gallo JR III, Miller T, Xu X, Burgess JO.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2002.00025.x ] [PMID: 11935507 ] [13] Al-harbi F, Nathanson D. In vitro  assessment of retention of four esthetic dowels to resin core foundation and teeth.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/j.prosdent.2003.09.014 ] [PMID: 14668755 ] [14] Qualtrough AJ, Chandler NP, Purton DG.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/S0022-3913(97)70081-7 ] [PMID: 9237140 ] [16] Corsalini M, Genovese K, Lamberti L, Pappalettere C, Carella M, Carossa S. A laboratory comparison of individual Targis/Vectris posts with standard fiberglass posts.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.7150/ijms.4998 ] [PMID: 23055816 ] [18] Di Comite M, Crincoli V, Fatone L, et al.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.3390/ma8063268 ] [19] Soares CJ, Castro CG, Santos Filho PC, Soares PV, Magalhaes D, Martins LR.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2008.00367.x ] [PMID: 18798782 ] [20] Mezzomo LA, Corso L, Marczak RJ, Rivaldo EG.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2010.00669.x ] [PMID: 21284758 ] [21] Lucena-Martín C, González-López S, Navajas-Rodríguez de Mondelo JM.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1067/mpr.2001.116775 ] [PMID: 11725276 ] [22] Lewis R, Smith BG.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1038/sj.bdj.4806505 ] [PMID: 3048342 ] [23] Mentink AG, Creugers NH, Meeuwissen R, Leempoel PJ, Käyser AF.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1365-2842.1993.tb01645.x ] [PMID: 10412480 ] [24] Powers J, Wataha J.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/S0109-5641(96)80036-4 ] [PMID: 9170996 ] [26] Tezvergil A, Lassila LV, Vallittu PK.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/S0109-5641(02)00092-1 ] [PMID: 12837394 ] [27] Sideridou I, Achilias DS, Kyrikou E. Thermal expansion characteristics of light-cured dental resins and resin composites.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/j.biomaterials.2003.09.078 ] [PMID: 14967543 ] [28] Saitoh M, Masutani S, Kojima T, Saigoh M, Hirose H, Nishiyama M. Thermal properties of dental materialscavity liner and pulp capping agent.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
[http://dx.doi.org/10.4012/dmj.23.399 ] [PMID: 15510872 ],Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/j.dental.2005.05.016 ] [PMID: 16198406 ] [31] Ellakwa  AE,  Morsy  MA,  El-Sheikh  AM.",OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2008.00318.x ] [PMID: 18482365 ] [32] Sciammarella CA, Lamberti L, Boccaccio A.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1117/1.2899039 ] [33] Sciammarella CA, Lamberti L, Boccaccio A, Cosola E, Posa D. General model for moiré contouring.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1117/1.2899040 ] [34] Boccaccio A, Casavola C, Lamberti L, Pappalettere C. Structural response of polyethylene foam-based sandwich panels subjected to edgewise compression.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.3390/ma6104545 ] [35] Boccaccio A, Martino F, Pappalettere C. A novel moiré-based optical scanning head for high-precision contouring.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1007/s00170-015-7002-9 ] [36] Sciammarella CA, Lamberti L, Boccaccio A, Sciammarella FM.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1111/j.1475-1305.2010.00733.x ] [37] Sciammarella CA, Boccaccio A, Lamberti L, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1007/s11340-012-9699-9 ] [38] Sciammarella CA, Lamberti L, Boccaccio A.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/TODENTJ-10-610.PMC5123133.pdf
"[http://dx.doi.org/10.1016/j.otc.2010.09.006 ] [PMID: 21093628 ] [2] Reamy BV, Derby R, Bunt CW.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.1016/j.pcl.2011.02.008 ] [PMID: 21453804 ],OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/S0733-8635(02)00057-8 ] [PMID: 12622275 ] [6] Pastore L, Lo Muzio L, Serpico R. Atrophic glossitis leading to the diagnosis of celiac disease.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1056/NEJMc070200 ] [PMID: 17568041 ] [7] Erriu M, Canargiu F, Orrù G, Garau V, Montaldo C. Idiopathic atrophic glossitis as the only clinical sign for celiac disease diagnosis: a case report.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1186/1752-1947-6-185 ] [PMID: 22762365 ] [8] Lehman JS, Bruce AJ, Rogers RS.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1902/jop.2006.060169 ] [PMID: 17209796 ] [9] Wu YC, Wang YP, Chang JY, Cheng SJ, Chen HM, Sun A.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.jfma.2013.11.010 ] [PMID: 24388269 ] [10] Madani FM, Kuperstein AS.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.mcna.2014.08.004 ] [PMID: 25443677 ] [11] Bessa CF, Santos PJ, Aguiar MC, do Carmo MA.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.2004.00200.x ] [PMID: 14675136 ] [12] Rogers RS III, Bruce AJ.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1468-3083.2004.00769.x ] [PMID: 15096129 ] [13] Lynge Pedersen AM, Nauntofte B, Smidt D, Torpet LA.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/odi.12337 ] [PMID: 25754744 ] [14] Järvinen J, Mikkonen JJ, Kullaa AM.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.1016/j.mehy.2014.03.010 ] [PMID: 24698850 ] [15] National Center for Health Statistics.,OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1080/07315724.1993.10718276 ] [PMID: 8440811 ] [17] Bøhmer T, Mowé M. The association between atrophic glossitis and protein-calorie malnutrition in old age.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1093/ageing/29.1.47 ] [PMID: 10690695 ] [18] Sun A, Lin HP, Wang YP, Chiang CP.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.2011.01122.x ] [PMID: 22188475 ] [19] Sun A, Wang YP, Lin HP, Chen HM, Cheng SJ, Chiang CP.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/odi.12035 ] [PMID: 23130817 ] [20] Prema K, Srikantia SG.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/B978-0-7020-4087-0.00059-0 ] [PMID: 24365359 ] [25] López M, Olivares JM, Berrios GE.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1093/alcalc/agt070 ] [PMID: 23926211 ] [26] Wu XY, Lu L. Vitamin B6 deficiency, genome instability and cancer.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.7314/APJCP.2012.13.11.5333 ] [PMID: 23317180 ],Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3748/wjg.v19.i7.1005 ] [PMID: 23467420 ] [28] Briani C, Dalla Torre C, Citton V, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3390/nu5114521 ] [PMID: 24248213 ] [29] Samad A, Mohan N, Balaji RV, Augustine D, Patil SG.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.jtemb.2014.09.002 ] [PMID: 25260885 ] [31] Bao ZX, Yang XW, Shi J, Liu LX.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.4317/medoral.21079 ] [PMID: 27031065 ] [32] Niewinski MM.,OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.jada.2008.01.011 ] [PMID: 18375224 ] [33] Catassi C, Rätsch IM, Fabiani E, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/S0140-6736(94)90989-X ] [PMID: 7904667 ] [34] Krzywicka B, Herman K, Kowalczyk-Zając M, Pytrus T. Celiac disease and its impact on the oral health status - review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.17219/acem/37212 ] [PMID: 25491679 ] [35] Campisi G, Di Liberto C, Iacono G, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1365-2036.2007.03535.x ] [PMID: 17919276 ] [36] Lähteenoja H, Toivanen A, Viander M, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1046/j.0909-8836.1998.eos106501.x ] [PMID: 9786318 ] [37] Rashid M, Zarkadas M, Anca A, Limeback H. Oral manifestations of celiac disease: a clinical guide for dentists.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4166/kjg.2014.63.4.244 ] [PMID: 24755750 ] [40] Dong YJ, Peng TK, Yin SJ.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/0741-8329(95)02052-7 ] [PMID: 8734840 ] [41] Himmerich H, Anghelescu I, Klawe C, Szegedi A. Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1093/alcalc/36.1.26 ] [PMID: 11139412 ] [42] Cunha SF, Melo DA, Braga CB, Vannucchi H, Cunha DF.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1590/S0365-05962012000100010 ] [PMID: 22481655 ] [43] Valentine JA, Scott J, West CR, St Hill CA.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.1985.tb00543.x ] [PMID: 3930674 ] [44] Maier H, Weidauer H, Zöller J, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1530-0277.1994.tb00030.x ] [PMID: 8048743 ] [45] Ogden GR, Wight AJ, Rice P. Effect of alcohol on the oral mucosa assessed by quantitative cytomorphometry.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.1999.tb02027.x ] [PMID: 10226944 ] [46] Abdollahi M, Radfar M. A review of drug-induced oral reactions.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3109/15569527.2011.574303 ] [PMID: 21517721 ] [49] Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1507/endocrj.EJ13-0332 ] [PMID: 24018893 ] [50] Ko SH, Ko SH, Ahn YB, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3346/jkms.2014.29.7.965 ] [PMID: 25045229 ] [51] Niafar M, Hai F, Porhomayon J, Nader ND.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1007/s11739-014-1157-5 ] [PMID: 25502588 ] [52] Long AN, Atwell CL, Yoo W, Solomon SS.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.2337/dc12-0980 ] [PMID: 23173145 ] [53] Palmery M, Saraceno A, Vaiarelli A, Carlomagno G. Oral contraceptives and changes in nutritional requirements.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1074/jbc.M113.459784 ] [PMID: 23902766 ] [55] Var C, Keller S, Tung R, Freeland D, Bazzano AN.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3390/nu6093353 ] [PMID: 25163030 ] [56] Jung SB, Nagaraja V, Kapur A, Eslick GD.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/imj.12697 ] [PMID: 25583062 ] [57] Wiholm BE, Kelly JP, Kaufman D, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1007/s10072-014-1701-0 ] [PMID: 24619070 ] [59] Andrès E, Noel E, Goichot B. Metformin-associated vitamin B12 deficiency.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1001/archinte.162.19.2251-a ] [PMID: 12390080 ] [60] Varughese GI, Scarpello JH.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1093/ageing/afl139 ] [PMID: 17264140 ] [61] Kotilainen H, Lokki ML, Paakkanen R, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1371/journal.pone.0091450 ] [PMID: 24638111 ] [62] Rumsby PC, Shepherd DM.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/0006-2952(81)90492-5 ] [PMID: 7337722 ] [63] Hanai H, Iida T, Takeuchi K, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.dld.2012.03.007 ] [PMID: 22542605 ] [64] Sankrityayan H, Majumdar AS.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.1139/cjpp-2015-0156 ] [PMID: 26571019 ] [65] Halasz CL.,OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1001/archderm.1990.01670350132025 ] [PMID: 1978637 ] [66] Montalar M, Nalda-Molina R, Rodríguez-Ibáñez M, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1080/10611860310001615947 ] [PMID: 14578108 ] [67] Uher R, Farmer A, Henigsberg N, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1192/bjp.bp.108.061960 ] [PMID: 19721108 ] [68] Scardina GA, Cacioppo A, Messina P. Changes of oral microcirculation in chemotherapy patients: A possible correlation with mucositis?",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"Diagnosis of Atrophic Tongue The Open Dentistry Journal, 2016, Volume 10    633 [http://dx.doi.org/10.1002/ca.22300 ] [PMID: 24123285 ] [69] Chaveli-López B.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4317/jced.51337 ] [PMID: 24596641 ] [70] Goregen M, Miloglu O, Buyukkurt MC, Caglayan F, Aktas AE.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.joms.2012.01.025 ] [PMID: 22609135 ] [72] Kumar NN, Panchaksharappa MG, Annigeri RG.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.archoralbio.2014.05.008 ] [PMID: 24859769 ] [73] Kano  O,  Urita  Y,  Ito  H,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.2147/NDT.S50135 ] [PMID: 24092978 ] [74] Boers-Doets CB, Epstein JB, Raber-Durlacher JE, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1634/theoncologist.2011-0111 ] [PMID: 22207567 ] [75] Montaldo C, Erriu M, Giovanna Pili FM, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"2013: 679312 [http://dx.doi.org/10.1155/2013/679312 ] [76] Suzuki N, Yoshida A, Nakano Y. Quantitative analysis of multi-species oral biofilms by TaqMan Real-Time PCR.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3121/cmr.3.3.176 ] [PMID: 16160072 ] [77] Zarco MF, Vess TJ, Ginsburg GS.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1601-0825.2011.01851.x ] [PMID: 21902769 ] [78] Mager DL, Ximenez-Fyvie LA, Haffajee AD, Socransky SS.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1034/j.1600-051X.2003.00376.x ] [PMID: 12834503 ] [79] Terai H, Shimahara M. Atrophic tongue associated with Candida.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.2005.00324.x ] [PMID: 16011607 ] [80] Pili FM, Erriu M, Piras A, Garau V. Application of the novel method in the diagnosis and treatment of median rhomboid glossitis Candida- associated.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4103/1305-7456.126268 ] [PMID: 24966760 ] [81] Gall-Troselj K, Mravak-Stipetić M, Jurak I, Ragland WL, Pavelić J. Helicobacter pylori colonization of tongue mucosaincreased incidence in atrophic glossitis and burning mouth syndrome (BMS).",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1034/j.1600-0714.2001.300909.x ] [PMID: 11555160 ] [82] Singh A, Verma R, Murari A, Agrawal A.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4103/0973-029X.141325 ] [PMID: 25364186 ] [83] Akpan A, Morgan R. Oral candidiasis.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1136/pmj.78.922.455 ] [PMID: 12185216 ] [84] Fukushima  C,  Matsuse  H,  Tomari  S,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/S1081-1206(10)61870-4 ] [PMID: 12839324 ] [85] Terai H, Shimahara M. Partial atrophic tongue other than median rhomboid glossitis.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1365-2230.2007.02383.x ] [PMID: 17441970 ] [86] Pili FM, Erriu M, Piras A, Garau V. Application of the novel method in the diagnosis and treatment of median rhomboid glossitis Candida - associated.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4103/1305-7456.126268 ] [PMID: 24966760 ] [87] Hagymási K, Tulassay Z. Helicobacter pylori infection: new pathogenetic and clinical aspects.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3748/wjg.v20.i21.6386 ] [PMID: 24914360 ] [88] Song Q, Lange T, Spahr A, Adler G, Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1099/0022-1317-49-4-349 ] [PMID: 10755629 ] [89] Li C, Musich PR, Ha T, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1136/jcp.48.7.662 ] [PMID: 7560176 ] [90] Amiri N, Abiri R, Eyvazi M, Zolfaghari MR, Alvandi A.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.archoralbio.2015.02.006 ] [PMID: 25766471 ] [91] Abadi AT, Mobarez AM, Teymournejad O, Karbalaei M. Concomitant colonization of helicobacter pylori in dental plaque and gastric biopsy.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/odi.12058 ] [PMID: 23294141 ] [94] Vakil N, van Zanten SV, Kahrilas P. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1601-0825.2007.01380.x ] [PMID: 17577320 ] [96] Petruzzi M, Lucchese A, Campus G, Crincoli V, Lauritano D, Baldoni E. Oral stigmatic lesions of gastroesophageal reflux disease (GERD).",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.4067/S0034-98872012000700014 ] [PMID: 23282706 ] [97] Scully C, Beyli M, Ferreiro MC, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1177/10454411980090010501 ] [PMID: 9488249 ] [98] Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.1988.tb01527.x ] [PMID: 3144584 ] [99] Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L. A clinical study of 674 patients with oral lichen planus in China.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1600-0714.2005.00341.x ] [PMID: 16091113 ] [100] Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I).",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.oraloncology.2010.06.006 ] [PMID: 20637681 ] [101] Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II).",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.oraloncology.2010.06.008 ] [PMID: 20637679 ] [102] Jones AS, Rafferty M, Fenton JE, Jones TM, Husband DJ.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1177/000348940711600203 ] [PMID: 17388231 ] [103] Riley CM, Day RL, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1754-4505.2011.00225.x ] [PMID: 22229594 ] [105] Johnson RH, Spaulding JM.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1601-0825.1996.tb00214.x ] [PMID: 8957926 ] [107] Fortuna G, Lozada-Nur F, Pollio A, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.1111/jop.12094 ] [PMID: 23772832 ] [108] Wright JT.,OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.det.2009.10.022 ] [PMID: 19945630 ] [109] Krämer SM, Serrano MC, Zillmann G, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1365-263X.2012.01247.x ] [PMID: 22937908 ] [110] Wright JT, Fine JD, Johnson LB.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/0030-4220(91)90426-D ] [PMID: 2052329 ] [111] Zimmer WM, Rogers RS III, Reeve CM, Sheridan PJ.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"Diagnosis of Atrophic Tongue The Open Dentistry Journal, 2016, Volume 10    635 [http://dx.doi.org/10.1016/0030-4220(92)90354-S ] [PMID: 1437063 ] [112] Winnie R, DeLuke DM.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/S0901-5027(05)80546-6 ] [PMID: 1602158 ] [113] Feng S, Yin J, Li J, Song Z, Zhao G. Melkersson-Rosenthal syndrome: a retrospective study of 44 patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3109/00016489.2014.927587 ] [PMID: 24963969 ] [114] Kanerva M, Moilanen K, Virolainen S, Vaheri A, Pitkäranta A. Melkersson-Rosenthal syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.otohns.2007.11.015 ] [PMID: 18241724 ] [115] Ozgursoy OB, Karatayli Ozgursoy S, Tulunay O, Kemal O, Akyol A, Dursun G. Melkersson-Rosenthal syndrome revisited as a misdiagnosed disease.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/j.amjoto.2008.02.004 ] [PMID: 19027510 ] [116] Elias MK, Mateen FJ, Weiler CR.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1007/s00415-012-6603-6 ] [PMID: 22836908 ] [117] Guggenheimer  J,  Moore  PA,  Rossie  K,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1067/moe.2000.104477 ] [PMID: 10807713 ] [118] Guggenheimer  J,  Moore  PA,  Rossie  K,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1067/moe.2000.104476 ] [PMID: 10807712 ] [119] Simonsen JR, Harjutsalo V, Järvinen A, et al.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1016/0030-4220(87)90342-2 ] [PMID: 3468467 ] [121] Shulman JD, Carpenter WM.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.1111/j.1601-0825.2005.01208.x ] [PMID: 16792723 ] [122] Gómez-Moyano E, Martínez-Pilar L, Pérez-Belmonte LM, Godoy-Díaz DJ.",OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"[http://dx.doi.org/10.3949/ccjm.81a.13102 ] [PMID: 25183842 ] [123] Jainkittivong A, Langlais RP.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
[http://dx.doi.org/10.3109/15569527.2013.861477 ] [PMID: 24303868 ] © Erriu et al.,Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/17/TODENTJ-10-619.PMC5123136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
"Received September 7, 2016 /C15Revision received September 19, 2016 /C15Accepted September 26, 2016 /C15Available online 30 September 2016 http://dx.doi.org/10.1016/j.molmet.2016.09.010 Brief Communication 1208MOLECULAR METABOLISM 5 (2016) 1208 e1215 /C2112016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/4d/main.PMC5123192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
"Abbreviations: Abcg5, ATP-binding cassette sub-family G member 5; Abcg8, ATP-binding cassette sub-family G member 8; Actb, beta actin; Akr1d1, aldo-keto-reducta se family member 1; ANOVA, analysis of variance; BMR, basal metabolic rate; CD, control diet; CA, cholic acid; CDCA, chenodeoxycholic acid; CIDEA, cell death inducing DFFA- like effector; COX4, cytochrome c oxidase subunit 4; Cyp7a1, cholesterol 7 alpha-hydroxylase; Cyp27a1, cholesterol 27 alpha-hydroxylase; DCA, de oxycholic acid; Dhcr7, 7- dehydrocholesterol reductase; DIO, diet-induced obesity; DEE, daily energy expenditure; Eef2, eukaryotic elongation factor 2; FT-ICR-MS, Fouri er transform-Ion Cyclotron Resonance-Mass Spectrometry; FT-IR, Fourier transform-infrared spectroscopy; GF, germfree; GUSB, beta-glucuronidase; HDCA, hyodeoxycholic a cid; Hmgcr, 3-hydroxy-3- methylglutaryl Coenzyme A reductase; Hmgcs, 3-hydroxy-3-methylglutaryl Coenzyme A synthase 1; HP, heat production; Hprt1, hypoxanthine guanine phosphoribosyl transferase; Hsd11b1, hydroxysteroid (11- b) dehydrogenase 1; Hsp90, heat shock protein 90; Ldlr, low density lipoprotein receptor; LHFD, high-fat diet based on lard; MCA, muricholic acid; Nr1h2, nuclear receptor subfamily 1, group H, member 2 (liver X receptor b); Nr1h3, nuclear receptor subfamily 1, group H, member 3 (liver X receptor a); Nr1h4, nuclear receptor subfamily 1, group H, member 4 (farnesoid X receptor a); PHFD, high-fat diet based on palm oil; PRDM16, PR domain containing 16; qPCR, quantitative real-time polymerase chain reaction; SPF, speci ﬁc pathogen free; Srebf1, sterol regulatory element binding transcription factor 1; TCA, taurocholic acid; Tf2b, transcription factor II B; TMCA, Tauromuricholic acid; UCP1, uncoupling protein 1; UDCA, ursodeoxycholic acid; UPLC-TOF-MS, ultraperformance li quid chromatography-time ofﬂight-mass spectrometry Received September 7, 2016 /C15Revision received September 26, 2016 /C15Accepted October 4, 2016 /C15Available online 13 October 2016 http://dx.doi.org/10.1016/j.molmet.2016.10.001 Original Article 1162MOLECULAR METABOLISM 5 (2016) 1162 e1174/C2112016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1146/annur- ev.nu.01.070181.001353 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
Science 307(5717):1915 e 1920. http://dx.doi.org/10.1126/science.1104816 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1136/gutjnl- 2012-303816 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1053/j.gastro.2014.02.008 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1096/fj.10-164921 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1038/ ismej.2012.27 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
Gut.http://dx.doi.org/10.1136/gutjnl-2015-310283 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1136/gutjnl-2015-310904 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
Scienti ﬁc Reports 6:19694. http://dx.doi.org/10.1038/srep19694 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1152/ajpgi.00488.2011 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/ 10.1016/j.cmet.2015.07.026 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1194/ jlr.M065847 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/ 10.1159/000328042 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1007/s00281- 013-0399-z .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1152/ ajpregu.00137.2012 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/j.jnutbio.2014.09.002 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1038/ismej.2014.79 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1002/mnfr.201500125 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1093/nar/gks596 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/j.jsbmb.2015.06.002 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/ 10.1038/ijo.2015.102 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/j.cmet.2013.01.003 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.2337/db13-0844 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/ 10.1038/nature05414 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1056/NEJM199503093321001 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/j.febs- let.2010.12.044 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1210/jc.2011-2329 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1530/JOE-13-0131 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1038/ismej.2013.155 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
BoneKEy Reports 3:479. http://dx.doi.org/10.1038/bone- key.2013.213 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/ j.jacl.2008.01.007 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1016/ j.bbamcr.2009.03.009 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
Cellular and Molecular Life Sciences: CMLS 70(23):4511 e 4526 http://dx.doi.org/10.1007/s00018-013-1387-0 .,OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1002/mnfr.201400840 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.2337/db07-1403 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1371/jour- nal.pone.0047713 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/ 10.1074/jbc.M112.421834 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1007/s00203-012-0822-1 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
http://dx.doi.org/10.1099/ ijs.0.64915-0 .,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/1b/main.PMC5123202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
"Abbreviations: LD, lipid droplet; Hig2, Hypoxia-inducible gene 2; TG, triglyceride; FFA, free fatty acid; WAT, white adipose tissue; BAT, brown adipose tissue; Ucp 1, uncoupling protein 1; HFD, high fat diet; SVF, stromal vascular fraction; SGBS, Simpson-Golabi-Behmel syndrome; eWAT, epididymal white adipose ti ssue; iWAT, inguinal white adipose tissue; ITT, insulin tolerance test; RER, respiratory exchange ratio; GTT, glucose tolerance test; NEFA, non-esteri ﬁed fatty acid Received September 7, 2016 /C15Revision received September 15, 2016 /C15Accepted September 19, 2016 /C15Available online 28 September 2016 http://dx.doi.org/10.1016/j.molmet.2016.09.009 Original Article MOLECULAR METABOLISM 5 (2016) 1149 e1161 /C2112016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/13/main.PMC5123203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
"Received September 6, 2016 /C15Revision received September 23, 2016 /C15Accepted September 27, 2016 /C15Available online 5 October 2016 http://dx.doi.org/10.1016/j.molmet.2016.09.011 Brief Communication 1200MOLECULAR METABOLISM 5 (2016) 1200 e1207/C2112016 The Author(s).",OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1038/nri2921 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1038/ nrm2391 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1007/s00424-007-0301-8 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.2337/db09- 1541 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/ 10.1080/07853890902729760 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.2337/db06-0911 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1017/S0029665109990206 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1152/ physrev.00017.2012 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1152/ ajpendo.00435.2007 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://www.ncbi.nlm.nih.gov.gat e2.inist.fr/pmc/articles/PMC2643223/ .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1111/j.1471- 4159.2006.04196.x .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.2337/db10-1743 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1016/j.cmet.2009.01.006 .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1074/jbc.M305905200 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/ 10.2337/db09-1003 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/ 10.1111/febs.13061 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1371/journal.pone.0018950 .Brief Communication 1206MOLECULAR METABOLISM 5 (2016) 1200 e1207/C2112016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
Nature Communications 7:10782. http://dx.doi.org/ 10.1038/ncomms10782 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1007/s00424-009-0750-3 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1093/nar/gkp425 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1016/ j.jnutbio.2010.04.015 .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.3390/ijms141224029 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1017/S0007114508971282 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1021/ja102758v .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1021/jm301254q .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1016/j.bbamcr.2013.12.008 .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1016/ j.bbamcr.2011.03.001 .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
Nature Chemical Biology 12(9):741 e 747. http://dx.doi.org/10.1038/nchembio.2134 .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1111/febs.12079 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
Genome Biology 16:8. http://dx.doi.org/10.1186/s13059-014- 0569-x .,OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/ 10.1007/s00125-012-2615-0 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
Journal of Diabetes Research 2014:195739. http://dx.doi.org/10.1155/2014/195739 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.2337/db12-0548 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-14-3786 .,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f7/main.PMC5123204.pdf
"”,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC5123205.pdf
"Received October 3, 2016 /C15Accepted October 3, 2016 /C15Available online 14 October 2016 http://dx.doi.org/10.1016/j.molmet.2016.10.002Commentary MOLECULAR METABOLISM 5 (2016) 1147 e1148 /C2112016 The Author(s).",OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC5123205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC5123205.pdf
http://dx.doi.org/10.1016/ j.molmet.2016.09.003 .,OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC5123205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/d7/main.PMC5123205.pdf
Available from: http://www.fhcrc.org/content/dam/public/Treatment-Suport/Long-Term-Follow-Up/physician.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2e/10/APJON-1-50.PMC5123448.pdf
Available from: http://www.turkkanser.org.tr/news.php?id=60 [Last accessed on 2014 Feb 19].,Non-OADS,/arxiv_data1/oa_pdf/be/84/APJON-1-33.PMC5123449.pdf
Available  from: http://www.who.it.,Non-OADS,/arxiv_data1/oa_pdf/ab/47/APJON-1-46.PMC5123451.pdf
Available  from: http://globocan.iarc.fr/factsheets/cancers/breast.asp.,Non-OADS,/arxiv_data1/oa_pdf/a1/bc/APJON-1-22.PMC5123455.pdf
Available from: http://globocan.iarc.fr [Last accessed on 2014 Apr 12].,Non-OADS,/arxiv_data1/oa_pdf/c7/76/APJON-2-42.PMC5123457.pdf
Available from: http://mohfw.nic.in/index1.php?lang=1&le vel=3&sublinkid=3627&lid=2194 [Last accessed on 2014  September 20].,OADS,/arxiv_data1/oa_pdf/c7/76/APJON-2-42.PMC5123457.pdf
Available from: https://canceratlasindia.org/map.htm [Last accessed on 2014 Apr 12].,Non-OADS,/arxiv_data1/oa_pdf/c7/76/APJON-2-42.PMC5123457.pdf
Available from: http://www.thehindu.com/2006/09/23/stories/2006092320210300.htm.,Non-OADS,/arxiv_data1/oa_pdf/c7/76/APJON-2-42.PMC5123457.pdf
"Geneva, Switzerland: World Health Organization; 2000 [Last updated in 2013 July; cited 2013]  Available from: http://www.who.int/mediacentre/factsheets/ fs204/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
[Last cited in 2013] Available from: http://www.census.,OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.cdc.gov/ vaccines/vpd-vac/hepb/downloads/PL-dis-hepB-color-office.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://aids.gov/pdf/viral- hepatitis-action-plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.cdc.gov/nchs/nsfg/abc_list.htm.,OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.acha-ncha.org/docs/ACHA-NCHA-II_ReferenceGroup_Executive Summary_Fall2012.pdfz.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.aids.gov/pdf/viral-hepatitis-action-plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.immunize.org/laws.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.iaas.umb.edu/ publications/general/AAs%20in%20MA%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Available from: http://www.census.gov/prod/cen2010/briefs/c2010br-11.pdf.,OADS,/arxiv_data1/oa_pdf/d8/d8/APJON-2-8.PMC5123458.pdf
Iran J Med Ethics Hist  Med [cited May 30] (Persian) 2009: Available from: http://journals.iums.ac.ir_files/pdf/_14785.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/af/APJON-2-26.PMC5123459.pdf
Available from: http://www.ijps.ir/article_5713_459.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/af/APJON-2-26.PMC5123459.pdf
"Available from: http://www.idosi.org/mejsr/mejsr17(2)13/1.pdf, 41.",Non-OADS,/arxiv_data1/oa_pdf/d3/af/APJON-2-26.PMC5123459.pdf
"[2] According to Senge, learning organizations  are “organizations where people continually expand their capacity to create the results they truly desire, where new and expansive patterns of thinking are nurtured, where collective aspiration is set free, and where people are continually learning to see the whole together.” (http://infed.org/mobi/peter-senge-and-the-learning-organization/) In his famous book, The Fifth Discipline , Senge asked the  following question: Are we “prisoners of the system or prisoners of our own thinking?” He encouraged people to Editorial Access this article online Quick Response Code: Website:  www.apjon.org DOI:  10.4103/2347-5625.146227Ilana Kadmon1, Livia Kislev2 1Hadassah-Hebrew University School of Nursing, Hadassah Medical Organization, Jerusalem, Israel; 2Israel Cancer  Association, Givatayim, Israel Corresponding author: Ilana Kadmon E-mail: ikadmon@hadassah.org.il Received: June 3, 2014, Accepted: September 30, 2014 This article will look at the theory of a Learning Organization  as described by Senge and the Israeli Breast Care Nurses as an example.",Non-OADS,/arxiv_data1/oa_pdf/05/a9/APJON-2-3.PMC5123461.pdf
"Through learning we extend our capacity to create, to be part of the generative process of life.” (http://infed.org/mobi/peter-senge-and-the-learning-organization/) The Israeli BCNs, who independently work with each  other in their institution, have established and formed a unique, active and motivated group that can be regarded  as a learning organization.",Non-OADS,/arxiv_data1/oa_pdf/05/a9/APJON-2-3.PMC5123461.pdf
Available from: http://www.who.int/cancer/prevention/en/ [Last accessed on 2014 July 17].,Non-OADS,/arxiv_data1/oa_pdf/51/9a/APJON-2-52.PMC5123462.pdf
Available from: http://www.who.int/nmh/events/ ncd_action_plan/en/.,OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.mrc-leu.soton.ac.uk/ dohad/files/ncdalliance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.tobaccoatlas.org.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.ncdalliance.org.,OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.who.int/nmh/publications/ncd_profiles2011/en/.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.who.int/healthsystems/ NCDdiscussionpaper3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.who.int/hrh/resources/observer12.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.anmf.org.au/ documents/reports/PHC_Australia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.icn.ch/images/stories/ documents/publications/ind/indkit2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.asco.org/sites/www.asco.org/files/obesity_ provider_guide_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.aihw.gov.au/publication-detail/?id=60129550047.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.surveymonkey.,Non-OADS,/arxiv_data1/oa_pdf/d4/0a/APJON-2-129.PMC5123466.pdf
Available from: http://www.cdc.gov/hepatitis/HBV/PDFs/ ChronicHepBTestingFlwUp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.hhs.gov/ash/initiatives/hepatitis.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.cdc.gov/hepatitis/pdfs/iom- hepatitisandlivercancerreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.ccrcal.org/PDF/ACS2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from:  http://www.census.gov/prod/cen2010/briefs/c2010br-11.pdf.,OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.urban.org/ uploadedpdf/410918_lowell_ma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.voanews.com/english/ archive/2005-05/2005-05-04-voa72.cfm.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from:  http://www.ccrcal.org/PDF/ ACS2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/60/APJON-2-192.PMC5123467.pdf
Available from: http://www.aihw.,Non-OADS,/arxiv_data1/oa_pdf/91/5d/APJON-2-144.PMC5123468.pdf
Available from: http://www.aihw.gov.au/cancer/cancer-in-australia/.,Non-OADS,/arxiv_data1/oa_pdf/91/5d/APJON-2-144.PMC5123468.pdf
Available from: http://www.abs.gov.au/websitedbs/d3310114.nsf/4a256353001af3ed4b2562bb00121564/5d3cc840c7bcef0bca2573410017db9a!OpenDocument.,Non-OADS,/arxiv_data1/oa_pdf/91/5d/APJON-2-144.PMC5123468.pdf
Available  from: http://canceraustralia.gov.au/affected-cancer/cancer- types/prostate-cancer/prostate-cancer-statistics.,Non-OADS,/arxiv_data1/oa_pdf/35/ca/APJON-2-169.PMC5123470.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/ca/APJON-2-169.PMC5123470.pdf
Available from: http://www.diagnosticimaging.com/digital-breast-tomosynthesis-doses- comparablemammography.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/APJON-2-186.PMC5123471.pdf
Available from: http://www.radiologytoday.net/archive/rt1111p32.shtml.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/APJON-2-186.PMC5123471.pdf
Available from: http://www.ffda.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/APJON-2-186.PMC5123471.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/90/de/APJON-2-152.PMC5123473.pdf
Available from: http://www.cityofhope.org/ document/2013-community-health-needs-assessment-report.,Non-OADS,/arxiv_data1/oa_pdf/c9/76/APJON-2-127.PMC5123474.pdf
Available from: http://www.seer.cancer.gov/csr/1975_2010/.,Non-OADS,/arxiv_data1/oa_pdf/c9/76/APJON-2-127.PMC5123474.pdf
Available from:  http://www2.ttcn.ne.jp/honkawa/2164.html.,Non-OADS,/arxiv_data1/oa_pdf/41/0e/APJON-2-136.PMC5123475.pdf
Available from: http://www.mhlw.go.jp/houdou/2003/07/h0725- 3.html.,Non-OADS,/arxiv_data1/oa_pdf/41/0e/APJON-2-136.PMC5123475.pdf
Available from: http://nursingworld.org/NursingbytheNumbersFactSheet.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c4/af/APJON-2-89.PMC5123483.pdf
Available from: http://www.hrsa.gov/about/news/pressreleases/2010/100922nursingworkforce.html.,Non-OADS,/arxiv_data1/oa_pdf/c4/af/APJON-2-89.PMC5123483.pdf
Available from: http://www.bls.gov/ooh/Healthcare/Registered-nurses.htm.,Non-OADS,/arxiv_data1/oa_pdf/c4/af/APJON-2-89.PMC5123483.pdf
Available from: http://www.downloads.mhs.com/whitePapers/Practical- Guide-to-MSCEIT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/af/APJON-2-89.PMC5123483.pdf
Available from: http://www.aacn.nche.edu/Education/pdf/ BaccEssentials08.pdf [Last accessed on 2010 Jul 26].,Non-OADS,/arxiv_data1/oa_pdf/5f/f7/APJON-2-99.PMC5123484.pdf
Available  from: http://www.pewresearch.org/fact-tank/2015/04/23/why- muslims-are-the-worlds-fastest-growing-religious-group/ [Last  accessed on 2015 Oct 29].,Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
http://data.worldbank.org/sites/default/files/ section2.pdf [Last accessed on 2015 Oct 29].,Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
World health Organization 2015. http://www.who.int/gho/ publications/world_health_statistics/EN_WHS2015_Part2.,Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"The demographic profile of Arab countries, Economic and Social  Commission for Western Asia (ESCWA), United Nations, 2013.  http://www.escwa.un.org/information/publications/edit/upload/E_ ESCWA_SDD_13_TP-14_E.pdf [Last accessed on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"Chronic Disease and Aging in The Eastern Mediterranean Region:  From Research To Policy and Practice, Center for Studies on  Aging - Lebanon Issue 3, September 2010. http://www.csa.org.",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"The population of Israel 1990-2009 Demographic Characteristics,  The Israeli Central Bureau of Statistics, 2010. http://www.cbs.",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
http://www.peopleil.org/ details.aspx?itemID=7385&searchMode=0&index=3 [Last  accessed on 2015 Oct 29].,OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"The Arab population in Israel 2008, The Israeli Central Bureau  of Statistics, 2010. http://www.cbs.gov.il/www/statistical/ arab_pop08e.pdf [Last accessed on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"Media Release: Causes of Death in Israel, 2012, The Israeli  Central Bureau of Statistics, 2014. http://www.cbs.gov.il/reader/ newhodaot/hodaa_template_eng.html?hodaa=201405323 [Last  accessed on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"19. International Literacy Statistics A review of Concepts,  Methodology and Current Data, UNESCO Institute for  Statistics, 2008. http://www.uis.unesco.org/Library/Documents/ Literacyreport2008_en.pdf [Last accessed on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"Empowering Women,  Developing Society: Female Education in the Middle East and  North Africa, Population Reference Bureau, Washington DC, USA;  2009. http://www.prb.org/pdf/EmpoweringWomeninMENA.pdf  [Last accessed on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
"Offenhauer P ., Women In Islamic Societies: A Selected Review  Of Social Scientific Literature, A Report Prepared by the Federal  Research Division, Library of Congress, 2005. http://www.loc.gov/rr/frd/pdf-files/Women_Islamic_Societies.pdf [Last accessed  on 2015 Oct 29].",Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
Middle  Eastern J of Age and Aging 2010;1. http://www.me-jaa.com/ content0.htm [Last accessed on 2015 Nov 09].,Non-OADS,/arxiv_data1/oa_pdf/48/82/APJON-3-205.PMC5123487.pdf
Available from: http://www.hints.cancer.,Non-OADS,/arxiv_data1/oa_pdf/3c/04/APJON-3-192.PMC5123488.pdf
Available from: http://hints.cancer.gov/faq.aspx.,Non-OADS,/arxiv_data1/oa_pdf/3c/04/APJON-3-192.PMC5123488.pdf
Available from: http://www.cdc.gov/cancer/breast/.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/APJON-3-170.PMC5123489.pdf
Available from:  http://www.cancer.gov/cancertopics/types/breast.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/APJON-3-170.PMC5123489.pdf
Available from: http://www.cancer.gov/cancertopics/ factsheet/Risk/stress.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/APJON-3-170.PMC5123489.pdf
[Patient Survey 2014] Available from: http://www.mhlw.go.jp/ toukei/saikin/hw/iryosd/14/dl/2-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a3/aa/APJON-3-176.PMC5123490.pdf
Available from:  http://www.uicc.org/world-cancer-declaration.,Non-OADS,/arxiv_data1/oa_pdf/a4/d6/APJON-3-118.PMC5123494.pdf
Available from:  http://www.census.gov/.,OADS,/arxiv_data1/oa_pdf/7b/4d/APJON-3-157.PMC5123497.pdf
Available from: http://www.prb.org/Publications/ Datasheets/2013/2013-world-population-data-sheet.aspx.,OADS,/arxiv_data1/oa_pdf/7b/4d/APJON-3-157.PMC5123497.pdf
Available from: http://www.fecca.org.au/images/ stories/pdfs/cancer_cald_communities_report2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/51/0f/APJON-3-148.PMC5123499.pdf
Available from: http://www.aihw.gov.,Non-OADS,/arxiv_data1/oa_pdf/51/0f/APJON-3-148.PMC5123499.pdf
Available from: http://intranet.sswahs.nsw.gov.au/sswahs/ cancer/PDF/CALD%20Cancer%20Information%20and%20 Support%20Project%20Report%202014%20.pd.,Non-OADS,/arxiv_data1/oa_pdf/51/0f/APJON-3-148.PMC5123499.pdf
Available from: http://www.istizada.com/complete-list-of-arabic- speaking-countries-2014/.,Non-OADS,/arxiv_data1/oa_pdf/51/0f/APJON-3-148.PMC5123499.pdf
"A specific format of Qigong exercise, the “Six Healing  Sound” Qigong exercise (see a webpage in Wikipedia for  more details: http://en.wikipedia.org/wiki/Liu_Zi_Jue),  was used in the study because it was considered easy to  learn and practice.",Non-OADS,/arxiv_data1/oa_pdf/70/ed/APJON-2-232.PMC5123500.pdf
"Available from: http://www.globocan.iarc.fr/Default.aspx  (last accessed in October 20th, 2015).",Non-OADS,/arxiv_data1/oa_pdf/70/ed/APJON-2-232.PMC5123500.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available from:  http://www.who.int/cancer/events/breast_cancer_month/en/.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available  from: http://www3.ha.org.hk/cancereg/breast_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available from: http://www.randomization.com.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available from:  http://www.phsource.us/PH/PDF/EPI/Chapter%2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available  from: http://www.ncsi.org.uk/wp-content/uploads/Outcome- Measures-for-Evaluating-Cancer-Aftercare.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
Available from: http://www.southstaffordshirepct.nhs.uk/.../ Hand%20hygiene%20competency.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/APJON-2-276.PMC5123502.pdf
http://www.bath.ac.uk/casp/assets/Oral_Cancer_ Study_x2008x.pdf  8.,Non-OADS,/arxiv_data1/oa_pdf/1a/fd/APJON-2-242.PMC5123504.pdf
Available from: http://www.commonwealthfund.org/usr_doc/ betancourt_culturalcompetence_576.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/a9/APJON-2-227.PMC5123507.pdf
Available  from: http://www.quickfacts.census.gov/qfd/states/15000.,OADS,/arxiv_data1/oa_pdf/3d/a9/APJON-2-227.PMC5123507.pdf
Available from: http://www2.ed.gov/policy/ elsec/leg/esea02/pg104.html.,Non-OADS,/arxiv_data1/oa_pdf/3d/a9/APJON-2-227.PMC5123507.pdf
"Follow Sarah on Twitter  @SarahHKagan and look for her myths of aging column at http://www.mysuncoast.com/ health/kagan/.Précis for living in limbo and speaking  legibly: Reporting qualitative description  of oral tongue cancer experience Oral tongue cancer is a diagnosis that, while less common  than many solid tumors, reminds us as oncology nurses  how critical it is to understand patient experience in order  to improve practice.",Non-OADS,/arxiv_data1/oa_pdf/89/18/APJON-2-240.PMC5123508.pdf
Available from: http://www.merck.com/ mmhe/print/sec02/ch013/ch013c.html.,Non-OADS,/arxiv_data1/oa_pdf/cf/5f/APJON-2-271.PMC5123511.pdf
Available from:  http://www.fda.gov/drugs/developmentapprovalprocess/ developmentresources/druginteractionslabeling/ ucm110632.htm#ADRs:%20Prevalence%20and%20 Incidence.,Non-OADS,/arxiv_data1/oa_pdf/cf/5f/APJON-2-271.PMC5123511.pdf
Available from:  http://www.uspharmacist.com/content/s/82/c/14138/.,Non-OADS,/arxiv_data1/oa_pdf/cf/5f/APJON-2-271.PMC5123511.pdf
Available from: https://www.nccih.nih.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: http://www.parl.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: http://www.hc-sc.gc.ca/ahc-asc/ branch-dirgen/hpfb-dgpsa/nhpd-dpsn/index-eng.php.,OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from:  http://www.bcna.ca/files_3/ documents/Alternativehealthcarefinallygettingitsdue.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: https://www.circle.ubc.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: https://www.crnbc.ca/Standards/Lists/ StandardResources/437CompandAlternativeHealthCare.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: http://www.cameoprogram.org.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from: http://www.ohri.ca/decisionaid.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available  from: http://www.oicc.ca/en.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Available from:  http://www.cameoprogram.org/wp-content/uploads/2015/05/ CAM-in-Canada-print-version.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/f7/APJON-2-205.PMC5123512.pdf
Complementary and Alternative  Medicine in Cancer Treatment 2012. http://www.cancer.gov/ cancertopics/pdq/cam/cam‑cancer/patient/viewed November  2014.,Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
Traditional Medicine in  Republic of Indonesia 2013. http://www.searo.who/int/entity/ medicines/topics/traditional medicine.,Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
Complementary and alternatives  therapies 2010<http://canceraustralia.gov.au/about‑us/ position‑statements/compelmentary‑and‑alternative>/ viewed January 2015.,Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
"Koithan, M.Let’s talk about complementary and alternative  therapies: The journal for Nurse Practitioners‑  JNP 2009.  http://www.npjjournal.org./viewed March 2015.",Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
<http://www.cancer.org/treatment/treatmentsideeffects/ complementrayalternativemedicine/complementary ‑and ‑ alternative ‑methods‑for ‑cancer ‑managment>/viewed August  2015.,Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
Traditional medicine  2008 August http://www.who.int/mediacentre/factsheets/ fs134/en/viewed August 2015 36.,Non-OADS,/arxiv_data1/oa_pdf/b7/cb/APJON-3-241.PMC5123515.pdf
Available from: http://www.nova.edu/ssss/ QR/QR17/callary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/af/APJON-3-233.PMC5123519.pdf
Available from:  https://www.hfnet.nih.go.jp/usr/kiso/pamp.,Non-OADS,/arxiv_data1/oa_pdf/e3/66/APJON-3-272.PMC5123520.pdf
Available from:  http://www.chemocare.com/chemotherapy/side‑effects/ fatigue‑and‑cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e3/66/APJON-3-272.PMC5123520.pdf
Available from: https://www.nurse.or.jp/home/publication/ toukei.,Non-OADS,/arxiv_data1/oa_pdf/e3/66/APJON-3-272.PMC5123520.pdf
Available  from: http://www.cancer.org/./cancerfactsstatistics/ global‑cancer‑facts‑ figures‑2nd‑e.,Non-OADS,/arxiv_data1/oa_pdf/5a/83/APJON-3-289.PMC5123521.pdf
Available from:  http://www.nch.com.np/article/read/opd_clinics/OPD/ Clinics.,Non-OADS,/arxiv_data1/oa_pdf/5a/83/APJON-3-289.PMC5123521.pdf
Available from: http://www.cancer.org/research/ cancerfactsstatistics/cancerfactsfigures 2015/index.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/APJON-3-259.PMC5123524.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/4a/a4/APJON-3-220.PMC5123525.pdf
Available  from: http://www.caresearch.com.au/caresearch.,Non-OADS,/arxiv_data1/oa_pdf/4a/a4/APJON-3-220.PMC5123525.pdf
In:  Cancer Control 2015 Available from: http://www.cancercontrol.,Non-OADS,/arxiv_data1/oa_pdf/4a/a4/APJON-3-220.PMC5123525.pdf
Cancer Survival for Common Cancers;  2014; Available from: http://www.cancerresearchuk.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/APJON-3-252.PMC5123527.pdf
Available from: http://www.cancerresearchuk.org/ health‑professional/cancer‑statistics/statistics ‑by‑cancer ‑ type/breast‑cancer/incidence‑invasive#heading‑Three.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/APJON-3-252.PMC5123527.pdf
Available from: http://www.consejogeneralenfermeria.org/index.php/.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/APJON-3-108.PMC5123529.pdf
Available from: http://www.boe.es/boe/dias/2006/07/27/pdfs/A28122-28165.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/APJON-3-108.PMC5123529.pdf
Available from: http://www.boe.es/boe/dias/2009/12/31/pdfs/ BOE-A-2009-21161.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/APJON-3-108.PMC5123529.pdf
Available from: http://www.foroenfermeria.es/wordpress2/wp-content/uploads/2012/03/prescripcionenfermera.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/APJON-3-108.PMC5123529.pdf
Available at: https://www.coib.cat/ [Accessed 1 Jan. 2016].,Non-OADS,/arxiv_data1/oa_pdf/d3/68/APJON-3-108.PMC5123529.pdf
Available at http://globocan.iarc.fr/Default.aspx  2.,Non-OADS,/arxiv_data1/oa_pdf/da/2b/APJON-3-25.PMC5123530.pdf
2014 Available at http://www.cfr.org/diseases-noncommunicable/emerging-global-health-crisis/p33883  3.,Non-OADS,/arxiv_data1/oa_pdf/da/2b/APJON-3-25.PMC5123530.pdf
Available at http://canceratlas.cancer.org 4.,Non-OADS,/arxiv_data1/oa_pdf/da/2b/APJON-3-25.PMC5123530.pdf
Available at: http://www.who.int/hrh/resources/observer12/en/index.html    6.,Non-OADS,/arxiv_data1/oa_pdf/da/2b/APJON-3-25.PMC5123530.pdf
Available from: http://www.apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=80&codcch=275.,Non-OADS,/arxiv_data1/oa_pdf/22/1f/APJON-3-51.PMC5123531.pdf
Available from: http://www.jjckb.xinhuanet.com/2015-11/03/c_134779811.htm.,Non-OADS,/arxiv_data1/oa_pdf/22/1f/APJON-3-51.PMC5123531.pdf
Available from: http://www.5.statcan.gc.ca/subject-sujet/subtheme-soustheme.action?pid=30000&id=-30000&lang=eng&more=0.,OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from: http://www.statcan.gc.ca/tables-tableaux/ sum-som/l01/cst01/demo26k-eng.htm.,OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from: http://www.cancer.ca/en/cancer-information/ cancer-type/breast/statistics/?region=bc.,Non-OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from: http://www.cancer.ca/en/cancer-information/ cancer-type/breast/statistics.,Non-OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from: http://www.cancer.ca/en/about-us/for-media/ media-releases/national/2013/south-asians-in-ontario-tremendously-under-screened-for-cancer/?region=bc.,Non-OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from:  http://www.12.statcan.gc.ca/census-recensement/2006/ref/ rp-guides/ethnic-ethnique-eng.cfm.,OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
Available from: http://www.dimax.rutgers.,Non-OADS,/arxiv_data1/oa_pdf/62/3c/APJON-3-86.PMC5123532.pdf
"Search terms Electronic databases were searched using the following search terms, “CIPN” or “cisplatin” or “taxanes” or “paclitaxel” or “docetaxel” or “oxaliplatin” or “carboplatin” or “platinum compounds” or “proteasome inhibitors” and “peripheral neuropathy” or “CIPN” and “mechanism of action” or “pharmaceutical agent” or “nutrient” or “herb” or “herbal medicines” or “chinese herbal medicines” or “ayurvedic herbal medicines.” Risk bias assessment The risk bias of both animal and human studies was assessed using the Cochrane risk of bias assessment tool (http://handbook.cochrane.org/,part 2, Chapter 8).",Non-OADS,/arxiv_data1/oa_pdf/53/79/APJON-3-73.PMC5123533.pdf
Table 1: Evidenced-based practice resources (selected) Guideline source Guideline internet address National Guideline Clearinghouse http://www.guideline.gov/ National Comprehensive Cancer  Networkhttp://www.nccn.org/ Agency for Healthcare Research and  Qualityhttp://www.ahrq.gov/ Clinical Trials.Gov (NIH) http://clinicaltrials.gov/ Center for Evidence-based Medicine http://www.cebm.net/ Turning Research into Practice  Databasehttp://www.tripdatabase.com/index.html National Institute for Health and  Clinical Excellencehttp://www.nice.org.uk/ Cochrane Database of Systematic  Reviewswww.cochrane.org Campbell Systematic Reviews http://www.campbellcollaboration.org British Medical Journal Clinical  Evidencewww.clinicalevidence.com Evidence matters Web of Science www.isiknowledge.com Scopus www.scopus.com/home.url Medline/PubMed EMBASE http://www.ncbi.nlm.nih.gov/ pubmed?term=EMBACE Bandolier www.jr2.ox.ac.uk/Bandolier Cumulative Index of Nursing and  Allied Health Literaturewww.ebscohost.com/nursing/products/ cinahl-databases/cinahl Joanna Briggs Institute www.JoannaBriggs.eduONS Pep — Putting Evidence into  Practicehttp://www2.ons.org/Research/PEP ONS EBP Toolkit https://www2.ons.org/Research/EBPRA/ Toolkit The National Comprehensive  Cancer Networkwww.nccn.org Figure 1:  Levels of evidence.,Non-OADS,/arxiv_data1/oa_pdf/1c/a8/APJON-3-17.PMC5123536.pdf
Available from: http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/1c/a8/APJON-3-17.PMC5123536.pdf
Cancer Care and Oncology Services  Standards; 2008. http://www.accreditation.ca/accreditation programs/qmentum/standards/cancercare/.,Non-OADS,/arxiv_data1/oa_pdf/03/89/APJON-3-21.PMC5123537.pdf
Available from: http://www.globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/APJON-3-33.PMC5123540.pdf
Available from: http://www.keionline.org/sites/default/files/IIHI_Oncology_Trend_Report_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/APJON-3-33.PMC5123540.pdf
Available  from: http://www.ncbi.nlm.nih.gov/books/NBK13570/ 5.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/APJON-3-33.PMC5123540.pdf
Available from: http://globocan.iarc.fr/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/01/e1/APJON-3-37.PMC5123542.pdf
Available from: http://www.un.org.ua/en/information-centre/news/2011.,Non-OADS,/arxiv_data1/oa_pdf/7a/9a/APJON-3-41.PMC5123543.pdf
Available from: http://www.ganjoho.jp/reg_stat/statistics/dl/2015.,OADS,/arxiv_data1/oa_pdf/7a/9a/APJON-3-41.PMC5123543.pdf
Onishi: Complementary Therapy for Cancer Survivors Asia-Paci ﬁ c Journal of Oncology Nursing • Jan-Mar 2016 • Vol 3 • Issue 1 44http://www.2.ttcn.ne.jp/honkawa/2164.html.,Non-OADS,/arxiv_data1/oa_pdf/7a/9a/APJON-3-41.PMC5123543.pdf
Available from: http://www.mhlw.go.jp/houdou/2003/07/h0725-3.html.,Non-OADS,/arxiv_data1/oa_pdf/7a/9a/APJON-3-41.PMC5123543.pdf
Available from: http://www.law.e-gov.go.jp/announce/H18HO098.html.,Non-OADS,/arxiv_data1/oa_pdf/7a/9a/APJON-3-41.PMC5123543.pdf
Available from: http://www.who.int/cancer/prevention/en.,Non-OADS,/arxiv_data1/oa_pdf/26/d5/APJON-3-30.PMC5123544.pdf
Available from:  http://www.international.aanp.org/Practice/APNRoles.,Non-OADS,/arxiv_data1/oa_pdf/26/d5/APJON-3-30.PMC5123544.pdf
Available from: http://www.data.worldbank.org/indicator/ SH.XPD.PCAP .,OADS,/arxiv_data1/oa_pdf/26/d5/APJON-3-30.PMC5123544.pdf
(See Quality Dying Initiative at http://sunnybrook.ca for additional information about this initiative.),Non-OADS,/arxiv_data1/oa_pdf/8d/d6/APJON-3-66.PMC5123548.pdf
Available from: http://www.who.int/cancer/palliative/definition/en/.,Non-OADS,/arxiv_data1/oa_pdf/8d/d6/APJON-3-66.PMC5123548.pdf
Available from: http://www.who.int/cancer/publications/palliative-care-atlas/en/.,Non-OADS,/arxiv_data1/oa_pdf/8d/d6/APJON-3-66.PMC5123548.pdf
"Clinical Resources rEuropean Migration Network: http://ec.europa.eu/ dgs/home-affairs/ﬁnancing/fundings/migration- asylum-borders/asylum-migration-integration-fund/ european-migration-network/index en.htmrEuropean Union Agency for Fundamental Rights: http://fra.europa.eu/en References Afzali, M., Shahhosseini, Z., & Hamzeghardeshi, Z.",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://ec.europa.eu/ eurostat/documents/4168041/6742650/KS-QA-15-003- EN-N.pdf/b7786ec9-1ad6-4720-8a1d-430fcfc55018 C´aritas Espa ˜nola.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://www.caritas.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://www.eliamep.gr/ wp-content/uploads/en/2009/04/research brief spain.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://irregular-migration.net European Center for Disease Prevention and Control.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://ecdc.europa.eu/en/publications/Publications/ Expert-opinion-irregular-migrants-public-health-needs- Sept-2015.pdf European Commission.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://ec.europa.eu/dgs/home-affairs/what-we-do/ networks/european_migration_network/reports/docs/ ad-hoc-queries/298.emn_ad-hoc_query_irregular migration_updated_wider_dissemination_en.pdf European Migration Network.,OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://ec.europa.eu/ dgs/home-affairs/what-we-do/networks/european_ migration_network/docs/emn-glossary-en-version.pdf European Union Agency for Fundamental Rights.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://fra.europa.eu/ sites/default/ﬁles/fra_uploads/1827-FRA_2011 Migrants in_an_irregular_situation_EN.pdf Eurostat.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
"Retrieved from http://ec.europa.eu/ social/main.jsp?langId =en&catId =502&newsId =1007& furtherNews =yes Gittell, R., & Thompson, J. P. (2001).",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from https://www.un.org/en/documents/udhr/ United Nations.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from https://treaties.un.org/doc/ Publication/UNTS/Volume%20999/volume-999-I-14668- English.pdf United Nations.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://www.ohchr.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
Retrieved from http://www.unhcr.,Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
"Retrieved from http://yosisanidaduniversal.net/portada.php Yost, E. (1955).",Non-OADS,/arxiv_data1/oa_pdf/c1/0e/JNU-48-448.PMC5123581.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management 2016:12 471–476Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  471 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S117204Predictive value of NT -proBNP for 30-day  mortality in patients with non-ST -elevation  acute coronary syndromes: a comparison  with the GRACE and TIMI risk scores Dirk AAM Schellings1,2 Ahmet Adiyaman1 Jan-Henk E Dambrink1 AT Marcel Gosselink1 Elvin Kedhi1 Vincent Roolvink1 Jan Paul Ottervanger1 Arnoud WJ van’t Hof1 1Department of Cardiology, Isala  Heart Centre, Zwolle, 2Department  of Cardiology, Slingeland Hospital,   Doetinchem, the NetherlandsBackground: The biomarker N-terminal pro-brain natriuretic peptide (NT -proBNP) predicts  outcome in patients with non-ST -elevation acute coronary syndromes (NSTE-ACS).",Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
"4–6Correspondence: Ahmet Adiyaman Department of Cardiology, Isala Heart Centre, Dr. Van Heesweg 2, 8025 AB, Zwolle, the NetherlandsTel +31 38 424 8012Fax +31 38 424 3222Email v.r.c.derks@isala.nlJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: Schellings et alRunning head recto: NT -proBNP for risk assessment in non-ST -elevation acute coronary syndromesDOI: http://dx.doi.org/10.2147/VHRM.S117204",Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
Available from: http://www.escardio.org/guidelines.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
"Vascular Health and Risk Management 2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 476 Schellings et al 13.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/vhrm-12-471.PMC5123586.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 477–480Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  477 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S120944Platelet count and platelet indices in women with  preeclampsia Muneera A AlSheeha1 Rafi S Alaboudi1 Mohammad A Alghasham1 Javed Iqbal2 Ishag Adam1 1Department of Obstetrics and  Gynaecology, College of Medicine,   Qassim University, Buriadah,   2Department of Obstetrics  and Gynecology, Maternity and Children’s  Hospital, Qassim,   Kingdom of Saudi ArabiaBackground: Although the exact pathophysiology of preeclampsia is not completely understood,  the utility of different platelets indices can be utilized to predict preeclampsia.",Non-OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
"8 Various indices are used to measure  platelet functions, for example, the platelet count (PC), mean platelet volume (MPV), the PC to MPV ratio, and platelet distribution width (PDW); PDW measures platelet Correspondence: Ishag Adam Department of Obstetrics and Gynaecology, College of Medicine, Qassim University, PO Box 6655, Buriadah 51452, Kingdom of Saudi ArabiaTel +966 5 3764 4287Email ishagadam@hotmail.comJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: AlSheeha et alRunning head recto: Platelet count and platelet indices in women with preeclampsiaDOI: http://dx.doi.org/10.2147/VHRM.S120944",Non-OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 480 AlSheeha et al prospective studies are needed from early pregnancy to reach  a definitive conclusion.,Non-OADS,/arxiv_data1/oa_pdf/9a/78/vhrm-12-477.PMC5123587.pdf
"Rasband WS ImageJ, http://imagej.nih.gov/ij/, .",OADS,/arxiv_data1/oa_pdf/aa/60/JMNI-15-042.PMC5123607.pdf
NASA Johnson Technical Re - ports Server http://ston.jsc.nasa.gov/collections/TRS/  _techrep/TM-2014-217394.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/33/JMNI-15-060.PMC5123609.pdf
NASA Technical Reports Server  http:/ / http://ntrs.nasa.gov/archive/nasa/casi.ntrs.nasa.gov/  20100033747.pdf.,OADS,/arxiv_data1/oa_pdf/7c/33/JMNI-15-060.PMC5123609.pdf
"A mechanized, pressure sensitive gait carpet  (6.10 m long x 0.89 m wide) registered the x and y coordinates  of every footfall in real-time with a 0.64 cm spatial resolution  (GAITRite Inc., Clifton, New Jersey, http://www.gaitrite.com)  at 120 Hz.",Non-OADS,/arxiv_data1/oa_pdf/e6/00/JMNI-15-103.PMC5123614.pdf
"In total, 166 cita-tions were obtained through the literature search; 58 ad-ditional citations were included at the discretion of the authors (Table, Supplemental Digital Content 1 [available at:  http://links.lww.com/JTN/A0]  , which shows additional  citations).",OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
doi:  http://dx.doi.org/10.1016/j.arth.2004.09.043        HQ Specialty Pharma  .,OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
"Retrieved from  http://www.cdc.gov/nchs/data/ahcd/ nhamcs_emergency/2011_ed_web_tables.pdf         Nikolajsen ,  L.  ,     Finnerup ,  N. B.  ,     Kramp ,  S.  ,     Vimtrup ,  A. S.  ,     Keller ,   J.  ,   &   Jensen ,  T. S.    ( 2006 ).",OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
Retrieved from  http://www.pfizer.com/news/press-release/ press-release-detail/pfizer_reports_top_line_results_from_a_ phase_3_study_of_lyrica_pregabalin_capsules_cv_in_adults_ with_post_traumatic_peripheral_neuropathic_pain        Pfizer  .,Non-OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
"Retrieved from  http://www.fda.gov/ forconsumers/consumerupdates/ucm239747.htm         Vadivelu ,  N.  ,     Urman ,  R. D.  ,     Hines ,  R. L.  ,   &   Hines ,  R. L.",Non-OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
"Retrieved from  http://www.agencymeddirectors.wa.gov/ Files/2015AMDGOpioidGuideline.pdf          Wibbenmeyer ,  L.  ,     Eid ,  A.  ,     Liao ,  J.  ,     Heard ,  J.  ,     Horsfield ,  A.  ,     Kral ,   L.   , …   Rosenquist ,  R   .",OADS,/arxiv_data1/oa_pdf/37/09/jtran-23-361.PMC5123624.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7187–7198OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7187Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10965 0 effect of smoking on the genetic makeup of   toll-like receptors 2 and 6 Muhammad Kohailan1 Mohammad alanazi1 Mahmoud rouabhia2 abdullah alamri1 narasimha reddy Parine1 abdullah alhadheq1 santhosh Basavarajappa3 abdul aziz abdullah  al-Kheraif3 abdelhabib semlali1 1genome research chair, Department  of Biochemistry, college of science,   King saud University, riyadh, Kingdom  of saudi arabia; 2Département de  stomatologie, Faculté de Médecine  Dentaire, groupe de recherche  en Écologie Buccale, Université  laval, Québec city, Qc , canada;   3Dental Biomaterial research chair,   Department of Dental health, college  of applied Medical sciences, King  saud University, riyadh, Kingdom  of  saudi arabiaBackground:  Cigarette smoking is a major risk factor for lung cancer, asthma, and oral cancer,  and is central to the altered innate immune responsiveness to infection.",Non-OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
"Keywords:  polymorphism, toll-like receptor, genotyping, smoking, TLR2, TLR6 Introduction Tobacco smoking is a major public health concern that causes high mortality and  morbidity worldwide.1 The global prevalence of smoking among people aged $15 years  is estimated to be 22%2 and counting for ∼5–6 million deaths per year worldwide.3 This  number is projected to increase to ∼10 million per year by 2030.4 In Saudi Arabia, the  prevalence of smoking is variable, reaching .50% in certain regions of the country.5  A large number of diseases are attributed to smoking.6,7 Smoking accounts for ∼30%  of all cancer deaths in the developed countries, the majority of which is caused by  lung cancer.8 In addition, smoking can cause death by influencing cardiovascular and  respiratory diseases.9,10 Several commentaries written by epidemiologists indicate that  tobacco smoke is a multipotent carcinogenic mixture that can cause cancers of the  lower urinary tract including the renal pelvis and bladder;11,12 the upper aerodigestive  tract including the oral cavity, pharynx, larynx, and esophagus; and the pancreas.13–18  To promote asthma or cancers, tobacco smoking deregulates multiple cell properties  including adhesion, migration,19 and growth.20 These effects were reported with gingival correspondence: abdelhabib semlali Department of Biochemistry, college  of science, King saud University,  PO Box 2454, riyadh 11451, Kingdom  of saudi arabia Tel +966 1 467 6035 Fax +966 1 467 5802 email asemlali@ksu.edu.s aJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kohailan et al Running head recto: Effect of smoking on TLR2 and TLR6 DOI: http://dx.doi.org/10.2147/OTT.S109650",Non-OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
"As shown in Figure 1, regional  linkage disequilibrium (LD) plot was established using SNP  Annotation and Proxy Search ( http://www.broadinstitute.org/ mpg/snap/ldplot.ph p).",OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/34/ott-9-7187.PMC5123654.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/80/opth-10-2319.PMC5123656.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2319–2324Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2319Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11905 5 interactive navigation-guided ophthalmic plastic  surgery: navigation enabling of telescopes and  their use in endoscopic lacrimal surgeries Mohammad Javed ali1 swati singh1 Milind n naik1 swathi Kaliki2 Tarjani Vivek Dave1 1The institute of Dacryology,   2The Operation eyesight Universal  institute for eye Cancer, l.V.",Non-OADS,/arxiv_data1/oa_pdf/6d/80/opth-10-2319.PMC5123656.pdf
"Prasad  eye institute, road no 2, Banjara hills,  hyderabad, india email drjaved007@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ali et al Running head recto: Interactive navigation-guided ophthalmic plastic surgery DOI: http://dx.doi.org/10.2147/OPTH.S119055",Non-OADS,/arxiv_data1/oa_pdf/6d/80/opth-10-2319.PMC5123656.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6d/80/opth-10-2319.PMC5123656.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/80/opth-10-2319.PMC5123656.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/ott-9-7177.PMC5123657.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7177–7185OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7177Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11330 7 The prognostic value of systemic and local  inﬂammation in patients with laryngeal   squamous cell carcinoma Jie Wang1,* shengzi Wang1 Xinmao song1,* Wenjiao Zeng2 shuyi Wang3 Fu chen1 hao Ding1 1Department of radiation Oncology,   eye, ear, nose, and Throat hospital,   Fudan University, 2Department of  Pathology, shanghai Medical school,   Fudan University, 3Department of  Pathology, eye, ear, nose, and Throat  hospital, Fudan University, shanghai,   People’s republic of china *These authors contributed equally  to this workBackground:  Cancer-related systemic inflammation has been demonstrated to be associated  with poor outcome in multiple types of cancers.",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/ott-9-7177.PMC5123657.pdf
"Keywords:  laryngeal squamous cell carcinoma, systemic inflammation, neutrophil- to-lymphocyte ratio, platelet-to-lymphocyte ratio, tumor infiltrating lymphocytes Introduction Laryngeal squamous cell carcinoma (LSCC) is one of the most common malignancies  that remains as a significant cause of morbidity and mortality in head and neck.1 It is  estimated that the new cases of laryngeal cancer expected among men and women in  China in 2015 are 23,700 and 2,600, respectively; and the estimated number of deaths  from laryngeal cancer is about 14,500.2 Despite improvements in therapeutic modali - ties, the American Cancer Society indicates that there is a trend toward a decreasing  5-year survival rate among patients with laryngeal cancer in the recent years.3 Thus,  identification of novel and effective biomarkers for prediction of LSCC patients with  poor prognosis or at high risk of early recurrence would be of great significance and  may be beneficial for the development of effective therapeutic schemes.correspondence: shengzi Wang Department of radiation Oncology, eye,  ear, nose, and Throat hospital, Fudan  University, 83 Fenyang road, shanghai  200031, People’s republic of china Tel +86 189 1776 1761 email shengziwang@fudan.edu.c nJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Prognostic value of systemic and local inflammation in LSCC patients DOI: http://dx.doi.org/10.2147/OTT.S113307",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/ott-9-7177.PMC5123657.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/ott-9-7177.PMC5123657.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/b4/ott-9-7177.PMC5123657.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2981–2987Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2981OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11360 2 Perceptions and impact of bipolar disorder  in Japan: results of an internet survey Koichiro Watanabe1 eiji harada2 Takeshi inoue3 Yuka Tanji2 T oshiaki Kikuchi1 1Department of Neuropsychiatry,   Kyorin University, school of Medicine,   T okyo, 2Medical science, Medicines  Development Unit-Japan, eli lilly  Japan KK, hyogo, 3Department of  Psychiatry, T okyo Medical University,   T okyo, JapanAbstract:  Bipolar disorder is a recurrent and episodic illness.",Non-OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
"Furthermore, it is unknown which  factors may contribute to a change in diagnosis to bipolar disorder after an initial  incorrect diagnosis.correspondence: Yuka Tanji Medical science, eli lilly Japan KK, 7-1-5,  isogamidori, chuo-ku, Kobe 651-0086,  hyogo, Japan Tel +81 78 242 9197 Fax +81 78 242 9526 email tanji_yuka@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Watanabe et al Running head recto: Bipolar disorder in Japan DOI: http://dx.doi.org/10.2147/NDT.S113602",Non-OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
Available from: http://www.soumu.go.jp/johotsusintokei/statistics/ data/140627_1.pdf.,OADS,/arxiv_data1/oa_pdf/48/e4/ndt-12-2981.PMC5123658.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5a/94/nss-8-321.PMC5123659.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5a/94/nss-8-321.PMC5123659.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 321–328Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  321 OrigiNal reSearch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S114969Defining the rest interval associated with the  main sleep period in actigraph scoring Chin Moi Chow1 Shi Ngar Wong1 Mirim Shin1 Rebecca G Maddox2 Kristy-lee Feilds3 Karen Paxton4 Catherine Hawke4 Philip Hazell3 Katharine Steinbeck5 1Discipline of Exercise and Sport  Science, Faculty of Health Sciences,   2Sydney Medical School, 3Discipline of  Psychiatry, 4School of Rural Health,   5Discipline of Paediatrics and Child  Health, Sydney Medical School, The  University of Sydney, Sydney, NSW,  australiaAbstract:  Actigraphy is increasingly used for sleep monitoring.",Non-OADS,/arxiv_data1/oa_pdf/5a/94/nss-8-321.PMC5123659.pdf
"9Correspondence: Chin Moi Chow  Discipline of Exercise and Sport Science, Faculty of Health Sciences, The University of Sydney, K222, 75 east Street, Lidcombe, Sydney, NSW 2141, AustraliaTel +61 2 9351 9332Fax +61 2 9351 9204Email chin-moi.chow@sydney.edu.auJournal name: Nature and Science of Sleep Article Designation: ORIGINAl ReSeARcHY ear: 2016V olume: 8Running head verso: chow et alRunning head recto: Defining the night rest interval in Actiwatch 2DOI: http://dx.doi.org/10.2147/NSS.S114969",Non-OADS,/arxiv_data1/oa_pdf/5a/94/nss-8-321.PMC5123659.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/5a/94/nss-8-321.PMC5123659.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1763–1776Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1763Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S11268 5 Chronotherapy with low-dose modified-release  prednisone for the management of rheumatoid  arthritis: a review Stefano Paolo Beltrametti1 Aurora ianniello2 Clara Ricci3 1Department of Rheumatology,   S. Andrea Hospital, vercelli,   2Rheumatology Outpatient Clinic,   Novara, 3Primula Multimedia S.p.A,   Pisa, italyAbstract:  To date, rheumatoid arthritis (RA) remains a debilitating, life-threatening disease.",Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
"The interplay of B- and T-cells, macrophages, chondrocytes, osteoclasts,  and synovial cells, along with the release of a plethora of growth factors and cytokines  (eg, tumor necrosis factor alpha, interleukin [IL]-1 β, IL-6, IL-8, IL-12, and IL-17)  triggers the immune–inflammatory process typical of the disease.1,2 Damage of joints  and extra-articular organs may cause severe functional disabilities, reduced quality  of life (QoL), and increased mortality.3–6 In particular, morning symptoms (MS) such Correspondence: Stefano Paolo  Beltrametti Department of Rheumatology,  S. Andrea Hospital, Corso Mario  Abbiate, 21, 13100 vercelli, italy Tel +39 016 159 3496 Fax +39 016 159 3860 email paolo.beltrametti@aslvc.piemonte.it Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Beltrametti et al Running head recto: Prednisone in rheumatoid arthritis DOI: http://dx.doi.org/10.2147/TCRM.S112685",Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
Available from:  http://acrabstracts.org/abstract/prevalence-of-morning-stiffness-in- a-us-registry-population-of-rheumatoid-arthritis-patients /.,Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/9c/tcrm-12-1763.PMC5123661.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/d8/tcrm-12-1757.PMC5123662.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1757–1762Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1757ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11230 2 Thyroid dysfunction among type 2 diabetic female  egyptian subjects ibrahim n elebrashy1 amr el Meligi1 laila Rashed2 Randa F salam1 elham Y oussef1 shaimaa a Fathy1 1Department of internal Medicine,   Diabetes, and endocrinology,   2Department of Medical Biochemistry,   Faculty of Medicine, Cairo University,   giza, egyptPurpose:  High prevalence of thyroid disorders is more common in type 1 diabetes compared  to type 2 diabetes, due to associated autoimmunity.",Non-OADS,/arxiv_data1/oa_pdf/c9/d8/tcrm-12-1757.PMC5123662.pdf
"It has been observed that Correspondence: Randa F salam Department of internal Medicine, Cairo  University, Cairo University Road,  giza, egypt Tel +20 10 0140 7278 email randa.salam@live.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Elebrashy et al Running head recto: Thyroid dysfunction in type 2 diabetics DOI: http://dx.doi.org/10.2147/TCRM.S112302",Non-OADS,/arxiv_data1/oa_pdf/c9/d8/tcrm-12-1757.PMC5123662.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c9/d8/tcrm-12-1757.PMC5123662.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/d8/tcrm-12-1757.PMC5123662.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/85/opth-10-2311.PMC5123663.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2311–2317Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2311Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12042 8 a randomized double-masked study to compare  the ocular safety, tolerability, and efficacy of  bromfenac 0.075% compared with vehicle in  cataract surgery subjects Kamran hosseini1 Thomas Walters2 robert DaVanzo3 richard l lindstrom4 1insite Vision inc., alameda, C a, 2Texan  eye, austin, TX, 3Cornerstone health  Care, high Point, nC, 4Minnesota eye  Consultants, Bloomington, M n, UsaPurpose:  The aim of this study was to evaluate the safety, tolerability, and efficacy of a  low-dose version of bromfenac 0.075% in DuraSite® (bromfenac 0.075%) compared with  DuraSite® vehicle (vehicle) alone for the treatment of postoperative inflammation and ocular  pain after cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/eb/85/opth-10-2311.PMC5123663.pdf
"Typically, antibiotics are used for infection prophylaxis, postoperative  steroids are used for cystoid macular edema (CME) and inflammation prevention, and Correspondence: Kamran hosseini insite Vision inc., 965 atlantic avenue  alameda, Ca 94501, Usa Tel +1 510 747 1264 email kamran.hosseini@sunpharma.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Hosseini et al Running head recto: Bromfenac 0.075% in DuraSite DOI: http://dx.doi.org/10.2147/OPTH.S120428",Non-OADS,/arxiv_data1/oa_pdf/eb/85/opth-10-2311.PMC5123663.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/eb/85/opth-10-2311.PMC5123663.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/85/opth-10-2311.PMC5123663.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 207–216Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  207 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S119596T wo-year results after convective radiofrequency  water vapor thermal therapy of symptomatic  benign prostatic hyperplasia Christopher M Dixon1 Edwin Rijo Cedano2 Dalibor Pacik3 Vítězslav Vit3 Gabriel Varga3 Lennart Wagrell4 Thayne R Larson5 Lance A Mynderse6 1Department of Urology, Phelps  Memorial Hospital, Sleepy Hollow,   New Y ork, NY, USA; 2Department of  Urology, Clinical Canela, La Romana,  Dominican Republic;  3Department  of Urology, Brno University Hospital, Brno, Czech Republic;   4Urologcentrum, Stockholm, Sweden;   5Institute of Medical Research,   Scottsdale, AZ, 6Department of  Urology, Mayo Clinic, Rochester,  MN, USAObjective: The objective of this study was to assess the effectiveness and safety of convective  radiofrequency (RF) water vapor thermal therapy in men with lower urinary tract symptoms  (LUTS) associated with benign prostatic hyperplasia (BPH); a pilot study design with 2-year  follow-up evaluations.",Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
"1,4–7 Despite the availability of a variety of established and well- studied treatments, most men are reluctant to undergo a major surgical procedure due to Correspondence: Christopher M Dixon Department of Urology, Phelps Memorial Hospital, 777 North Broadway, Suite 203, Sleepy Hollow, NY 10591, USAEmail cdixon3879@aol.comJournal name: Research and Reports in Urology Article Designation: CLINICAL TRIAL REPORTY ear: 2016V olume: 8Running head verso: Dixon et alRunning head recto: Rezu-m System for LUTS due to BPH DOI: http://dx.doi.org/10.2147/RRU.S119596",Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 216 Dixon et al Acknowledgment The study was funded by NxThera, Inc., Maple Grove, MN,  USA.",Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
Available from: http://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neuro-genic-Male-LUTS-Guidelines-2015-v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/14/rru-8-207.PMC5123707.pdf
", 2007) and in the regulation of inositolTables of Links TARGETS Nuclear hormone receptorsaEnzymesb PP AR α Akt (PKB) PPAR β/δ Caspase 3 PPAR γ Caspase 7 GSK3 β HDACPTENLIGANDS β-catenin GW6471 β-tubulin Octanoic acid ATP T0070907 Ciglitazone Valproic acid Decanoic acid These Tables list key protein targets and ligands in this article which ar e hyperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Pawson et al., 2014) and are permanently archived in the Concise Guide to PHARMACOLOGY 2013/14 (a,bAlexander et al., 2013a,b).VPA in haemorrhagic shock via PPAR γ BJP British Journal of Pharmacology (2015) 172 5306 –5317 5307",Non-OADS,/arxiv_data1/oa_pdf/42/72/BPH-172-5306.PMC5123713.pdf
Supporting Information Additional Supporting Information may be found in the on- line version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13320Figure S1 Compounds structurally similar to VP A show var- iable HDAC inhibitory activity.,Non-OADS,/arxiv_data1/oa_pdf/42/72/BPH-172-5306.PMC5123713.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/37/cia-11-1697.PMC5123721.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1697–1706Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1697OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11643 0 Impact of whole body electromyostimulation on  cardiometabolic risk factors in older women with  sarcopenic obesity: the randomized controlled  FOrMOsA-sarcopenic obesity study Katharina Wittmann1 Cornel sieber2 simon von stengel1 Matthias Kohl3 ellen Freiberger2 Franz Jakob4 Michael lell5 Klaus engelke1 Wolfgang Kemmler1 1Institute of Medical Physics, Faculty  of Medicine, Friedrich-Alexander  University of erlangen-n ürnberg,   2Institute for Biomedicine of Aging,   Faculty of Medicine, Friedrich- Alexander University of erlangen- nürnberg, erlangen, 3Faculty of  Medical and life sciences, University  of Furtwangen, 4Musculoskeletal  research Center, University of  Würzburg, Würzburg, 5Department  of radiology and nuclear Medicine,   Klinikum nürnberg, Paracelsus  Medizinische Privatuniversität,   nürnberg, germanyBackground:  Sarcopenic obesity (SO) is characterized by a combination of low muscle and  high fat mass with an additive negative effect of both conditions on cardiometabolic risk.",Non-OADS,/arxiv_data1/oa_pdf/21/37/cia-11-1697.PMC5123721.pdf
uni-er langen.d e;   mail@katharina-wittmann.d e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wittmann et al Running head recto: Whole body electromyostimulation and the metabolic syndrome DOI: http://dx.doi.org/10.2147/CIA.S116430,Non-OADS,/arxiv_data1/oa_pdf/21/37/cia-11-1697.PMC5123721.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/21/37/cia-11-1697.PMC5123721.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/21/37/cia-11-1697.PMC5123721.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/7b/cia-11-1707.PMC5123722.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1707–1714Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1707OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11665 8 Correlation between age and gender in Candida   species infections of complete denture wearers:  a retrospective analysis Jolanta e loster1 Aneta Wieczorek1 Bartłomiej W Loster2 1Department of Dental Prosthetics,   2Department of Orthodontics,   Institute of Dentistry, Jagiellonian  University Medical College,   Kraków, PolandAim:  Denture-related stomatitis is a disorder that often affects denture wearers.",Non-OADS,/arxiv_data1/oa_pdf/c3/7b/cia-11-1707.PMC5123722.pdf
"The current thinking is that the etiology is multifactorial but, in many cases, it  includes a pathogenic response to Candida infection.8–10 Denture plaque can be a  reservoir of bacteria and fungi and may be responsible for respiratory tract diseases.11 Correspondence: Jolanta e loster Department of Dental Prosthetics,  Institute of Dentistry, Jagiellonian  University Medical College,  Montelupich 4, 31-155 Kraków,   Poland Tel +48 12 424 55 55 email jolanta.loster@uj.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Loster et al Running head recto: Candida  species infections DOI: http://dx.doi.org/10.2147/CIA.S116658",Non-OADS,/arxiv_data1/oa_pdf/c3/7b/cia-11-1707.PMC5123722.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c3/7b/cia-11-1707.PMC5123722.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c3/7b/cia-11-1707.PMC5123722.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1081–1087Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1081 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S113996Combined epidural morphine and bupivacaine  in the treatment of lumbosacral radicular  neuropathic pain: a noncontrolled prospective  study Simone Vigneri1,2 Gianfranco Sindaco2 Marco La Grua2 Matteo Zanella2 Laura Ravaioli2 Valentina Paci2 Gilberto Pari2 1Department of Experimental  Biomedicine and Clinical  Neurosciences, University of Palermo,  Palermo,  2Advanced Algology  Research and Pain Medicine Unit,  Santa Maria Maddalena Hospital,  Occhiobello, RO, ItalyObjective: The aim of this study was to investigate the therapeutic effectiveness of epidural  morphine and bupivacaine in patients with chronic lumbosacral radicular neuropathic pain after  the cessation of treatment.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
"3 Some  older studies reported that opioids have poor efficacy for neuropathic pain, although this conclusion has been progressively questioned because of the lack of compelling Correspondence: Simone Vigneri Advanced Algology Research and Pain Medicine Unit, Santa Maria Maddalena Hospital, Via Gorizia 2, 45030 Occhiobello, RO, ItalyTel +39 04 2576 8400Fax +39 04 2576 8460Email simone.vigneri@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Vigneri et alRunning head recto: Epidural treatment for lumbosacral neuropathic painDOI: http://dx.doi.org/10.2147/JPR.S113996",Non-OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1087 Epidural treatment for lumbosacral neuropathic pain  22.,Non-OADS,/arxiv_data1/oa_pdf/e7/02/jpr-9-1081.PMC5123724.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 783–787Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 783 Original rEsEarCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S115565 Validation of diagnostic codes for Charcot–Marie– T ooth disease in the Danish national Patient  registry signe Vaeth1 Uffe Birk Jensen1 rikke Christensen1 henning andersen2 1Department of Clinical genetics,   aarhus University hospital, aarhus n,  2Department of n eurology, aarhus  University hospital, aarhus C,   DenmarkPurpose: To validate the diagnostic codes for Charcot–Marie–Tooth disease (CMT) in the  Danish National Patient Registry (DNPR) using positive predictive value (PPV) as a measure  of validity.",Non-OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
"Few studies were performed nationwide, and no study had used  nationwide register-based data.3Correspondence: signe Vaeth Department of Clinical genetics, aarhus University hospital, skejby, Brendstrupgårdsvej 21 C, DK-8200, aarhus n, DenmarkTel +45 7845 5510Fax +45 8678 3181Email vaeth@dadlnet.dkJournal name: Clinical Epidemiology Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Vaeth et alRunning head recto: Validation of the Charcot-Marie-Tooth diagnosisDOI: http://dx.doi.org/10.2147/CLEP .S115565",OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
Available from: http://www.statistikbanken.dk/.,OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/c2/46/clep-8-783.PMC5123725.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/44/clep-8-769.PMC5123726.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/44/clep-8-769.PMC5123726.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology Clinical Epidemiology 2016:8 769Dovepress submit your manuscript | www.dovepress.com Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/98/44/clep-8-769.PMC5123726.pdf
"The incorrect sentence read as “The ten combinations of indicator diseases, age, and sex with the highest FYRDH among individuals of Danish origin, as well as the ten indi-cator diseases with the highest FYRHD among individuals of African origin, are shown in Table 1.”   The correct sentence should read “The ten combinations  of indicator diseases, age, and sex with the highest FYRHD among individuals of Danish origin, as well as the ten indica-tor diseases with the highest FYRHD among individuals of African origin, are shown in Table 2.”Table 2 was missed from being included in the paper and  is as follows:   Table 2 ten combinations of indicator disease, sex and age in  the Danish population and the african population with the highest  FYrHD Indicator disease Population FYRHD (95% CI) Lymphoma african 22.105 (6.397–43.665) thrombocytopenia african 18.000 (8.799–29.824) Herpes zoster african 17.891 (10.302–27.171) Pneumococcal  pneumonia african 15.000 (3.560–33.991) Syphilis african 11.364 (4.105–22.735) Viral meningitis and  encephalitisafrican 10.256 (3.199–22.169) Other CNS infections african 8.511 (2.679–18.691) mononucleosis african 6.250 (0.362–25.479) Candida  infection african 5.000 (1.610–11.379) Lung abscess/empyema without pneumoniaafrican 4.762 (0.304–20.204) Syphilis male 30 years 13.376 (7.465–21.024) Hepatitis a male 20 years 7.805 (3.417–14.566) Syphilis male 50 years 7.038 (2.838–13.844) Syphilis male 40 years 6.101 (1.943–13.740) Hepatitis a male 30 years 5.464 (2.403–10.369) Endocarditis Female 20 years 4.774 (1.763–10.111) Candida  infection male 30 years 4.009 (2.463–6.121) Syphilis male 20 years 4.000 (1.298–9.209) Other StIs male 30 years 3.997 (2.370–6.266) Non ‘a’ viral hepatitis male 30 years 3.551 (2.811–4.417) Abbreviations:  FYRHD, 5-year risk of an HIV diagnosis; CI, confidence interval;  CNS, central nervous system; StIs, sexually transmitted infections.Journal name: Clinical Epidemiology Article Designation: ErratumY ear: 2016V olume: 8Running head verso: Omland et alRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/CLEP .S125923",Non-OADS,/arxiv_data1/oa_pdf/98/44/clep-8-769.PMC5123726.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/ijn-11-6207.PMC5123727.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6207–6216International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6207OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11027 4 Pharmacokinetics and safety of DTs-108, a human  oligopeptide bound to sN-38 with an esterase- sensitive cross-linker in patients with advanced  malignancies: a Phase I study romain coriat1 sandrine J Faivre2 Olivier Mir3 chantal Dreyer2 stanislas ropert3 Mohammed Bouattour2 robert Desjardins4 François goldwasser3 eric raymond5 1gastroenterology and Digestive  Oncology Unit, cochin Teaching  hospital, Université Paris Descartes  sorbonne Paris cité, Paris,   2Department of Medical Oncology,   Beaujon T eaching hospital, Université  Paris  Diderot, Paris 7, clichy,   3Department of Medical Oncology,   cochin Teaching hospital, Université  Paris Descartes sorbonne Paris cité,   Paris, France; 4Drais Pharmaceuticals,   Bridgewater, NJ, Usa; 5groupe  hospitalier Paris saint-Joseph, Paris,   FranceBackground:  DTS-108 is a hydrosoluble prodrug, where the SN-38 moiety is covalently  linked to a 20-amino acid vector peptide by a specific esterase-sensitive cross-linker, releasing  7-ethyl-10-hydroxycampthotecin (SN-38) by esterase bond cleavage.",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/ijn-11-6207.PMC5123727.pdf
"Irinotecan (CPT-11, Campto®, Camptosar®, Pfizer, Inc., New Y ork, NY, USA)  appeared as a paradigm for prodrug delivery of SN-38, exhibiting a broad spectrum of correspondence: romain coriat gastroenterology and Digestive  Oncology Unit, cochin Teaching  hospital, Université Paris Descartes  sorbonne Paris cité, 27 rue du faubourg  st jacques, 75014 Paris, France Tel +33 1 5841 1952 email romain.coriat@aphp.f r  eric raymond groupe hospitalier Paris saint-Joseph,  185 rue raymond losserand 75014 Paris, France email eraymond@hpsj.f r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Coriat et al Running head recto: Phase I and pharmacokinetics of DTS-108 DOI: http://dx.doi.org/10.2147/IJN.S110274",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/ijn-11-6207.PMC5123727.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/ijn-11-6207.PMC5123727.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/7d/ijn-11-6207.PMC5123727.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 187–198Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 187 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S108783 Evaluation of BODE index and its relationship  with systemic inflammation mediated by  proinflammatory biomarkers in patients  with COPD Naushad Ahmad Khan1,2 Mradul Kumar Daga1 Istaq Ahmad2 Govind Mawari1 Suman Kumar3 Naresh Kumar1 Syed Akhter Husain2 1Department of Medicine, Maulana  Azad Medical College, 2Department  of Biosciences, Jamia Millia Islamia,   3Department of Microbiology,   Maulana  Azad Medical College,   New Delhi, IndiaIntroduction: BODE index, a multidimensional grading system which is based on Body mass  index, airway Obstruction, Dyspnea scale, and Exercise capacity, has been increasingly used for  the evaluation of chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
"Keywords: BODE index, chronic obstructive pulmonary disease, systemic inflammation,  biomarkers Introduction Chronic obstructive pulmonary disease (COPD) is a disorder characterized by pro- gressive development of airflow limitation and an enhanced chronic inflammatory response in the airways, 1 and is predicted to become the third most frequent cause of  death in the world by 2030.2 The major manifestation of airflow obstruction in COPD is the reduction in  forced expiratory volume in 1 second (FEV1).3 However, according to the European Correspondence: Mradul Kumar Daga Department of Medicine, 129, BL Taneja Block, Maulana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi - 110002, IndiaTel +91 11 2322 2964Fax +91 11 2322 2964Email drmraduldaga@gmail.comJournal name: Journal of Inflammation Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Khan et alRunning head recto: BODE index and systemic inflammation in COPDDOI: http://dx.doi.org/10.2147/JIR.S108783",Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
"http://www.atsjournals.org/doi/abs/10.1164/ajrccmcon- ference.2015.191.1_MeetingAbstracts.A2937 and http://www.atsjournals.org/doi/book/10.1164/ajrccm-confer - ence.2015.B38 Author contributions NAK contributed substantially as the first author by design- ing the study, assisting in data collection, carrying out experi-mental work, interpreting the data, drafting the manuscript, and approving the final version of the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosismanagement.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 198 Khan et al,Non-OADS,/arxiv_data1/oa_pdf/8e/21/jir-9-187.PMC5123728.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2016:8 77–81Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 77 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S117214 Positive clinical outcomes derived from  using Streptococcus salivarius K12 to prevent  streptococcal pharyngotonsillitis in children:  a pilot investigation Francesco Di Pierro1 Maria Colombo2 Alberto Zanvit3 Amilcare S Rottoli4 1Scientific Department, Velleja  Research, Milan, 2Pediatric  Department, University of Parma,   Parma, 3Stomatology Institute,   4Pediatric Department, Uboldo  Hospital, Cernusco S/N, Milan, ItalyBackground: Streptococcus salivarius K12 (BLIS K12®) is a probiotic strain producing the  bacteriocins salivaricin A2 and salivaricin B, both of which strongly antagonize the growth of  Streptococcus pyogenes, the most important bacterial cause of pharyngeal infections in humans.",Non-OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
"Keywords: Streptococcus salivarius K12, pediatric infections, pharyngotonsillitis, rhinitis, flu,  tracheitis, laryngitis, stomatitis, enteritis, otitis Introduction The oral probiotic Streptococcus salivarius strain K12 (also referred to here as BLIS  K12®) is known to produce the megaplasmid-encoded class I lantibiotics, salivaricin  A2, and salivaricin B.1 Expression of these two salivaricins enables BLIS K12 to coun- teract the growth of Streptococcus pyogenes2 and, also to a lesser extent, Haemopilus  influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis, all of which are  involved in the etiopathogenesis of acute otitis media.3 BLIS K12 colonizes the oral Correspondence:  Francesco Di Pierro Scientific Department, Velleja Research,  Viale Lunigiana 23, 20125 Milano, ItalyTel +39 349 552 7663Fax + 39 0523 511894Email f.dipierro@vellejaresearch.comJournal name: Drug, Healthcare and Patient Safety Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Di Pierro et alRunning head recto: Clinical outcomes derived from using K12 in childrenDOI: http://dx.doi.org/10.2147/DHPS.S117214",Non-OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
"Drug, Healthcare and Patient Safety 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 81 Clinical outcomes derived from using K12 in children different use of antibiotics, vaccines, or immune stimulant  supplements or else occurred along the year of study, being the two groups comparable in this perspective, too (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/f5/02/dhps-8-077.PMC5123729.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 221–230Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 221 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S117590 Reduced butyrylcholinesterase activity is an  early indicator of trauma-induced acute systemic  inflammatory response Aleksandar R Zivkovic Jochen Bender Thorsten Brenner Stefan Hofer*Karsten Schmidt* Department of Anesthesiology,   Heidelberg University Hospital,  Heidelberg, Germany *These authors contributed equally to  this workPurpose: Early diagnosis of systemic inflammatory response syndrome is fundamentally  important for an effective and a goal-directed therapy.",Non-OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
"4,6  Previously, it has been shown that patients diagnosed with severe systemic  inflammation Correspondence: Aleksandar R Zivkovic;  Stefan HoferDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120 Heidelberg, GermanyTel +49 6221 56 36 843; +49 6221 56  37 787Fax +49 6221 56 5345Email aleksandar.zivkovic@med.uni-heidelberg.de; stefan.hofer@med.uni-heidelberg.deJournal name: Journal of Inflammation Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Zivkovic et alRunning head recto: Reduced butyrylcholinesterase activity indicates acute inflammationDOI: http://dx.doi.org/10.2147/JIR.S117590",Non-OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 230 Zivkovic et al  22.,Non-OADS,/arxiv_data1/oa_pdf/42/c3/jir-9-221.PMC5123730.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/d2/ijn-11-6195.PMC5123731.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6195–6206International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6195OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12114 1 In vitro inflammatory effects of hard metal  (Wc–co) nanoparticle exposure andrea l armstead1,2 Bingyun Li1–3 1Department of Orthopaedics, School  of Medicine, 2School of Pharmacy,   West Virginia University, 3Mary  Babb Randolph Cancer Center,   Morgantown, WV, UsaAbstract:  Identifying the toxicity of nanoparticles (NPs) is an important area of research as  the number of nanomaterial-based consumer and industrial products continually rises.",Non-OADS,/arxiv_data1/oa_pdf/64/d2/ijn-11-6195.PMC5123731.pdf
"Depending on the NPs, this accumulation within  the cell may cause toxicity or induce a secondary immune response and stimulate  a local or systemic inflammatory process.5–7 Therefore, along with addressing the  direct toxic effects of the multitude of NPs currently used in consumer products, it is  important to consider the inflammatory response that these materials may generate  upon exposure.5 Macrophage-mediated inflammation typically occurs in response to bacterial or  viral infections and tissue injuries as a part of the normal healing process, but it can  also occur as a result of foreign particle inhalation.5,8 Depending on the stimulus,  macrophages differentiate into either a “classically” activated M1 or an “alternatively”  activated M2 phenotype, which have signature characteristics that distinguish them  from one another.9–14 Classical M1 macrophages play important roles in infection  clearance, typically in response to lipopolysaccharide (LPS), which stimulates a Correspondence: Bingyun Li Department of Orthopaedics, School  of Medicine, West Virginia University, 1  Medical center Drive, Morgantown, WV  26506-9196, Usa Tel +1 304 293 1075 Fax +1 304 293 7070 email bili@hsc.wvu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Armstead and Li Running head recto: Inflammatory effects of hard metal nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S121141",Non-OADS,/arxiv_data1/oa_pdf/64/d2/ijn-11-6195.PMC5123731.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/64/d2/ijn-11-6195.PMC5123731.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/d2/ijn-11-6195.PMC5123731.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 167–176Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 167 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S118595evaluation, management and prevention of lower  extremity youth ice hockey injuries Charles A Popkin1 Brian M Schulz2 Caroline N Park1 Thomas S Bottiglieri1 T Sean Lynch1 1Department of Orthopedic Surgery,   Center for Shoulder, elbow and  Sports Medicine at Columbia  University, New Y ork, NY, 2Kerlan‑Jobe  Orthopedic Clinic, Los Angeles,  CA, USAAbstract: Ice hockey is a fast-paced sport played by increasing numbers of children and adoles- cents in North America and around the world.",Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
"However, some recent injury prevention strategies are trying to lower the Correspondence: Charles A Popkin Department of Orthopedic Surgery, Center for Shoulder, elbow and Sports Medicine at Columbia University, 622 west 168th Street, New York, NY 10032, USATel +1 212 305 4787Fax +1 212 305 9754email cp2654@columbia.eduJournal name: Open Access Journal of Sports Medicine Article Designation: REvIEWY ear: 2016volume: 7 Running head verso: Popkin et alRunning head recto: Y outh ice hockey injuriesDOI: http://dx.doi.org/10.2147/OAJSM.S118595",Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
Available from: http://www.iihf.com/iihf-home/the-iihf/members.,Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open‑access‑journal‑of‑sports‑medicine‑journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
visit http://www.dovepress.com/testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/58/oajsm-7-167.PMC5123732.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/38/40263_2016_Article_390.PMC5124051.pdf
https://www.drugabuse.gov/publications/ media-guide/glossary .,Non-OADS,/arxiv_data1/oa_pdf/f5/38/40263_2016_Article_390.PMC5124051.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/a5/traumamon-21-03-22456.PMC5124107.pdf
Available from: http://www.oxforddictionaries.com/deﬁnition/english/accident .,Non-OADS,/arxiv_data1/oa_pdf/88/a5/traumamon-21-03-22456.PMC5124107.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/94/traumamon-21-03-20686.PMC5124109.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/d0/traumamon-21-03-20013.PMC5124121.pdf
Available from: http://www.iran-press-service.com/ips/ articles-2006/march-2006/norouz_19306.shtml .,Non-OADS,/arxiv_data1/oa_pdf/2f/d0/traumamon-21-03-20013.PMC5124121.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/27/traumamon-21-03-19110.PMC5124122.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/da/traumamon-21-03-22078.PMC5124123.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/8f/traumamon-21-03-31341.PMC5124126.pdf
Available from: http://www.who.int/environmental_health_emergencies/ vulnerable_groups/en.Accessed .,Non-OADS,/arxiv_data1/oa_pdf/f6/8f/traumamon-21-03-31341.PMC5124126.pdf
Available from: http://www.un.org/en/letsﬁghtracism/issues.shtml .,Non-OADS,/arxiv_data1/oa_pdf/f6/8f/traumamon-21-03-31341.PMC5124126.pdf
Available from: http://www.ifrc.org/en/what-wedo/ disaster-management/about-disasters/what-is-a-disaster/what-is- vulnerability /.,Non-OADS,/arxiv_data1/oa_pdf/f6/8f/traumamon-21-03-31341.PMC5124126.pdf
Available from: http://www.unfpa.org/ resources/protecting-women-emergency-situations .,Non-OADS,/arxiv_data1/oa_pdf/f6/8f/traumamon-21-03-31341.PMC5124126.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/13/traumamon-21-03-23005.PMC5124127.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/ec/traumamon-21-03-33608.PMC5124335.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CRYABHSPB5 Myoﬁbrillar myopathy MutationMolecular dynamicsBioinformatics 1.,Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.11.0042214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"26 527 –535, http://dx.doi.org/10.1097/WCO.0b013e328364d6b1 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"117 244 –253, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"85 381 –385, http://dx.doi.org/10.1111/cge.12169 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"19 483 –492, http://dx.doi.org/10.1111/j.1750-3639.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"(Paris) 171 715 –729, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"80 354 –366, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"20 92–95,http://dx.doi.org/10.1038/1765 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"342 379 –386, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Oncotarget 23 9007 –9016, http://dx.doi.org/10.18632/oncotarget.6928 ; H. Shinohara, Y. Inaguma, S. Goto, T. Inagaki, K. Kato, αβcrystallin and HSP28 are en- hanced in the cerebral cortex of patients with Alzheimer's disease, 1993.",OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"119 203 –208, http://dx.doi.org/10.1016/0022-510X(93)90135-L .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"242 56 –66,http://dx.doi.org/10.1111/j.1432-1033.1996.0056r.x .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Bioinformatics 25 1754 –1760, http://dx.doi.org/10.1093 /bioinformatics/btp324 .6 J.P. Fichna et al.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"20 1297 –1303, http://dx.doi.org/10.1101/gr.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"26 1781 –1802, http://dx.doi.org/10.1002/jcc.20289 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Neurology 54 1033 –1041, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"7 81, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Acta 1860 (1 Pt B) 149 –166, http://dx.doi.org/10.1016/j.bbagen.2015.06.008 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"93 (1) 181 –190, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Muscle 5 29, http://dx.doi.org/10.1186/s13395-015-0056-4 (eCollection 2015).",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Autophagy 10 (2) 374 –375, http://dx.doi.org/10.4161/auto.27173 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Biochemistry 44 14854 –14869, http://dx.doi.org/10.1021/bi0503910 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"PLoS One 2 e498, http://dx.doi.org/10.1371/journal.pone.0000498 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"22 66 –72,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"430 107 –112, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"66 62 –81,http://dx.doi.org/10.1007/s00018-008-8327-4 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Cell 15 2335 –2346, http://dx.doi.org/10.1091/mbc.E03-12-0893 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"79 393 –403, http://dx.doi.org/10.1016/j.exer.2004.06.015 .",OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"1 e31, http://dx.doi.org/10.1038/cddis.2010.3 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"111 411 –417, http://dx.doi.org/10.1007/s10549-007-9796-0 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Biochemistry 46 6308 –6317, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"14 684 –695, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"Acta 1860 (1 Pt B) 240 –245, http://dx.doi.org/10.1016/j.bbagen.2015.08.014 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
"PLoS One 10 e0126761, http://dx.doi.org/10.1371/journal.pone.0126761 .",Non-OADS,/arxiv_data1/oa_pdf/3d/03/main.PMC5124346.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/main.PMC5124349.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.10.005 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/main.PMC5124349.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 4 (2016) 222 e228,Non-OADS,/arxiv_data1/oa_pdf/f4/6a/main.PMC5124349.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/ce/main.PMC5124350.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.10.001,OADS,/arxiv_data1/oa_pdf/c0/ce/main.PMC5124350.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.10.001,Non-OADS,/arxiv_data1/oa_pdf/78/a3/main.PMC5124352.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,3 3–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/78/a3/main.PMC5124352.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Physical activityAfrican AmericanWomenIntervention moderation 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.008 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1007/s13142- 014-0265-0 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1249/01.mss.0000227639.83607.4d .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.2105/AJPH.2016.303064 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1037/hea0000142 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1093/eurpub/ckw051 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1177/ 1090198114557128 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1161/CIR.0000000000000350 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1016/j.genhosppsych.2009.08.001 .,OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
Age Ageing 32:81 –87.http://dx.doi.org/10.1093/ageing/32.1.81 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.1007/s12160-010-9166-8 .,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.4278/ajhp.140502-QUAN- 181.,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5124353.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/c7/main.PMC5124354.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.11.003 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/c7/main.PMC5124354.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 34 e37,Non-OADS,/arxiv_data1/oa_pdf/b8/c7/main.PMC5124354.pdf
"Overall, these previous studies are highly suggestive that mitochondrial O 2•−contributes to the pathogenesis of hypertension; however, it remains unclear if increased http://dx.doi.org/10.1016/j.redox.2016.11.011 Received 17 October 2016; Received in revised form 10 November 2016; Accepted 12 November 2016⁎Correspondence to: Free Radicals in Medicine Program, Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, 985850 Nebraska Medical Center, Omaha, NE 68198-5850, United States.",Non-OADS,/arxiv_data1/oa_pdf/5b/4a/main.PMC5124355.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/4a/main.PMC5124355.pdf
Appendix A. Suplementary Information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.11.011 .,Non-OADS,/arxiv_data1/oa_pdf/5b/4a/main.PMC5124355.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gene expression pro ﬁling Length biasTranscriptome Cochliomyia hominivorax Calliphoridae 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/1e/main.PMC5124356.pdf
http://dx.doi.org/10.1016/j.gdata.2016.11.002 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/1e/main.PMC5124356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/1e/main.PMC5124356.pdf
The quality of the reads was assessed before and after the trimming step using the program FASTQC ( http://www.bioinformatics.babraham.,OADS,/arxiv_data1/oa_pdf/4d/1e/main.PMC5124356.pdf
"Supplementary data associated with this article can be found in the online version, at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/1e/main.PMC5124356.pdf
"In one study, it was shown that it does not a ﬀect the E. coli http://dx.doi.org/10.1016/j.redox.2016.11.004 Received 1 November 2016; Received in revised form 7 November 2016; Accepted 9 November 2016⁎Correspondence to: Department of Pathology, University of Alabama at Birmingham, BMRII-534, 901 1919th Street S., Birmingham, AL 35294-0017, United States.",Non-OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5124357.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5124357.pdf
"Speciﬁcally, we measured the activities of mitochon- http://dx.doi.org/10.1016/j.redox.2016.11.003 Received 18 October 2016; Accepted 2 November 2016⁎Corresponding author.",OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5124358.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5124358.pdf
http://dx.doi.org/10.14336/ AD.12016.10627 .,Non-OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5124358.pdf
http://dx.doi.org/10.1155/2015/512618 .,Non-OADS,/arxiv_data1/oa_pdf/36/b7/main.PMC5124358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/main.PMC5124359.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.11.001 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/1d/main.PMC5124359.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.ijpddr.2016.11.001 .,OADS,/arxiv_data1/oa_pdf/3b/1d/main.PMC5124359.pdf
"PDI (ACA1_189420) functional domain prediction To understand the functions of PDI ACA1_189420, we predicted its functional domains via the NCBI Conserved Domain Search website ( http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi ).",OADS,/arxiv_data1/oa_pdf/3b/1d/main.PMC5124359.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.10.006,OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
"CA Cancer J Clin 66,7–30.http://dx.doi.org/10.3322/caac.21332 .Table 4.",OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1097/IGC .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1080/01635580902825670 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1097/IGC.0000000000000219 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1038/bjc.2014.305 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
"World J Surg Oncol 12, 58. http://dx.doi.org/10.1186/1477-7819-12-58 .",Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
"Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatecto-my.Med Oncol 30, 721. http://dx.doi.org/10.1007/s12032-013-0721-6 .",Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1016/j.ejca.2011.06.034 .,OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1371/journal.pone.0083069 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1371/journal.pone.0111886 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1016/j.jss.2015.06.014 .,OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1038/bjc.2013.785 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1007/s13277-015-3613-x .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.2147/OTT.S82174 [eCollection 2015].,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1371/journal.pone.0108062 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1111/j.1440-1827.2009.02369.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1111/j.1600-0897.2011.01068.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
"Nat Rev Immunol 15,7 3–86.http://dx.doi.org/10.1038/nri3789 .",Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
http://dx.doi.org/10.1038/nri3920 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
Gynecol Oncol .http://dx.doi.org/10.1016/j.ygyno.2016.05.007 .,OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
J Immunol Res .http://dx.doi.org/10.1155/2015/191832 .,Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
"Sci Rep 5, 15263. http://dx.doi.org/10.1038/srep15263 .Translational Oncology Vol.",Non-OADS,/arxiv_data1/oa_pdf/4e/f7/main.PMC5124360.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Tourette syndromeADHD Glutamate Fronto-striatal circuitMRS 1.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.013 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.tins.2006.01.001 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
81 –82http://dx.doi.org/10.1176/appi.books.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
Gen. Psychiatry 49 (7):584. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.jpsychores.2009.09.002 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
29 (1):13 –28.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.neuroscience.,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
25 (6): 487–497 (Available at: http://www.ncbi.nlm.nih.gov/pubmed/9468109 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1097/01.chi.0000181046.52078.f4 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
Front Psychiatry 2:1 –8.http://dx.doi.org/10.3389/fpsyt.2011.00065 (NOV).,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
2343 –2347 http://dx.doi.org/10.1016/j.cub.2014.08.038 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1006/jmrb.1993.1055 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1111/j.1600-0447.2011.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/mrm.20901 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1007/ s10334-013-0427-y .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1088/0031- 9155/30/4/008 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/jmri.10057 .22 J. Naaijen et al.,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1097/00004583-199707000-00021 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
18:15 –18.http://dx.doi.org/10.1002/mrm.25568 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1089/cap.2013.0081 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1007/s10803-006-0213-z .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1097/00004583-198907000-00015 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
24 (1):9 –25.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
Imaging 22 (1):13–22.http://dx.doi.org/10.1002/jmri.20356 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/S0887-8994(01)00262-4 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/0006-8993(85)90936-9 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
52:74 –88.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1176/appi.ajp.2011.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.pharmthera.2011.09.006 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
"http://dx.doi.org/10.1176/ajp.2007.164.6.942 .Provencher, S.W., 1993.",Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/ mrm.1910300604 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/nbm.698 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1152/jn.00060.2015 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
Available at:.http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1136/pgmj.2010.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1093/brain/123.3.425 (Jan- uary 1997).,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.jpsychores.2008.03.006 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
Lan- cet Psychiatry 2 (1):68 –87.http://dx.doi.org/10.1016/S2215-0366(14)00132-1 .,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
35 (1):79 –85.http://dx.doi.org/10.1007/s10802-006- 9086-z .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1097/00004583-199706000-00023 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1016/j.mehy.2009.,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
17 (1):39 –59.http://dx.doi.org/ 10.1007/s11065-007-9019-9 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1002/hbm.22588 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1080/ 00048670802050546 .,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
http://dx.doi.org/10.1097/ANA.,Non-OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC5124361.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/8f/main.PMC5124362.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.10.003,OADS,/arxiv_data1/oa_pdf/f2/8f/main.PMC5124362.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/97/ba/40800_2016_Article_41.PMC5124431.pdf
Available from: http://www.gipdatabank.nl .,Non-OADS,/arxiv_data1/oa_pdf/97/ba/40800_2016_Article_41.PMC5124431.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Qun Zhou, MD, PhD, Associate  Professor,  Department of Biochemistry and Molecular Biology,  University of Maryland School of Medicine, 108 North Greene  Street, Baltimore, MD 21201,  United States.",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/WJBC-7-231.PMC5124699.pdf
"World J Biol MINIREVIEWS 231 November 26, 2016 |Volume 7 |Issue 4| WJBC|www.wjgnet.comWorld J Biol Chem  2016 November 26; 7(4): 231-239  ISSN 1949-8454 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4331/wjbc.v7.i4.231",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/WJBC-7-231.PMC5124699.pdf
wjgnet.com/ 1949-8454 /full/v7/i4/231.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/WJBC-7-231.PMC5124699.pdf
"This figure was produced using Servier  medical art, available from http://www.servier.com/Powerpoint- image-bank.Duru N et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/WJBC-7-231.PMC5124699.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/WJBC-7-231.PMC5124699.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Salvatore Tolone, MD, PhD, Second  University of Naples, Division of General and Bariatric Surgery,  Via Pansini 5, 80131 Naples, Italy.",Non-OADS,/arxiv_data1/oa_pdf/1e/08/WJGS-8-719.PMC5124700.pdf
"With this  in mind, we sought to review studies that identified the  factors that predict outco me after laparoscopic total REVIEW 719 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comPre-operative clinical and instrumental factors as antireflux  surgery outcome predictorsSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.719World J Gastrointest Surg   2016 November 27; 8(11): 719-728 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1e/08/WJGS-8-719.PMC5124700.pdf
World J Gastrointest Surg  2016;  8(11): 719­728  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/1e/08/WJGS-8-719.PMC5124700.pdf
com/1948 ­9366/full/v8/i11/719.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/08/WJGS-8-719.PMC5124700.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1e/08/WJGS-8-719.PMC5124700.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to : Dr. Philip A Berry,  Department of Gas- troenterology and Hepatology, Guy’s and St Thomas’ NHS  Foundation Trust, Westminster Bridge Road, London SE1 7EH,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/3c/b7/WJGS-8-729.PMC5124701.pdf
World J Gastrointest Surg  2016; 8(11): 729-734   Available from: URL: http://www.wjgnet.com/1948-9366/full/ v8/i11/729.htm   DOI: http://dx.doi.org/10.4240/wjgs.v8.i11.729 INTRODUCTION Histoacryl glue therapy is licensed in the United  Kindom for emergency treatment of bleeding varices.,Non-OADS,/arxiv_data1/oa_pdf/3c/b7/WJGS-8-729.PMC5124701.pdf
"Its chemical composition is a monomer, n-butyl-2-MINIREVIEWS 729 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comPitfalls in histoacryl glue injection therapy for oesophageal,  gastric and ectopic varices: A reviewSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.729World J Gastrointest Surg   2016 November 27; 8(11): 729-734 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3c/b7/WJGS-8-729.PMC5124701.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3c/b7/WJGS-8-729.PMC5124701.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Fabio C M Torricelli,  Department of  Surgery, Hospital das Clinicas, University of Sao Paulo Medical  School, Av.",Non-OADS,/arxiv_data1/oa_pdf/9d/38/WJGS-8-735.PMC5124702.pdf
"Although  a short period of training can improve laparoscopic  surgical skills, full laparoscopic training in medical MINIREVIEWS 735 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comImpact of laparoscopic surgery training laboratory on  surgeon's performanceSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.735World J Gastrointest Surg   2016 November 27; 8(11): 735-743 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9d/38/WJGS-8-735.PMC5124702.pdf
"World  J Gastrointest Surg  2016; 8(11): 735­743  Available from: URL:  http://www.wjgnet.com/1948 ­9366/full/v8/i11/735.htm   DOI:  http://dx.doi.org/10.4240/wjgs.v8.i11.735 INTRODUCTION Laparoscopic surgery has gained popularity in the  last few decades, replacing open standard technique  in several procedures from general surgery, gastro­ intestinal surgery, gynecology and urology.",Non-OADS,/arxiv_data1/oa_pdf/9d/38/WJGS-8-735.PMC5124702.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9d/38/WJGS-8-735.PMC5124702.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sofoklis Panteleimonitis, MBChB, BSc,  MRCS, Research Fellow  in Colorectal Surgery, School of Health  Sciences and Social Work, University of Portsmouth, University  House, Winston Churchill Avenue, Portsmouth PO1 2UP,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/32/75/WJGS-8-744.PMC5124703.pdf
"In female  patients only two studies assessed urological and three SYSTEMATIC REVIEWS 744 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comCritical analysis of the literature investigating urogenital  function preservation following robotic rectal cancer  surgerySubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.744World J Gastrointest Surg   2016 November 27; 8(11): 744-754 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/32/75/WJGS-8-744.PMC5124703.pdf
World J  Gastrointest Surg  2016; 8(11): 744­754  Available from: URL:  http://www.wjgnet.com/1948-9366/full/v8/i11/744.htm   DOI:  http://dx.doi.org/10.4240/wjgs.v8.i11.744 INTRODUCTION Colorectal cancer  is one of the most common cancers  in the developed world[1-3] with rectal cancers making  up a third of t hose cancers[2-4].,Non-OADS,/arxiv_data1/oa_pdf/32/75/WJGS-8-744.PMC5124703.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/32/75/WJGS-8-744.PMC5124703.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Ajita Prabhu, MD, FACS,  Department of  General Surgery, University Hospitals Case Medical Center, Case  Western Reserve University, 11100 Euclid Avenue, Cleveland,  OH 44106, United States.",Non-OADS,/arxiv_data1/oa_pdf/14/6c/WJGS-8-755.PMC5124704.pdf
"We  report a rare case of gallstone ileus with impaction at  the jejunum and at a Meckel’s diverticulum in a 64-year- old female managed by laparoscopic converted to CASE REPORT 755 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comGallstone ileus associated with impaction at Meckel’s  diverticulum: Case report and literature reviewSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.755World J Gastrointest Surg   2016 November 27; 8(11): 755-760 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/14/6c/WJGS-8-755.PMC5124704.pdf
World J Gastrointest Surg  2016; 8(11): 755-760  Available  from: URL: http://www.wjgnet.com/1948-9366/full/v8/i11/755.,Non-OADS,/arxiv_data1/oa_pdf/14/6c/WJGS-8-755.PMC5124704.pdf
htm  DOI: http://dx.doi.org/10.4240/wjgs.v8.i11.755 INTRODUCTION We are reporting a case of gallstone ileus involving  multiple gallstones managed by laparoscopic converted  to open small bowel resections of impacted stones  at the jejunum and at a Meckel’s diverticulum (MD).,Non-OADS,/arxiv_data1/oa_pdf/14/6c/WJGS-8-755.PMC5124704.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/14/6c/WJGS-8-755.PMC5124704.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: René Fahrner, MD,  Division of General,  Visceral and Vascular Surgery, University Hospital Jena, Am Klinikum 1 , D-07740 Jena,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/d4/ab/WJGS-8-761.PMC5124705.pdf
"Published by Baishideng Publishing CASE REPORT 761 November 27, 2016 |Volume 8 |Issue 11 | WJGS|www.wjgnet.comTreatment options for spontaneous and postoperative  sclerosing mesenteritisSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4240/wjgs.v8.i11.761World J Gastrointest Surg   2016 November 27; 8(11): 761-765 ISSN 1948-9366 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d4/ab/WJGS-8-761.PMC5124705.pdf
"World J Gastrointest Surg  2016; 8(11): 761-765   Available from: URL: http://www.wjgnet.com/1948-9366/full/ v8/i11/761.htm   DOI: http://dx.doi.org/10.4240/wjgs.v8.i11.761 INTRODUCTION Sclerosing mesenteritis is a rare, benign pathology of  the abdominal adipose tissue[1].",Non-OADS,/arxiv_data1/oa_pdf/d4/ab/WJGS-8-761.PMC5124705.pdf
"Available from: URL: http://cursoenarm.net/UPTODA TE/ contents/mobipreview.htm?5/61/6096?source=HISTORY 8 Harvin G , Graham A. Sclerosing Mesenteritis: A Rare Cause of  Small Bowel Obstruction.",Non-OADS,/arxiv_data1/oa_pdf/d4/ab/WJGS-8-761.PMC5124705.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d4/ab/WJGS-8-761.PMC5124705.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ying-Qiu Huang, Professor  of Medicine,   Chief Physician , Department of Gastroenterology, General  Hospital of Benxi Steel and Iron (Group) Co., LTD, Fifth Clinical  College of China Medical University, 29 Renmin Road, Pingshan  District, Benxi 117000, Liaoning Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/75/98/WJH-8-1419.PMC5124714.pdf
"Core tip:  Primary biliary cholangitis (PBC), previously  called primary biliary cirrhosis, is an autoimmune non- suppurative inflammatory disease of the bile duct  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1419World J Hepatol   2016  November 28; 8(33): 1419-1441 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/75/98/WJH-8-1419.PMC5124714.pdf
World J Hepatol  2016; 8(33): 1419-1441   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/v8/ i33/1419.,Non-OADS,/arxiv_data1/oa_pdf/75/98/WJH-8-1419.PMC5124714.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i33.1419 INTRODUCTION Primary biliary cholangitis (PBC)[1-8] is a relatively rare  chronic intrahepatic cholestatic illness characterized by  a T-lymphocyte-mediated attack on small intralobular  biliary ducts and the presence of elevated plasma  concentrations of specific anti-mitochondrial antibodies  (AMAs), resulting in hepatic fibrosis and, ultimately,  hepatic cirrhosis or hepatic failure, with the potential for  hepatic cellular carcinoma via complications[9-11].",Non-OADS,/arxiv_data1/oa_pdf/75/98/WJH-8-1419.PMC5124714.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/75/98/WJH-8-1419.PMC5124714.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  María Eugenia Mamprin, PhD,  Professor  of Pharmacology,  Área Farm acología, Facultad de Ciencias  Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario,  Suipacha 531, Rosario S2002 LRK,  Argentina.",Non-OADS,/arxiv_data1/oa_pdf/a6/54/WJH-8-1442.PMC5124715.pdf
The evolution of hema -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1442World J Hepatol   2016  November 28; 8(33): 1442-1451 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/a6/54/WJH-8-1442.PMC5124715.pdf
World J Hepatol  2016;  8(33): 1442 ­1451  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/a6/54/WJH-8-1442.PMC5124715.pdf
"htm  DOI: http://dx.doi.org/10.4254/ wjh.v8.i33.1442INTRODUCTION To date, acute liver failure continues to be a defeating  syndrome in the clinical practice due to its rapid develop­ ment and its high risk of mortality.",Non-OADS,/arxiv_data1/oa_pdf/a6/54/WJH-8-1442.PMC5124715.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a6/54/WJH-8-1442.PMC5124715.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Naohiko Makino, MD, PhD, Associate Professor,  Department of Gastroenterology, Faculty of Medicine,  Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/WJH-8-1452.PMC5124716.pdf
Multiple logistic regression  analysis was used to determine the relationship between  the pancreatic hyperechogenicity and clinical and bio-Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1452World J Hepatol   2016  November 28; 8(33): 1452-1458 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/67/c2/WJH-8-1452.PMC5124716.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/c2/WJH-8-1452.PMC5124716.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/67/c2/WJH-8-1452.PMC5124716.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Daniela Catalano, MD,  Department of  Medicine, the School of Medicine of the University of Catania, Policlinico, Via Santa Sofia 78, 95100 Catania,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/fc/e6/WJH-8-1459.PMC5124717.pdf
Multiple  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1459World J Hepatol   2016  November 28; 8(33): 1459-1465 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/fc/e6/WJH-8-1459.PMC5124717.pdf
World J Hepatol  2016; 8(33): 1459 ­1465   Available from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/ v8/i33/1459.,Non-OADS,/arxiv_data1/oa_pdf/fc/e6/WJH-8-1459.PMC5124717.pdf
"htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i33.1459 INTRODUCTION Liver diseases, already in the past, were considered at  least partly a consequence of unhealthy lifestyles and  adverse environmental conditions, a concept that was  very well addressed also by pathologists[1].",Non-OADS,/arxiv_data1/oa_pdf/fc/e6/WJH-8-1459.PMC5124717.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fc/e6/WJH-8-1459.PMC5124717.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Oya Balci Sezer, MD,  Department of  Pediatric Gastroenterology, Hepatology and Nutrition, Baskent  University, Baglica Kampusu Eskisehir Yolu, 20 km Baglıca,  06540 Ankara, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/c1/40/WJH-8-1466.PMC5124718.pdf
The presence  of ascites in all age groups was significantly associated Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1466World J Hepatol   2016  November 28; 8(33): 1466-1470 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/c1/40/WJH-8-1466.PMC5124718.pdf
World J Hepatol  2016; 8(33): 1466 ­1470  Available  from: URL:  http://www.wjgnet.co m/1948 ­5182 /full/v8/i33/1466.,Non-OADS,/arxiv_data1/oa_pdf/c1/40/WJH-8-1466.PMC5124718.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i33.1466 INTRODUCTION Esophageal variceal bleeding is among the most serious  consequences of chronic liver disease[1].,Non-OADS,/arxiv_data1/oa_pdf/c1/40/WJH-8-1466.PMC5124718.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c1/40/WJH-8-1466.PMC5124718.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Sittisak Honsawek, MD, PhD,  Department  of Biochemistry, Faculty of Medicine, Chulalongkorn University,  King Chulalongkorn Memorial Hospital, Thai Red Cross Society,  1873 Rama IV Road, Patumwan, Bangkok 10330,  Thailand.",Non-OADS,/arxiv_data1/oa_pdf/ee/66/WJH-8-1471.PMC5124719.pdf
RESULTS BA children had significantly greater circulating uPAR and Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1471World J Hepatol   2016  November 28; 8(33): 1471-1477 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ee/66/WJH-8-1471.PMC5124719.pdf
World J Hepatol  2016; 8(33): 1471-1477   Available from: URL:  http://www.wjgnet.com/ 1948-5182 /full/ v8/i33/1471.htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i33.1471 INTRODUCTION Biliary atresia (BA) is a severe chronic cholestatic liver  disease of unknown etiology in young infants.,Non-OADS,/arxiv_data1/oa_pdf/ee/66/WJH-8-1471.PMC5124719.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ee/66/WJH-8-1471.PMC5124719.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Xiao- Hui Xiang,  Department of  Hepatopancreatobiliary and Splenic Medicine, Affiliated Hospital,  Logistics University of People’s Armed Police Force, 220 Chenglin  Road, Hedong District, Tianjin 300162,  China.",Non-OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
"In addition, concepts  related to pathology characteristics, epidemiology and  medicalization, metabolic syndrome and its combination  of symptoms including insulin resistance, biomarkers Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i33.1478World J Hepatol   2016  November 28; 8(33): 1478-1488 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
World J Hepatol  2016; 8(33): 1478-1488   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/v8/ i33/1478.,Non-OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i33.1478 INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is defined  by liver fat deposition with a concentration of hepatic  triglycerides exceeding 5% of liver weight in the absence  of excessive alcohol intake.,Non-OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
Highly  related concepts including all concepts from the Gene  Ontology (GO) and the Medical Subject Headings (MeSH)  were categorized by semantic search technology using  GoPubMed® search engine (http://www.gopubmed.org/ web/gopubmed/).,OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ad/ae/WJH-8-1478.PMC5124720.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  T Bruce Ferguson Jr, MD, FAHA, FACC,  FACS, Professor,  CV Sciences, East Carolina Heart Institute,  East Carolina Diabetes and Obesity Institute, Brody School  of Medicine at East Carolina University, 115 Heart Drive,  Greenville, NC 27615, United States.",Non-OADS,/arxiv_data1/oa_pdf/0c/8c/WJC-8-623.PMC5124721.pdf
"In fac t, it is the physiology of these  arterial grafts that is the mechanism for their impact REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.623 623 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 623-637 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/0c/8c/WJC-8-623.PMC5124721.pdf
wjgnet.com/ 1949-8462 /full/v8/i11/ 623.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/8c/WJC-8-623.PMC5124721.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0c/8c/WJC-8-623.PMC5124721.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Jackson J Liang, DO, Division of  Cardiology, Electrophysiology Section, Hospital of the University  of Pennsylvania, 3400 Spruce Street, 8 Gates Building, Phila - delphia, PA 19104, United States.",Non-OADS,/arxiv_data1/oa_pdf/4c/fc/WJC-8-638.PMC5124722.pdf
World J Cardiol  2016;  8(11): 638-646  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/WJC-8-638.PMC5124722.pdf
com/ 1949-8462 /full/v8/i11/ 638.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/WJC-8-638.PMC5124722.pdf
"The MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.638 638 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 638-646 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/4c/fc/WJC-8-638.PMC5124722.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4c/fc/WJC-8-638.PMC5124722.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Marco Canepa, MD, PhD, Assistant  Professor  of Cardiology, Cardiovascular Disease Unit, Department  of Internal Medicine, University of Genova and IRCCS Azienda  Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la  Ricerca sul Cancro, Largo Rosanna Benzi, 10, 16132 Genova,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/2b/d8/WJC-8-647.PMC5124723.pdf
"We  compared patients with and without AF, and assessed  the association between AF and all-cause mortality by ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.647 647 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 647-656 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Retrospective Cohort Study",Non-OADS,/arxiv_data1/oa_pdf/2b/d8/WJC-8-647.PMC5124723.pdf
World J Cardiol  2016;  8(11): 647-656  Ava ilable from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/2b/d8/WJC-8-647.PMC5124723.pdf
com/ 1949-8462 /full/ v8/i11/ 647.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/d8/WJC-8-647.PMC5124723.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2b/d8/WJC-8-647.PMC5124723.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Elia De Maria, MD, PhD, Chief of  Arrhythmology Lab, Cardiology Unit, Ramazzini Hospital, Via  Molinari 1, 41012 Carpi (Modena),   Italy.",Non-OADS,/arxiv_data1/oa_pdf/b4/94/WJC-8-657.PMC5124724.pdf
"CONCLUSION In Riata™ leads the delivery of a low current during ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.657 657 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 657-666 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/b4/94/WJC-8-657.PMC5124724.pdf
World J Cardiol  2016; 8(11): 657 ­666  Available from: URL:   http://www.wjgnet.com/ 1949 ­8462 /full/v8/i11/ 657.htm  DOI:  http://dx.doi.org/ 10.4330 /wjc.v8.i11.,Non-OADS,/arxiv_data1/oa_pdf/b4/94/WJC-8-657.PMC5124724.pdf
"Available  from: URL: http://www.innovationsincrm.com/cardiac ­rhythm ­ management/2012/november/353 ­lead­integrity ­measurement ­ during-defibrillator-generator-replacement 16 Webber MR , Allen RF, Stiles MK.",Non-OADS,/arxiv_data1/oa_pdf/b4/94/WJC-8-657.PMC5124724.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b4/94/WJC-8-657.PMC5124724.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited man uscript Correspondence to: Dr. Ignatios Ikonomidis, MD, FESC,  2nd  Department of Cardiology, University of Athens Medical School,  Attikon Hospital, Rimini 1, Haidari, 12462 Athens,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/e5/5e/WJC-8-667.PMC5124725.pdf
"METHODS Forty psoriatic patients without cardiovascular disease, ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.667 667 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 667-675 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/e5/5e/WJC-8-667.PMC5124725.pdf
World J Cardiol  2016;  8(11): 667-675  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/e5/5e/WJC-8-667.PMC5124725.pdf
com/ 1949-8462 /full/v8/i11/ 667.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/5e/WJC-8-667.PMC5124725.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e5/5e/WJC-8-667.PMC5124725.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Mahdi Najafi, MD, Associate Professor,  Department of Anesthesiology, Tehran Heart Center, Tehran  University of Medical Sciences,  North Kargar Street, Tehran  1411713138, Iran.",Non-OADS,/arxiv_data1/oa_pdf/48/57/WJC-8-676.PMC5124726.pdf
"Long-term 6.5-year  overall and opium-stratified survival, adjusted survival  curves based on opium consumption as well as possible  predictors of all-cause mortality using multiple cox  regression were determined by statistical analysis.ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.676 676 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 676-683 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC Prospective Study",Non-OADS,/arxiv_data1/oa_pdf/48/57/WJC-8-676.PMC5124726.pdf
wjgnet.com/ 1949-8462 /full/v8/i11/ 676.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/57/WJC-8-676.PMC5124726.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/48/57/WJC-8-676.PMC5124726.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Bhaskar Bhardwaj, MD, Resident  Physician,  Department of Internal Medicine, University of  Missouri Kansas City School of Medicine, 2301 Holmes Street,  Kansas City, MO 64108, United States.",Non-OADS,/arxiv_data1/oa_pdf/e2/9c/WJC-8-684.PMC5124727.pdf
"This association of polycythemia vera with PVT has not CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4330/wjc.v8.i11.684 684 Novembe r 26, 2016 |Volume 8 |Issue 11 | WJC|www.wjgnet.comWorld J Cardiol  2016 November 26; 8(11): 684-688 ISSN 1949-8462 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/e2/9c/WJC-8-684.PMC5124727.pdf
World J Cardiol  2016; 8(11): 684-688  Available from: URL:   http://www.wjgnet.com/ 1949-8462 /full/v8/i11/ 684.htm  DOI:  http://dx.doi.org/ 10.4330 /wjc.v8.i11.,Non-OADS,/arxiv_data1/oa_pdf/e2/9c/WJC-8-684.PMC5124727.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e2/9c/WJC-8-684.PMC5124727.pdf
"ªKembu Nakamoto, et al., 2016; Published by Mary Ann Liebert, In c. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.SURGICAL INFECTIONS Volume 17, Number 6, 2016Mary Ann Liebert, Inc.DOI: 10.1089/sur.2015.267 724",Non-OADS,/arxiv_data1/oa_pdf/c4/8e/sur.2015.267.PMC5124732.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 25, Number 23, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2016.0222 1808",Non-OADS,/arxiv_data1/oa_pdf/96/12/scd.2016.0222.PMC5124737.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Number 11, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2016.0107 677",Non-OADS,/arxiv_data1/oa_pdf/2b/59/dia.2016.0107.PMC5124747.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.schres.,OADS,/arxiv_data1/oa_pdf/70/29/nihms827318.PMC5124763.pdf
A  similarity search was performed against the UniProt Knowledgebase (http://www.uniprot.org/) for functional annotation of genes using a threshold of E-value <  1e −5.,OADS,/arxiv_data1/oa_pdf/69/f2/srep37487.PMC5124961.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Ding, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/69/f2/srep37487.PMC5124961.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/69/f2/srep37487.PMC5124961.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mirko D’Onofrio, Professor,  Department  of Radiology, G.B.",Non-OADS,/arxiv_data1/oa_pdf/8b/80/WJG-22-9661.PMC5124972.pdf
"mirko.donofrio@univr.i t Telephone:  +39-45-8124301 Fax:  +39-45-8027490 Received:  June 24, 2016EDITORIAL 9661 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9661World J Gastroenterol   2016 November 28; 22(44): 9661-9673  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8b/80/WJG-22-9661.PMC5124972.pdf
World J Gastroenterol  2016;  22(44): 9661-9673  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8b/80/WJG-22-9661.PMC5124972.pdf
com/1007-9327/full/v22/i44/9661.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/80/WJG-22-9661.PMC5124972.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/8b/80/WJG-22-9661.PMC5124972.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Fabio Nascimbeni, MD, PhD,  Division  of Internal Medicine and Metabolism, Nuovo Ospedale Civile  Sant'Agostino Estense - Department of Biomedical, Metabolic  and Neural Sciences, University of Modena and Reggio Emilia  and Azienda Ospedaliera of Modena, Via Giardini 1355, 41126  Modena, Italy.",Non-OADS,/arxiv_data1/oa_pdf/50/8b/WJG-22-9674.PMC5124973.pdf
"This REVIEW 9674 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9674World J Gastroenterol   2016 November 28; 22(44): 9674-9693  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/50/8b/WJG-22-9674.PMC5124973.pdf
"World J  Gastroenterol  2016; 22(44): 9674-9693  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9674.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9674 INTRODUCTION The storage of excess lipids is not among the physiologic  functions of the liver , which normally is almost devoid  of fat content[1].",Non-OADS,/arxiv_data1/oa_pdf/50/8b/WJG-22-9674.PMC5124973.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/50/8b/WJG-22-9674.PMC5124973.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Milena Ilic, MD, PhD, Faculty of Medical  Sciences, University of Kragujevac, S. Markovica 69, 34000  Kragujevac, Serbia.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"Globally, about REVIEW 9694 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9694World J Gastroenterol   2016 November 28; 22(44): 9694-9705  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
http://www.wjgnet.com/1007-9327/full/v22/i44/9694.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9694 INTRODUCTION Pancreatic cancer is the one of leading causes of cancer  mortality in developed countries and one of the most  lethal malignant neoplasms across the world[1-3].,Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"Available from:  URL: http://globocan.iarc.fr 2 Ferlay J , Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo  M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality  worldwide: sources, methods and major patterns in GLOBOCAN  2012.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"Available from: URL: http://seer.cancer.gov/ csr/1975_2013/ 4 Hidalgo M , Cascinu S, Kleeff J, Labianca R, Löhr JM,  Neoptolemos J, Real FX, Van Laethem JL, Heinemann V.  Addressing the challenges of pancreatic cancer: future directions  for improving outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
Available from: URL: http://www3.who.int.,Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"Available from:  URL: http://www.cancer.org 57 Silverman DT , Hoover RN, Brown LM, Swanson GM, Schiffman  M, Greenberg RS, Hayes RB, Lillemoe KD, Schoenberg JB,  Schwartz AG, Liff J, Pottern LM, Fraumeni JF.",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/c0/c3/WJG-22-9694.PMC5124974.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Miodrag L Lukic, MD, PhD, Professor,  Center for Molecular Medicine and Stem Cell Research, Faculty  of Medical Sciences, University of Kragujevac, Svetozara  Markovica 69, 34000 Kragujevac,  Serbia.",Non-OADS,/arxiv_data1/oa_pdf/21/d2/WJG-22-9706.PMC5124975.pdf
"This review discusses the current evidence on MINIREVIEWS 9706 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9706World J Gastroenterol   2016 November 28; 22(44): 9706-9717  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/21/d2/WJG-22-9706.PMC5124975.pdf
World J Gastroenterol  2016; 22(44): 9706-9717   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i44/9706.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/21/d2/WJG-22-9706.PMC5124975.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/21/d2/WJG-22-9706.PMC5124975.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Yan-Qiang Huang, Professor, Department  of Medical Microbiology and Immunology, Youjiang Medical  University for Nationalities, No.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/WJG-22-9718.PMC5124976.pdf
"hyq77615@163.co m Telephone:  +86-776-2853272 Fax:  +86-776-2853272 Received:  June 8, 2016MINIREVIEWS 9718 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9718World J Gastroenterol   2016 November 28; 22(44): 9718-9726  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/WJG-22-9718.PMC5124976.pdf
"World J Gastroenterol  2016; 22(44): 9718-9726  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9718.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9718 INTRODUCTION As one of the most common pathogens, Helicobacter  pylori  (H. pylori ) is a Gram negative microaerophilic  bacterium which is closely related to chronic gastritis,  peptic ulcer disease, gastric cancer and mucosa  associated lymphoid tissue lymphoma[1].",Non-OADS,/arxiv_data1/oa_pdf/ff/99/WJG-22-9718.PMC5124976.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/ff/99/WJG-22-9718.PMC5124976.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Franco Scaldaferri,  Gastroenterology  Division, Catholic University of Sacred Heart, Largo Gemelli 8,  00168 Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/c2/09/WJG-22-9727.PMC5124977.pdf
"francoscaldaferri@gmail.com Telephone:  +39-6-30156018 Fax:  +39-6-30156018 Received:  June 27, 2016 Peer-review started:  June 27, 2016 First decision:  July 29, 2016 Revised:  August 23, 2016 Accepted:  September 14, 2016 Article in press:  September 14, 2016 Published online: November 28, 2016 Abstract AIM To explore the influence of Infliximab (IFX) on cancer  progression in a murine model of colonic cancer  associated to chronic colitis.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9727 9727 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9727-9733  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c2/09/WJG-22-9727.PMC5124977.pdf
"World J Gastroenterol  2016; 22(44): 9727-9733  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9727.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9727 INTRODUCTION Inflammatory bowel disease (IBD), such as Crohn’s  disease (CD) and ulcerative colitis (UC), is a chronic,  relapsing inflammatory disorder of the digestive tract  resulting from a loss of homeostasis between the  intestinal immune system and the gut microbiota in  genetically-predisposed individuals[1].",Non-OADS,/arxiv_data1/oa_pdf/c2/09/WJG-22-9727.PMC5124977.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/c2/09/WJG-22-9727.PMC5124977.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to: Alberto Tommasini, MD, PhD,  Institute  for Maternal and Child Health - IRCCS “Burlo Garofolo”, Via  dell’Istria 65/1, I-34137 Trieste,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/WJG-22-9734.PMC5124978.pdf
"Statistical analyses were performed to find significant  9734 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Ex vivo  response to mucosal bacteria and muramyl  dipeptide in inflammatory bowel diseaseBasic Study Claudia Loganes, Erica Valencic, Alessia Pin, Elisa Marini, Stefano Martelossi, Samuele Naviglio, Luigina De  Leo, Tarcisio Not, Lorenzo Monasta, Alberto Tommasini, Annalisa MarcuzziSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9734World J Gastroenterol   2016 November 28; 22(44): 9734-9743  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/WJG-22-9734.PMC5124978.pdf
World J Gastroenterol  2016;  22(44): 9734-9743  Available from: URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9734.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/c9/WJG-22-9734.PMC5124978.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/7f/c9/WJG-22-9734.PMC5124978.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9744 9744 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9744-9751  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7a/a2/WJG-22-9744.PMC5124979.pdf
"Hernández-Bartolomé A, López-Rodríguez R, Borque MJ,  González-Moreno L, Real-Martínez Y , García-Buey L, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2/angiopoietin-1 as non- invasive biomarker of cirrhosis in chronic hepatitis C. World J  Gastroenterol  2016; 22(44): 9744-9751  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9744.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9744 INTRODUCTION Chronic liver disease (CLD) caused by hepatitis C  virus (HCV) is an important public health problem  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/7a/a2/WJG-22-9744.PMC5124979.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/7a/a2/WJG-22-9744.PMC5124979.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Masahiro Yamamoto, PhD,  Tsumura  Research Laboratories, Tsumura & Co., 3586 Yoshiwara, Ami,  Inashiki, Ibaraki  300-1192, Japan.",Non-OADS,/arxiv_data1/oa_pdf/48/0d/WJG-22-9752.PMC5124980.pdf
"9752 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Transient receptor potential vanilloid 1-immunoreactive  signals in murine enteric glial cellsBasic Study Masahiro Yamamoto, Mitsue Nishiyama, Seiichi Iizuka, Shigeaki Suzuki, Norihiro Suzuki, Sadakazu Aiso, Jin  NakaharaSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9752World J Gastroenterol   2016 November 28; 22(44): 9752-9764  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/48/0d/WJG-22-9752.PMC5124980.pdf
"World J  Gastroenterol  2016; 22(44): 9752-9764  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9752.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9752 INTRODUCTION The enteric nervous system (ENS), an integrative  neuronal network that resides within the gut wall,  autonomously controls gastrointestinal (GI) motility,  secretion and blood flow without major inputs from the  brain[1,2].",Non-OADS,/arxiv_data1/oa_pdf/48/0d/WJG-22-9752.PMC5124980.pdf
"Imaging analysis for IHC In IHC from intestinal sections, the green fluorescence  of glial fibrillary acidic protein (GFAP) in MP was  detected and quantitated using Image J image analysis  software (version 1.40g; National Institute of Health,  Bethesda, MD, United States, http://rsbweb.nih.gov/ ij/)[28].",OADS,/arxiv_data1/oa_pdf/48/0d/WJG-22-9752.PMC5124980.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/48/0d/WJG-22-9752.PMC5124980.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Yun-Wen Zheng, PhD, Associate  Professor,  Department of Surgery and Organ Transplantation,  Faculty of Medicine, University of Tsukuba, Tsukuba-shi, Ibaraki  305-8575, Japan.",Non-OADS,/arxiv_data1/oa_pdf/ce/73/WJG-22-9765.PMC5124981.pdf
"ywzheng@md.tsukuba.ac.jp Telephone:  +81-29-8533221 Fax:  +81-29-8533222 Received:  July 21, 2016 Peer-review started:  July 22, 2016 First decision:  September 20, 2016 Revised:  October 5, 2016 Accepted:  October 27, 2016   Article in press:  October 27, 2016 Published online: November 28, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9765 9765 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9765-9774  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ce/73/WJG-22-9765.PMC5124981.pdf
"World J Gastroenterol  2016; 22(44): 9765-9774  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9765.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9765 INTRODUCTION Colorectal cancer is the fourth most common cause  of cancer-related deaths globally, and the number  of deaths has increased to approximately 700000  annually[1].",Non-OADS,/arxiv_data1/oa_pdf/ce/73/WJG-22-9765.PMC5124981.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/ce/73/WJG-22-9765.PMC5124981.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source: Unsolicited manuscript Correspondence to: Dr. Chao Wang, Associate Professor,   Department of Laboratory Medicine, Medical School, Yangtze  University, 1 Nanhuan Road, Jingzhou 434023, Hubei Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/bc/83/WJG-22-9775.PMC5124982.pdf
"Hepatocyte apoptosis was measured  9775 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Naringenin protects against isoniazid- and rifampicin- induced apoptosis in hepatic injuryBasic Study Chao Wang, Rui-Qin Fan, Yan-Xiang Zhang, Hao Nie, Kan LiSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9775World J Gastroenterol   2016 November 28; 22(44): 9775-9783  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bc/83/WJG-22-9775.PMC5124982.pdf
"World J Gastroenterol  2016; 22(44): 9775-9783  Available  from: URL: http://www.wjgnet.com/1007-9327/full/v22/ i44/9775.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9775 INTRODUCTION Tuberculosis (TB) is a deadly communicable disease caused by mycobacteria, and it remains a serious  global public health issue.",Non-OADS,/arxiv_data1/oa_pdf/bc/83/WJG-22-9775.PMC5124982.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/bc/83/WJG-22-9775.PMC5124982.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Xiao-Hua Zhang,  Department of  Gastroenterology, Jinling Hospital, 305 Zhong Shan Dong Lu,  Nanjing 210002, Jiangsu Province, China.",Non-OADS,/arxiv_data1/oa_pdf/12/30/WJG-22-9784.PMC5124983.pdf
"9784 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Effects of ω-3 fatty acids on toll-like receptor 4 and nuclear  factor-κB p56 in lungs of rats with severe acute pancreatitis Basic Study Bin Wang, Xiao-Wei Wu, Mei-Xia Guo, Min-Li Li, Xiao-Bing Xu, Xin-Xin Jin, Xiao-Hua ZhangSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9784World J Gastroenterol   2016 November 28; 22(44): 9784-9793  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/12/30/WJG-22-9784.PMC5124983.pdf
World J Gastroenterol  2016; 22(44): 9784-9793  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9784.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9784 INTRODUCTION Severe acute pancreatitis (SAP) is a critical illness  associated with long-term treatment and high mor - tality.,Non-OADS,/arxiv_data1/oa_pdf/12/30/WJG-22-9784.PMC5124983.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/12/30/WJG-22-9784.PMC5124983.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Si Hyung Lee, MD,  Department of  Internal Medicine, Yeungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 42415,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/fe/e0/WJG-22-9794.PMC5124984.pdf
"MGC developed in 11 patients of  the H. pylori  tested group (7 in the H. pylori -negative  subgroup, 3 in the H. pylori -eradicated subgroup, and  1 in the H. pylori -persistent subgroup) and 4 patients   9794 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Association between Helicobacter pylori  status and  metachronous gastric cancer after endoscopic resectionRetrospective Study Sung Bum Kim, Si Hyung Lee, Seung Il Bae, Yo Han Jeong, Se Hoon Sohn, Kyeong Ok Kim, Byung Ik Jang,  Tae Nyeun KimSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9794World J Gastroenterol   2016 November 28; 22(44): 9794-9802  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/fe/e0/WJG-22-9794.PMC5124984.pdf
World J  Gastroenterol  2016; 22(44): 9794-9802  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9794.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9794 INTRODUCTION Endoscopic resection (ER) including endoscopic mucosal  resection and endoscopic submucosal dissection  (ESD) is a recognized as one of treatment options for  curative resection of early gastric cancer (EGC) without  simultaneous concomitant lymph node metastasis[1-4].,Non-OADS,/arxiv_data1/oa_pdf/fe/e0/WJG-22-9794.PMC5124984.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/fe/e0/WJG-22-9794.PMC5124984.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Yoon Kyung Jeon, MD, PhD, Department  of Pathology, Seoul National University Hospital, 101 Daehak- ro, Jongno-gu, Seoul 03080, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/c0/9f/WJG-22-9803.PMC5124985.pdf
"Univariate  and multivariate survival analyses were performed  according to adjuvant therapy status.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9803 9803 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9803-9812  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c0/9f/WJG-22-9803.PMC5124985.pdf
World J Gastroenterol  2016; 22(44): 9803-9812   Available from: URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9803.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/c0/9f/WJG-22-9803.PMC5124985.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/c0/9f/WJG-22-9803.PMC5124985.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Da-Ru Lu, PhD, Professor,  State Key  Laboratory of Genetic Engineering and MOE Key Laboratory  of Contemporary Anthropology, Institute of Genetics, School of  Life Sciences, Fudan University, Life Science Building, Jiangwan  Campus of Fudan University, No.",Non-OADS,/arxiv_data1/oa_pdf/3f/8c/WJG-22-9813.PMC5124986.pdf
"METHODS Two hundred and twenty five newly diagnosed chronic  9813 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE IFIT1  polymorphisms predict interferon- α treatment  efficiency for hepatitis B virus infectionRetrospective Study Dong-Ying Xie, Shi-Ming Wang, Jing-Min Yang, Liang-Hui Wang, Hong-Yan Chen, Cong Huai, Jia Shang, Qing  Mao, Chun-Liang Lei, Guang-Han Luo, Ji Qian, Da-Ru LuSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9813World J Gastroenterol   2016 November 28; 22(44): 9813-9821  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3f/8c/WJG-22-9813.PMC5124986.pdf
World J Gastroenterol  2016;  22(44): 9813-9821  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/3f/8c/WJG-22-9813.PMC5124986.pdf
com/1007-9327/full/v22/i44/9813.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/8c/WJG-22-9813.PMC5124986.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/3f/8c/WJG-22-9813.PMC5124986.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Chang Won Kim, MD,  Department of  Radiology, Medical Research Institute, Pusan National University  School of Medicine and Research Institute for Convergence of  Biomedical Science and Technology, Pusan National University  Hospital, 10, 1-Ga, Ami-Dong, Seo-Gu, Pusan 602-739,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/ff/eb/WJG-22-9822.PMC5124987.pdf
"9822 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Therapeutic efficacy and stent patency of transhepatic  portal vein stenting after surgeryRetrospective Study Ung Bae Jeon, Chang Won Kim, Tae Un Kim, Ki Seok Choo, Joo Yeon Jang, Kyung Jin Nam, Chong Woo Chu,  Je Ho RyuSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9822World J Gastroenterol   2016 November 28; 22(44): 9822-9828  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ff/eb/WJG-22-9822.PMC5124987.pdf
World J  Gastroenterol  2016; 22(44): 9822-9828  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9822.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9822 INTRODUCTION Acquired portal vein (PV) stenosis is most commonly  observed after liver transplantation (LT)[1-3].,Non-OADS,/arxiv_data1/oa_pdf/ff/eb/WJG-22-9822.PMC5124987.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/ff/eb/WJG-22-9822.PMC5124987.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Cristina Stasi, MD, PhD,  Observatory of Epidemiology, Regional Health Agency of Tuscany,  Via P. Dazzi  1, 50141 Florence, Italy.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"In total, 9524 patients  were treated with pegylated interferon + ribavirin and/Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9829 9829 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9829-9835  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"World J Gastroenterol  2016; 22(44): 9829-9835  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i44/9829.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i44.9829 INTRODUCTION The screening of blood donors, which began in the early  1990s, has reduced the spread of hepatitis C virus (HCV)  in the population.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
Available from: URL: http://www.who.int/mediacentre/ factsheets/fs164/en/ 5 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"Available from: URL: http://www.euro.who.int/en/health-topics/ communicable-diseases/hepatitis/data-and-statistics 6 Ansaldi F , Bruzzone B, Salmaso S, Rota MC, Durando P,  Gasparini R, Icardi G. Different seroprevalence and molecular  epidemiology patterns of hepatitis C virus infection in Italy.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"Available from:  URL: http://www.progettoasco.it/riviste/rivista_simg/2006/05_200 6/3.pdf 8 Marcellin P , Cheinquer H, Curescu M, Dusheiko GM, Ferenci P,  Horban A, Jensen D, Lengyel G, Mangia A, Ouzan D, Puoti M,  Rodriguez-Torres M, Shiffman ML, Schmitz M, Tatsch F, Rizzetto  M. High sustained virologic response rates in rapid virologic  response patients in the large real-world PROPHESYS cohort  confirm results from randomized clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
Available  from: URL: http://apps.who.int/gb/ebwha/pdf files/WHA63-REC1/ WHA63 REC1-en.pdf 11 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
Available from: URL: http://apps.who.int/gho/ data/view.main.81300 12 European Association for Study of Liver.,Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"Available from: URL:  http://www.agenziafarmaco.gov.it/it/content/pubblicato-il-nuovo- algoritmo-la-terapia-dell’epatite-c-cronica 14 Stasi C , Milani S. Non-invasive assessment of liver fibrosis:  Between prediction/prevention of outcomes and cost-effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/WJG-22-9829.PMC5124988.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Young Min Park, MD, PhD,  Hepatology  Center, Department of Internal Medicine and Biomedical  Research Center, Bundang Jesaeng General Hospital, 20,  Seohyeon-ro 180 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi- do 13589, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
"HBeAg influenced HBsAg-NC in the 40-50 and 50-60  9836 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comORIGINAL ARTICLE Clinical features of HBsAg seroclearance in hepatitis B virus  carriers in South Korea: A retrospective longitudinal studyObservational Study Young Min Park, Seong Gyu LeeSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9836World J Gastroenterol   2016 November 28; 22(42): 9836-9843  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
World J Gastroenterol  2016; 22(44):  9836-9843  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
com/1007-9327/full/v22/i44/9836.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
"Available from: URL: http://www.R-project.org 16 Fung J , Wong DK, Seto WK, Kopaniszen M, Lai CL, Yuen MF.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/WJG-22-9836.PMC5124989.pdf
"Serum miR-122, -192 and -34a Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9844 9844 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9844-9852  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/15/bf/WJG-22-9844.PMC5124990.pdf
"World J  Gastroenterol  2016; 22(44): 9844-9852  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i44/9844.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i44.9844 INTRODUCTION With advances in the quality of life and various lifestyle  transitions, non-alcoholic fatty liver disease (NAFLD)  has become a growing public health concern world - wide, with a prevalence of about 15% in the general  population of China[1].",Non-OADS,/arxiv_data1/oa_pdf/15/bf/WJG-22-9844.PMC5124990.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/15/bf/WJG-22-9844.PMC5124990.pdf
"richie@forfey.co m Telephone: +44-77-36335924  Fax: +44-18-72252794 Received: July 8, 2016 Peer-review started: July 12, 2016 First decision: July 29, 2016 Revised: September 16, 2016 Accepted: October 19, 2016 Article in press: October 19, 2016 Published online:  November 28, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9853 9853 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 28; 22(44): 9853-9859  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/45/59/WJG-22-9853.PMC5124991.pdf
wjgnet.com/1007-9327/full/v22/i44/9853.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/59/WJG-22-9853.PMC5124991.pdf
Available from: URL: http://www.statssa.,OADS,/arxiv_data1/oa_pdf/45/59/WJG-22-9853.PMC5124991.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/45/59/WJG-22-9853.PMC5124991.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Jun Yong Park, MD, PhD,  Department  of Internal Medicine, Yonsei University College of Medicine, 250  Seongsanno, Seodaemun-gu, Seoul 120-752,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/15/b8/WJG-22-9860.PMC5124992.pdf
"Key words:  Spontaneous rupture; Hemoperitoneum;  Transarterial chemoembolization; Hepatic metastasis;  ThymomaCASE REPORT 9860 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9860World J Gastroenterol   2016 November 28; 22(44): 9860-9864  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/15/b8/WJG-22-9860.PMC5124992.pdf
World J Gastroenterol  2016;  22(44): 9860-9864  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/15/b8/WJG-22-9860.PMC5124992.pdf
com/1007-9327/full/v22/i44/9860.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b8/WJG-22-9860.PMC5124992.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/15/b8/WJG-22-9860.PMC5124992.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Naoya Yamada, MD,  Department of  Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji,  Shimotsuke-shi, Tochigi 329-0498, Japan.",Non-OADS,/arxiv_data1/oa_pdf/9b/23/WJG-22-9865.PMC5124993.pdf
"Long-term follow-up is needed with  respect to graft liver function and screening malignant  tumors.CASE REPORT 9865 November 28, 2016 |Volume 22 |Issue 44 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i44.9865World J Gastroenterol   2016 November 28; 22(44): 9865-9870  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9b/23/WJG-22-9865.PMC5124993.pdf
World J Gastroenterol  2016; 22(44): 9865-9870   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i44/9865.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/9b/23/WJG-22-9865.PMC5124993.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   4",Non-OADS,/arxiv_data1/oa_pdf/9b/23/WJG-22-9865.PMC5124993.pdf
Mechanisms of action according to basic principles of interactive guided imagery SM 2015. http://acadgi.com/ abouttheacademy/FAQs/index.html.,Non-OADS,/arxiv_data1/oa_pdf/29/e4/10.1177_1534735416636222.PMC5125023.pdf
2009; http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.,Non-OADS,/arxiv_data1/oa_pdf/29/e4/10.1177_1534735416636222.PMC5125023.pdf
2015. http://grants.nih.gov/reproducibility/ index.htm.,Non-OADS,/arxiv_data1/oa_pdf/29/e4/10.1177_1534735416636222.PMC5125023.pdf
Keywords: Acute coronary syndrome; Anticoagulation; Antiplatelet; Atrial ﬁbrillation; Bioabsorbable polymer; CoronaryEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/83D4 F0606921672B .,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/40119_2016_Article_63.PMC5125106.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.128 Cardiol Ther (2016) 5:109–132",Non-OADS,/arxiv_data1/oa_pdf/d7/3b/40119_2016_Article_63.PMC5125106.pdf
https://www.escardio.org/static_ﬁle/Escardio/Press-media/Press%20releases/2015/Congress/ARTS-HF_ Filippatos.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/40119_2016_Article_63.PMC5125106.pdf
http://www.clinicaltrialresults.org/Slides/ AHA2015/Bundgaard_BEAT.pptx .,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/40119_2016_Article_63.PMC5125106.pdf
https://www.medicines.org.uk/emc/ medicine/31243 .,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/40119_2016_Article_63.PMC5125106.pdf
"In general, larger randomized controlled studies with prolonged follow-up comparing DEB withEnhanced content: To view enhanced content for this article go to http://www.medengine.com/Redeem/6ED4 F060344985C9 .",Non-OADS,/arxiv_data1/oa_pdf/a5/58/40119_2016_Article_64.PMC5125107.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a5/58/40119_2016_Article_64.PMC5125107.pdf
"Results : After review, 26 cost-effectiveness analyses through Markov models were included; the identiﬁed economic evaluationsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 56E4F0607849495F .",Non-OADS,/arxiv_data1/oa_pdf/47/bc/40119_2016_Article_66.PMC5125108.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/47/bc/40119_2016_Article_66.PMC5125108.pdf
"Conclusion : This retrospective study supports clinical experience that DCCV is more likely to be successful when there is a shorter duration between the onset of AF and the date of DCCV, and shows that the use of dabigatran in comparison with warfarin facilitates earlier DCCV.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D6E4F06019D92124 .",Non-OADS,/arxiv_data1/oa_pdf/4c/7f/40119_2016_Article_67.PMC5125109.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4c/7f/40119_2016_Article_67.PMC5125109.pdf
Optical coherence tomography (OCT) showed a diffuse homogeneous intra-scaffold neointimal tissue with a minimum luminal area of 1.59 mm2atEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 97E4F0601BA643AA .,Non-OADS,/arxiv_data1/oa_pdf/69/71/40119_2016_Article_68.PMC5125110.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/69/71/40119_2016_Article_68.PMC5125110.pdf
"A substantial proportion of people with T2DM have concomitant hypertension (20–60%,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ CBE4F06021C48730 .",Non-OADS,/arxiv_data1/oa_pdf/2f/b2/40119_2016_Article_69.PMC5125111.pdf
http://www.who.int/cardiovascular_ diseases/en/ .,Non-OADS,/arxiv_data1/oa_pdf/2f/b2/40119_2016_Article_69.PMC5125111.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/48/52/40119_2016_Article_70.PMC5125112.pdf
"Overall, 92/117 (78.6%) of randomized patients experienced complete or partial effectiveness using either the initialEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B495F06071D58495 .",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
Trial registration :http://www.ClinicalTrials.,Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
"The pivotal global Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY)trial ( http://www.ClinicalTrials.gov identiﬁer:NCT00262600), compared DE [110-mg and 150-mg twice daily (BID)] with adjusted-dosewarfarin for a median follow-up period of 2 years in 18,113 patients with NVAF at risk for stroke [ 4].",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
"The long-term follow-up to RE-LY, the RELY-ABLE study ( http://www.ClinicalTrials.",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
"Trial DesignThe present trial ( http://www.ClinicalTrials.gov identiﬁer: NCT01493557) had a multicenter, randomized, active control open-label design to assess the efﬁcacy of two GIS managementstrategies in patients treated with DE at multiple sites in the United States and Canada.",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
"November, 2015. http://bit.ly/1r26yMg .",Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
2016. http://www.boehringer-ingelheim.ca/ content/dam/internet/opu/ca_EN/documents/human health/product_monograph/PradaxaPMEN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
http://bit.ly/1Oir7ﬁ .,Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
2012. http://bit.ly/1O6P3GY .,Non-OADS,/arxiv_data1/oa_pdf/74/0b/40119_2016_Article_71.PMC5125113.pdf
Clinical characteristics include spontaneous orEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ BDB5F0601B2CC15A .,Non-OADS,/arxiv_data1/oa_pdf/8b/97/40119_2016_Article_72.PMC5125114.pdf
Other end points included correctedEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4717F06012E1F795 .,Non-OADS,/arxiv_data1/oa_pdf/c7/ce/40119_2016_Article_73.PMC5125115.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c7/ce/40119_2016_Article_73.PMC5125115.pdf
"There has been particular interest recently in developing tubular stents, comprised of various materials, which can lower pressure in a similarEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/D5D 4F060157F138B .",Non-OADS,/arxiv_data1/oa_pdf/18/1d/40123_2016_Article_54.PMC5125116.pdf
https://clinicaltrials.gov/ct2/show/ NCT02023242 [Internet].,Non-OADS,/arxiv_data1/oa_pdf/18/1d/40123_2016_Article_54.PMC5125116.pdf
PathwaysEnhanced content To view enhance content for this article go to http://www.medengine.com/Redeem/ 78D4F060238B7888 .,Non-OADS,/arxiv_data1/oa_pdf/cc/d6/40123_2016_Article_55.PMC5125117.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cc/d6/40123_2016_Article_55.PMC5125117.pdf
Funding : This study was funded by an unrestricted grant from Research to Prevent Blindness.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C4E4F06011FF9225 .,Non-OADS,/arxiv_data1/oa_pdf/28/61/40123_2016_Article_56.PMC5125118.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/28/61/40123_2016_Article_56.PMC5125118.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/22/ab/40123_2016_Article_57.PMC5125119.pdf
"Stratifying by prior injections, patients with [20 priorEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A9E4F0602982B2D6 .",Non-OADS,/arxiv_data1/oa_pdf/ca/ca/40123_2016_Article_58.PMC5125120.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ca/ca/40123_2016_Article_58.PMC5125120.pdf
Available at http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ca/ca/40123_2016_Article_58.PMC5125120.pdf
"Conclusion : In this study, the authors showed that neuroticism trait in patients with GLC who have discontinued visiting their ophthalmologists was lower than that in patients who regularly visited them, on the basis of the Big Five personality traits as measured by the TIPT-J.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/2FE4 F0605E30C26D .",Non-OADS,/arxiv_data1/oa_pdf/a2/a3/40123_2016_Article_59.PMC5125121.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a2/a3/40123_2016_Article_59.PMC5125121.pdf
"The opposite occurs with minus-diopter lenses, where the image is focused behind the retina.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B295F0607B6F2E0B .",Non-OADS,/arxiv_data1/oa_pdf/7b/ac/40123_2016_Article_60.PMC5125122.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Ophthalmol Ther (2016) 5:215–222 221",Non-OADS,/arxiv_data1/oa_pdf/7b/ac/40123_2016_Article_60.PMC5125122.pdf
"Keywords: Macular hole; Ocriplasmin; Pharmacologic vitreolysis; Vitreomacular adhesion; Vitreomacular traction; Vitreoretinal interface INTRODUCTION Degeneration and liquefaction of the vitreous gel with age ultimately leads to formation of a posterior vitreous detachment (PVD), characterized by the separation of theEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ F295F0601C8A111C .",Non-OADS,/arxiv_data1/oa_pdf/19/76/40123_2016_Article_62.PMC5125123.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/19/76/40123_2016_Article_62.PMC5125123.pdf
"Our outcomes demonstrated that for 100 lm increase in CCT, IOP measured with GAT and NCT increased by 0.8 and 3.3 mmHg, respectively, in OD and by 1.4 and 2.9 mmHg inEnhanced content: To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8DB5F0603097FF30 .",Non-OADS,/arxiv_data1/oa_pdf/ab/de/40123_2016_Article_63.PMC5125124.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ab/de/40123_2016_Article_63.PMC5125124.pdf
"This can involve neovascularization of the iris, the opticEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ FDB5F0601EE074E9 .",Non-OADS,/arxiv_data1/oa_pdf/f6/d7/40123_2016_Article_64.PMC5125125.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f6/d7/40123_2016_Article_64.PMC5125125.pdf
"By 3 years, mean IOP was 14.6 mmHg in stent eyes (with medicationEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8D76F060234F3623 .",Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproductionin any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
Article ID 795357. http://dx.doi.org/10.1155/2015/795357 .,Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
26. http://www.clintrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
http://www.eugs.org .,Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
Ann Arbor: Truven Health Analytics; 2013. http://micromedex.com/products/product- suites/clinical-knowledge/redbook .,Non-OADS,/arxiv_data1/oa_pdf/fa/a0/40123_2016_Article_65.PMC5125126.pdf
"Conclusion : At 6 months, no signiﬁcant differences in mean IOP, mean number of IOP-lowering medications, VA, surgical success, or adverse events were noted betweenEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/ 5FD6F060144EDD43 .",Non-OADS,/arxiv_data1/oa_pdf/f4/83/40123_2016_Article_66.PMC5125127.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.232 Ophthalmol Ther (2016) 5:223–233",Non-OADS,/arxiv_data1/oa_pdf/f4/83/40123_2016_Article_66.PMC5125127.pdf
"In these patients, the treatment of ocular inﬂammation is partially dictated byEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ ED07F06040623D1D .",Non-OADS,/arxiv_data1/oa_pdf/ce/49/40123_2016_Article_67.PMC5125128.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ce/49/40123_2016_Article_67.PMC5125128.pdf
"In MGD, the occlusion of the terminal ducts leads to a cascade of changes including retention of meibomian lipids, abnormal tear lipid layer, signs of evaporative dry eye, as well as atrophy andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/0617 F060548478DE .",Non-OADS,/arxiv_data1/oa_pdf/b6/35/40123_2016_Article_70.PMC5125130.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b6/35/40123_2016_Article_70.PMC5125130.pdf
Compliance with Ethics Guidelines This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5395F0606A37D413 .,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
Available from: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm 312210.htm .,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
HIV and STI prevention among men who have sex with men.http://ecdc.europa.eu/en/publications/publications/hiv-sti-prevention-among-men-who-have-sex-with- men-guidance.pdf .,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
http://www.ema.europa.eu/ ema/index.jsp?curl=pages/news_and_events/news/ 2016/07/news_detail_002578.jsp&mid=WC0b01ac058004d5c1 .,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
http://www.cdc.gov/hiv/ pdf/prepguid elines2014.,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/01/a5/40121_2016_Article_128.PMC5125131.pdf
"However, the majority of pharmacies reported that only one factor would need toEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8595F060663EC278 .",Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2016. http://www.thecommunity guide.org/vaccines/index.html .,Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2012.http://w3.lara.state.mi.us/orr/Files/AdminCode/976_ 2011-013CH_AdminCode.pdf .,OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2006. https://www.mcir.org/wp- content/uploads/2014/04/MCIR-Brochure-FINAL-2- 13-2007.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2016. https://datawarehouse.hrsa.,OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2016. http://www.hhs.,Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
2015. http://www.thecommunityguide.org/ vaccines/clientreminder.html .,Non-OADS,/arxiv_data1/oa_pdf/76/c0/40121_2016_Article_129.PMC5125132.pdf
"Preterm infants, particularlyEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ F6E4F06044E2A44B .",Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
2012.http://apps.who.int/iris/bitstream/10665/44864/ 1/9789241503433_eng.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
http://www.cebm.net/ index.aspx?o=5653 .,Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
Oxford Centre for Evidence-Based Medicine http://www.cebm.,Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
"Rockville, MD: Agency forHealthcare Research and Quality; August 2013. http://www.effectivehealt hcare.ahrq.gov/reports/ ﬁnal.cfm .",Non-OADS,/arxiv_data1/oa_pdf/11/83/40121_2016_Article_130.PMC5125133.pdf
"No change in VI by birth cohort,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 60E6F0603A3DF39E .",Non-OADS,/arxiv_data1/oa_pdf/84/65/40121_2016_Article_131.PMC5125134.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/84/65/40121_2016_Article_131.PMC5125134.pdf
WHO and UNICEF estimates of immunization coverage: 2015 revision.http://www.who.int/immu nization/monitoring_ surveillance/data/bel.pdf .,Non-OADS,/arxiv_data1/oa_pdf/84/65/40121_2016_Article_131.PMC5125134.pdf
The studies reporting the incidence of myocardial infarction (MI) among HIV-infected patients showed that ATV (boosted and unboosted) was not associatedEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E0E6F0607F342B32 .,Non-OADS,/arxiv_data1/oa_pdf/60/ad/40121_2016_Article_132.PMC5125135.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/40121_2016_Article_132.PMC5125135.pdf
Available from https://www.nice.org.uk/ process/pmg6/resources/the-guidelines-manual-appendices-bi-1967364/chapter/2-appendix-c-method ology-checklist-randomised-controlled-trials .,Non-OADS,/arxiv_data1/oa_pdf/60/ad/40121_2016_Article_132.PMC5125135.pdf
"Funding : Theravance Biopharma Antibiotics, Inc.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 03E6F06001883855 .",Non-OADS,/arxiv_data1/oa_pdf/7b/80/40121_2016_Article_133.PMC5125136.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7b/80/40121_2016_Article_133.PMC5125136.pdf
"Theravance Biopharma Announces Marketing Authorization for VIBATIV(R) (Telavancin) inRussia for Treatment of Multiple InfectionsCaused by Gram-Positive Bacteria, Including MRSA Dublin, Ireland: Theravance Biopharma; 2015. http://investor.theravance.com/releasedetail.",Non-OADS,/arxiv_data1/oa_pdf/7b/80/40121_2016_Article_133.PMC5125136.pdf
A total of 233 studies show that chronic HCVEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ EAF6F06050476C59 .,Non-OADS,/arxiv_data1/oa_pdf/98/ac/40121_2016_Article_134.PMC5125137.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/98/ac/40121_2016_Article_134.PMC5125137.pdf
http://www.ihs.com/ country-industry-forecasting.html?ID=10659114512 .,Non-OADS,/arxiv_data1/oa_pdf/98/ac/40121_2016_Article_134.PMC5125137.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 6F07F0602CB8ADAE .,Non-OADS,/arxiv_data1/oa_pdf/60/76/40121_2016_Article_135.PMC5125138.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/60/76/40121_2016_Article_135.PMC5125138.pdf
Germany 2016. http://www.destatis.de .,Non-OADS,/arxiv_data1/oa_pdf/60/76/40121_2016_Article_135.PMC5125138.pdf
"For MSSA bacteremia, use of vancomycin was signiﬁcantly decreased only in the rmPCR period (32% of patients vs. 64 andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8517F0600FFF30F6 .",Non-OADS,/arxiv_data1/oa_pdf/be/6e/40121_2016_Article_136.PMC5125139.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/be/6e/40121_2016_Article_136.PMC5125139.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/2e/3a/40121_2016_Article_137.PMC5125140.pdf
http://www.cebm.net/ index.aspx?o=5653 .,Non-OADS,/arxiv_data1/oa_pdf/2e/3a/40121_2016_Article_137.PMC5125140.pdf
http://www.cebm.,Non-OADS,/arxiv_data1/oa_pdf/2e/3a/40121_2016_Article_137.PMC5125140.pdf
Available  from: http://www.mciindia.org/Rules-and-Regulation/ Teachers-Eligibility-Qualifications-Rgulations-1998.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from:  http://www.mciindia.org/Rules-and-Regulation/ Teachers-Eligibility -Qualifications-Rgulations-1998.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from: http://www.mciindia.org/ Rulesand-Regulation/Postgraduate-Medical-Education-Regula tions-2000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from: http://www.indmed.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from:  http://www.icmje.org/recommendations/browse/roles-and- responsibilities/defining-the-role- of-authors-and-contributors.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from: http://www.publicationethics.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from: http://www.ugc.ac.in/pdfnews/8539300_ english.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/04/IJA-60-793.PMC5125180.pdf
Available from: http://www.mciindia.,Non-OADS,/arxiv_data1/oa_pdf/94/14/IJA-60-796.PMC5125181.pdf
Available from: http://www.timesofindia.indiatimes.com/ world/.journal/./46810425.cms.,Non-OADS,/arxiv_data1/oa_pdf/94/14/IJA-60-796.PMC5125181.pdf
Available from: http://www.admin.,Non-OADS,/arxiv_data1/oa_pdf/94/14/IJA-60-796.PMC5125181.pdf
Available from: https://www.med.stanford.edu/academicaffairs/ administrators/handbook.html.,Non-OADS,/arxiv_data1/oa_pdf/94/14/IJA-60-796.PMC5125181.pdf
Available from:  http://www.bhu.ac.in/racbhu/regulation/8377302_English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/14/IJA-60-796.PMC5125181.pdf
Available from:  http://www.icudelirium.org/delirium/CAM-ICU- Training.,Non-OADS,/arxiv_data1/oa_pdf/cb/e3/IJA-60-814.PMC5125184.pdf
Available from:  http://www.apiindia.org/medicine_update_2013/chap95.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/e3/IJA-60-814.PMC5125184.pdf
Available from: http://www.cdsco.nic.in/ writereaddata/1971-98.,Non-OADS,/arxiv_data1/oa_pdf/cb/e3/IJA-60-814.PMC5125184.pdf
Visit http://www.njisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/40/5f/IJA-60-827.PMC5125186.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/77/4c/IJA-60-858.PMC5125193.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/77/4c/IJA-60-858.PMC5125193.pdf
96Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/25/a1/IJA-60-877.PMC5125204.pdf
"Introduction N-methyl -D-aspartate receptors (NMDARs) are a family of ionotropic glutamate receptors  that mediate a slow, Ca2+ permeable component of excitatory synaptic transmission in the  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c5/6a/nihms830120.PMC5125235.pdf
http://dx.doi.org/10.1016/j.coph.2014.11.008 .,OADS,/arxiv_data1/oa_pdf/c5/6a/nihms830120.PMC5125235.pdf
"RNF4 enhances the transcriptional activity of these factors,  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/d4/69/nihms810320.PMC5125238.pdf
"*Correspondence: mdoryan@techunix.technion.ac.il.9Co-first author10Present address: Genentech, 1 DNA Way, South San Francisco, CA 94080, USA11Lead contact SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and six figures and can be found with this article online at  http://dx.doi.org/10.1016/j.celrep.2016.08.024 .",Non-OADS,/arxiv_data1/oa_pdf/d4/69/nihms810320.PMC5125238.pdf
Survival Analyses of Breast Cancer Patients— Analyses of systemically-untreated  cohort of breast cancer patients including Kaplan-Mayer survival curves were performed  using kmplot.com  (http://kmplot.com/analysis/index.php?p=service&start=1 ).,OADS,/arxiv_data1/oa_pdf/d4/69/nihms810320.PMC5125238.pdf
http://dx.doi.org/10.1101/cshperspect.a014365 .,Non-OADS,/arxiv_data1/oa_pdf/d4/69/nihms810320.PMC5125238.pdf
The base mutations  in CHRNE  gene were described and numbered according  to criteria provided by the Ensembl genome browser  (http://www.ensembl.org).,OADS,/arxiv_data1/oa_pdf/36/ab/CMJ-129-2596.PMC5125339.pdf
"harvard.edu/pph2/), Sorting Intolerant from Tolerant  (SIFT)  software (http://sift.jcvi.org/) and MutationTaster (http:// www.mutationtaster.org/).",OADS,/arxiv_data1/oa_pdf/36/ab/CMJ-129-2596.PMC5125339.pdf
"The MG acinar unit area (MGAUA), MG acinar unit  longest diameter  (MGALD), and MG acinar unit shortest  diameter (MGASD) were measured with the internal software  and calculated in μm using the ImageJ software (Java software  program developed by the National Institutes of Health;  available: http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/61/59/CMJ-129-2617.PMC5125342.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/13/CMJ-129-2630.PMC5125344.pdf
doi: http://dx.doi.org/10.1016/8756‑3282(95)00258‑4.,OADS,/arxiv_data1/oa_pdf/20/13/CMJ-129-2630.PMC5125344.pdf
doi: http://dx.doi.org/10.1097/00003086‑ 200109000‑00027.,Non-OADS,/arxiv_data1/oa_pdf/20/13/CMJ-129-2630.PMC5125344.pdf
doi: http://dx.doi.org/10.1302/0301‑ 620X.84B8.13522.,Non-OADS,/arxiv_data1/oa_pdf/20/13/CMJ-129-2630.PMC5125344.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/13/CMJ-129-2630.PMC5125344.pdf
"[http://dx.doi.org/10.1111/j.1365-2044.1997.117-az0113.x ] [PMID: 9165963 ] [2] Apfel  CC,  Lärä  E,  Koivuranta  M,  Greim  CA,  Roewer  N.  A  simplified  risk  score  for  predicting  postoperative  nausea  and  vomiting: conclusions from cross-validations between two centers.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1097/00000542-199909000-00022 ] [PMID: 10485781 ] [3] Gan TJ, Diemunsch P, Habib AS, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1213/ANE.0000000000000002 ] [PMID: 24356162 ] [4] DiIorio TM, Sharkey PF, Hewitt AM, Parvizi J. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting?",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1007/s11999-010-1357-x ] [PMID: 20419358 ] [5] Chen JJ, Frame DG, White TJ.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1001/archinte.158.19.2124 ] [PMID: 9801179 ] [6] Hill RP, Lubarsky DA, Phillips-Bute B, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1097/00000542-200004000-00012 ] [PMID: 10754614 ] [7] Sculco PK, Pagnano MW.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1016/j.arth.2015.01.036 ] [PMID: 25680452 ] [8] Apfel CC, Korttila K, Abdalla M, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1056/NEJMoa032196 ] [PMID: 15190136 ] [9] Tsukada S, Wakui M, Hoshino A. Postoperative epidural analgesia compared with intraoperative periarticular injection for pain control following total knee arthroplasty under spinal anesthesia: a randomized controlled trial.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.2106/JBJS.M.01098 ] [PMID: 25187581 ] [10] Adam F, Chauvin M, Du Manoir B, Langlois M, Sessler DI, Fletcher D. Small-dose ketamine infusion improves postoperative analgesia and rehabilitation after total knee arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1213/01.ANE.0000142117.82241.DC ] [PMID: 15673878 ] [11] Barr J, Fraser GL, Puntillo K, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1097/CCM.0b013e3182783b72 ] [PMID: 23269131 ] [12] Strom BL, Berlin JA, Kinman JL, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1001/jama.1996.03530290046036 ] [PMID: 8569017 ] [13] Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS, Ranawat CS.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
[http://dx.doi.org/10.1016/j.arth.2007.03.034 ] [PMID: 17823012 ],OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1016/j.arth.2006.03.001 ] [PMID: 16781436 ] [15] Ali M, Pagnano MW, Horlocker T, Lennon RL.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1053/j.sart.2008.08.003 ] [16] Vendittoli PA, Makinen P, Drolet P, et al.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.2106/JBJS.E.00173 ] [PMID: 16452738 ] [17] Koh JC, Lee J, Kim SY, Choi S, Han DW.",OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"[http://dx.doi.org/10.1097/MD.0000000000002008 ] [18] Thagaard KS, Jensen HH, Raeder J. Analgesic and antiemetic effect of ketorolac vs. betamethasone or dexamethasone after ambulatory surgery.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
[http://dx.doi.org/10.1111/j.1399-6576.2006.01240.x ] [PMID: 17257175 ] © Schwarzkopf et al.,Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/TOORTHJ-10-505.PMC5125376.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2014.01.006Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Supplementary  data Supplementary data  associated  with  this  article  can  be found, in  the  online  version,  at  http://dx.doi.org/10.1016/ j.dcn.2014.01.006.",OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Journal  of  Research  on  Adolescence  21  (1),  153–165, http://dx.doi.org/10.1111/j.1532-7795.2010.00720.x.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Child  Development  64 (2), 467–482,  http://dx.doi.org/10.1111/j.1467-8624.1993.tb02922.x.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Human  Brain  Mapping  31  (4),  660–668, http://dx.doi.org/10.1002/hbm.20895.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Neuroscience  &  Biobehavioral  Reviews  32  (1),  1–19, http://dx.doi.org/10.1016/j.neubiorev.2007.04.016.",OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Science  302  (5643),  290–292, http://dx.doi.org/10.1126/science.1089134.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Journal of  Child  Psychology  and  Psychiatry  41  (1),  97–116, http://dx.doi.org/10.1111/1469-7610.00551.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Social  Neuroscience 5 (5–6), 461–482,  http://dx.doi.org/10.1080/17470910903526155.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Social  Cognitive  &  Affective  Neuroscience  7  (1),  81–92, http://dx.doi.org/10.1093/scan/nsr043.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Archives  of  General  Psychiatry  65  (11),  1303–1312, http://dx.doi.org/10.1001/archpsyc.65.11.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Trends  in  Cognitive  Sciences  16  (11),  533–540,  http://dx.doi.org/ 10.1016/j.tics.2012.09.005.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Journal of  Abnormal  Child  Psychology  39  (8),  1213–1225,  http://dx.doi.org/ 10.1007/s10802-011-9540-4.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Social  Development  16  (2),  361–388,  http://dx.doi.org/ 10.1111/j.1467-9507.2007.00389.x.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Psychological  Medicine  35  (2), 163–174,  http://dx.doi.org/10.1017/S0033291704003915.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Behaviour  Research  and  Therapy 49  (5),  331–338,  http://dx.doi.org/10.1016/j.brat.2011.02.008.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Clinical  Psychology  Review  32  (6),  447–453, http://dx.doi.org/10.1016/j.cpr.2012.05.002.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Social  Cognitive  and  Affective  Neuroscience  7  (1),  93–105, http://dx.doi.org/10.1093/scan/nsr044.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Human  Brain  Mapping  34  (3),  598–612, http://dx.doi.org/10.1002/hbm.21458.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Development  and  Psychopathology  23  (1),  115–129, http://dx.doi.org/10.1017/S0954579410000684.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
"Social Cognitive  and  Affective  Neuroscience  4  (3),  247–256, http://dx.doi.org/10.1093/scan/nsp012.",Non-OADS,/arxiv_data1/oa_pdf/23/87/main.PMC5125388.pdf
User guides and program soft-ware are available at http://ti.arc.nasa.gov/tech/asr/intelli-gent-robotics/ngt/stereo/.,Non-OADS,/arxiv_data1/oa_pdf/58/f0/RSE2-1-51.PMC5125405.pdf
In this paper we describe the method used for calculating ion temperatures throughout the duration of 76 geomagnetic storms during the period June 2008 to December 2013 and the details of the data that are available on CDAWeb (http://cdaweb.gsfc.nasa.gov/).,OADS,/arxiv_data1/oa_pdf/e8/0b/ESS2-2-39.PMC5125406.pdf
The ion temperatures are available to the public at CDAWeb (http://cdaweb.gsfc.nasa.gov/).,OADS,/arxiv_data1/oa_pdf/e8/0b/ESS2-2-39.PMC5125406.pdf
TWINS data are available at http://twins.swri.edu/ and the ion temperatures discussed are availableat http://cdaweb.gsfc.nasa.gov/.,OADS,/arxiv_data1/oa_pdf/e8/0b/ESS2-2-39.PMC5125406.pdf
"A surprising amount of damage occurred, despite the moderate main shock magnitu de and peak ground accelerations of 0.7 g and 0.35 g northeast and southeast of and near the epicenter (USGS : Peak ground acceleration for La Habra earthquake, http://earthquake.usgs.gov/earthquakes/shakemap/sc/s hake/15481673/stationlist.html#sCE.13883).",OADS,/arxiv_data1/oa_pdf/ba/8b/ESS2-2-378.PMC5125407.pdf
"Seismicity data are from the Advanced National Seismic System (2015, http://www.quake.geo.berkeley.edu/anss/catalog-search.html) and U.S. Geological Survey (2015, http://earthquake.",OADS,/arxiv_data1/oa_pdf/ba/8b/ESS2-2-378.PMC5125407.pdf
"We are gratefulfor data provided by the InternationalGNSS Service and the EarthScope Plate Boundary Observatory operated by UNAVCO Inc. We used http://geo-gate-way.org for analysis of the data, whichcan be used for modeling and accessing UAVSAR data products from the Alaska Satellite Facility.",OADS,/arxiv_data1/oa_pdf/ba/8b/ESS2-2-378.PMC5125407.pdf
GPS data products canbe accessed from http://geodesy.unr.edu.We particularly thank two reviewers for Earth and Space Science and Donald Argus whose careful reads and commentsimproved this paper.,Non-OADS,/arxiv_data1/oa_pdf/ba/8b/ESS2-2-378.PMC5125407.pdf
[Available at http://pubs.usgs.gov/of/2013/1165/.],Non-OADS,/arxiv_data1/oa_pdf/ba/8b/ESS2-2-378.PMC5125407.pdf
[2006] and at https://directory.eoportal.or g/web/eoportal/satellite-missions/s/st5.,Non-OADS,/arxiv_data1/oa_pdf/7e/fa/ESS2-2-115.PMC5125408.pdf
[Available at https://www.jstage.jst.go.jp/article/jgg1949/47/2/47_2_191/_article.],Non-OADS,/arxiv_data1/oa_pdf/7e/fa/ESS2-2-115.PMC5125408.pdf
The ST5 data are available at http://cdaweb.sci.gsfc.nasa.gov/cdaweb/sp_phys/.,OADS,/arxiv_data1/oa_pdf/7e/fa/ESS2-2-115.PMC5125408.pdf
The hemisphericpower data are from http://www.swpc.,OADS,/arxiv_data1/oa_pdf/7e/fa/ESS2-2-115.PMC5125408.pdf
These images are availablethrough NASA ’s Planetary Data System at the geosciences node hosted by Washington University in St. Louis (http://pds-geosciences.wustl.edu/).,OADS,/arxiv_data1/oa_pdf/7f/a2/ESS2-2-144.PMC5125412.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000053).,Non-OADS,/arxiv_data1/oa_pdf/e0/4e/bmjsem-2015-000053.PMC5125416.pdf
World Rugby (then called IRB) Regulation 10 (http://www.worldrugby.org) and SARU Concussionmanagement protocols (http://www.boksmart.com) were initially used in 2011 and 2012; these were based on the previous 2008 Concussion ConsensusStatement.,Non-OADS,/arxiv_data1/oa_pdf/e0/4e/bmjsem-2015-000053.PMC5125416.pdf
Concussion incidence rate was based on the player match-exposure and the number of concussion eventsand reported per 1000 player match-hours with corre- sponding 95% CIs.Reliability Three players were randomly selected using a randomnumber generator (http://www.random.org/).,OADS,/arxiv_data1/oa_pdf/e0/4e/bmjsem-2015-000053.PMC5125416.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2016- 000132).,Non-OADS,/arxiv_data1/oa_pdf/9d/01/bmjsem-2016-000132.PMC5125417.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2016-000181).,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/bmjsem-2016-000181.PMC5125418.pdf
The video recordings were initially edited using AdobeCreative Cloud Premier Pro (http://www.abobe.com) and then converted to .avi ﬁles using PRISM video con- verter software (http://www.nchsoftware.com).,OADS,/arxiv_data1/oa_pdf/fc/6d/bmjsem-2016-000181.PMC5125418.pdf
These.aviﬁles were played using Windows Media Player (http://www.microsoft.com).,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/bmjsem-2016-000181.PMC5125418.pdf
"response, violating a core assumption when assessing intrarater reliability.35 43Other procedures that aim to modify symptoms have reported similar immediate responses.44 45This phenomenon is clearly demon- strated in other symptom modi ﬁcation procedures (https://www.youtube.com/watch?v=Arkxz8rabGQ& utm_content=buffer6f7c4&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer).4. asking participating clinicians to produce assessments within and between patients would have been onerous and might have discouraged their participation.",Non-OADS,/arxiv_data1/oa_pdf/fc/6d/bmjsem-2016-000181.PMC5125418.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/6d/bmjsem-2016-000181.PMC5125418.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2016-000153).,Non-OADS,/arxiv_data1/oa_pdf/87/48/bmjsem-2016-000153.PMC5125421.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000095).,Non-OADS,/arxiv_data1/oa_pdf/5c/54/bmjsem-2015-000095.PMC5125422.pdf
"In addition, nine grey literature resources were consulted, including Google, Google Scholar, OpenDOAR (http://www.opendoar.org), Health Sciences Online (HSO) (http:// www.hso.info), ProQuest Dissertations & Theses, OAISter (http://oaister.worldcat.org), Sports Concussion Institute(http://concussiontreatment.com), Brain Trauma Foundation (https://www.braintrauma.org) and the Canadian Concussion Collaborative (http://casem-acmse.org/education/ccc).",Non-OADS,/arxiv_data1/oa_pdf/5c/54/bmjsem-2015-000095.PMC5125422.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/54/bmjsem-2015-000095.PMC5125422.pdf
2014. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 32.,Non-OADS,/arxiv_data1/oa_pdf/5c/54/bmjsem-2015-000095.PMC5125422.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000150).,Non-OADS,/arxiv_data1/oa_pdf/5d/b1/bmjsem-2016-000150.PMC5125423.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/b1/bmjsem-2016-000150.PMC5125423.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2016-000168).,Non-OADS,/arxiv_data1/oa_pdf/01/0e/bmjsem-2016-000168.PMC5125424.pdf
The online questionnaire was administered through Lime Survey (http://www.limesurvey.org).,OADS,/arxiv_data1/oa_pdf/01/0e/bmjsem-2016-000168.PMC5125424.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2016-000141).,Non-OADS,/arxiv_data1/oa_pdf/50/e1/bmjsem-2016-000141.PMC5125426.pdf
2003. http://Sportsci.org/index.html?jour/o3/03.htm& 1(accessed 31 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/50/e1/bmjsem-2016-000141.PMC5125426.pdf
2011. http://www.who.int/ dietphysicalactivity/pa/en/ (accessed Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
"Cambridge: Papworth Trust, 2012. http://www.papworth.org.",Non-OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
2009. http://guidance.nice.org.uk/PH17/Guidance/pdf/English (accessed Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
2002. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf (accessed Jan 2014).,OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
http://epoc.cochrane.org/epoc-specific-resources-review-authors(accessed 2014).,OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC003372 (accessed Dec 2012).,OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
2008. http://www.mrc.ac.uk/ Utilities/Documentrecord/index.htm?d=MRC004871 (accessedNov 2012).,OADS,/arxiv_data1/oa_pdf/d1/b7/bmjsem-2016-000109.PMC5125427.pdf
Available at: http://www.archaeobotany.de/database.html (accessed 27 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/47/e8/10.1177_0959683616650268.PMC5125436.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.008,OADS,/arxiv_data1/oa_pdf/e5/de/main.PMC5125590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1749–1756Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1749ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11844 2 Pharmaceutical interventions in the management  of tuberculosis in a pneumophtisiology  department, ivory Coast Danho Pascal abrogoua1 Boua alexis Thierry Kamenan1 Brou Jean Marcel ahui2 elisée Doffou3 1Department of Clinical Pharmacy  and Therapeutics, Faculty of  Pharmaceutical and Biological  sciences, Félix houphouët- Boigny University, 2Department of  Pneumophtisiology, Teaching hospital  of Cocody, 3Department of Pharmacy,   T eaching hospital of Y opougon,   abidjan, Cote d’ivoireObjectives:  This study aims to analyze the profile and relevance of pharmaceutical interventions  (PIs) in the management of tuberculosis (TB) at inpatient settings.",Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
"Assessment of the global situation has shown that clinicians often deviate Correspondence: Danho Pascal abrogoua Department of Clinical Pharmacy and  Therapeutics, Faculty of Pharmaceutical  and Biological sciences, Félix houphouët- Boigny University, 22 BP 1397 abidjan  22, Côte d’ivoire Tel +225 21 0794 9478 email abrogouadp@yahoo.f r Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Abrogoua et al Running head recto: Pharmaceutical interventions in tuberculosis inpatients DOI: http://dx.doi.org/10.2147/TCRM.S118442",Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
"Available from: http://apps.who.int/iris/bitstream/10665 /137094/1/9789241564809_eng.pd f. Accessed October 10, 2015.",OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
Available from:  http://www.ansm.sante.fr.,Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
Available from: http://apps.who.int/medicinedocs/documents/s20987fr/ s20987fr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/66/tcrm-12-1749.PMC5125718.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/tcrm-12-1717.PMC5125719.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1717–1720Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1717ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12270 0 The effect of body mass index on perioperative  thermoregulation Ayşe Belin Özer1 Aysun Yildiz Altun1 Ömer Lütfi Erhan1 T uba Çatak2 Ümit Karatepe1 İsmail Demirel1 Gonca Çag ˘lar T oprak3 1Department of anesthesiology  and intensive Care, Firat University  Medical School, Elazig ˘, 2Department  of anesthesiology and intensive Care  Clinic, Bingol State Hospital, Bingöl,   3Department of anesthesiology and  Intensive Care Clinic, Elazig Training  and Research Hospital, Elazig ˘, T urkeyPurpose:  We evaluated the effects of body mass index (BMI) on thermoregulation in obese  patients scheduled to undergo laparoscopic abdominal surgery.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/tcrm-12-1717.PMC5125719.pdf
"While  acceptable changes are controlled by the temperature regulation system, significant  changes may lead to metabolic dysfunction and even death.1 Besides the fact that anesthetic agents inhibit thermoregulation and cause vaso - dilation, the coldness of the operation room, cleaning of patients with cold solutions,  usage of cold and dry gases for ventilation, irrigation of the surgical field with cold  fluids, administration of intravenous cold fluids and blood transfusions, and evapo - ration from the surgical field have nonnegligible contributions to intraoperative or  postoperative hypothermia.2 Recent studies have shown that mild hypothermia (approximately 1 °C–2°C) triple  the incidence of cardiac events and surgical wound infections, lengthen the duration Correspondence: Ayşe Belin Özer Department of anesthesiology and  intensive Care, Firat University Medical  School, Yunus Emre Bulvarı, No 20,  Elazig ˘ 23119, Turkey Tel +90 424 233 3555 Fax +90 424 238 8096 email abelinozer@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Özer et al Running head recto: Effect of BMI on perioperative thermoregulation DOI: http://dx.doi.org/10.2147/TCRM.S122700",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/tcrm-12-1717.PMC5125719.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/tcrm-12-1717.PMC5125719.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/tcrm-12-1717.PMC5125719.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1709–1715Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1709ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11988 8 Treatment cost of narcolepsy with cataplexy  in Central europe Petra Maresova1 Michal novotny2,3 Blanka Klímová4 Kamil Kuča3,5 1Department of economics, Faculty  of informatics and Management,   2Department of Chemistry, Faculty  of science, University of hradec  Králové, 3Biomedical Research  Center, University hospital hradec  Králové, 4Department of applied  linguistics, Faculty of informatics and  Management, 5Faculty of informatics  and Management, University of  hradec Králové, hradec Králové,   Czech RepublicBackground:  Narcolepsy is a lifelong, rare neurological sleep disorder characterized by  chronic, excessive attacks of daytime sleepiness.",Non-OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
"Partinen et al6 dealt  with epidemiological observations from studies in People’s Republic of China and Correspondence: Kamil Kuča Biomedical Research Centre, University  hospital hradec Králové, sokolska 581,  500 05 hradec Kralove, Czech Republic Tel +420 603 289 166 email kamil.kuca@fnhk.c z Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Maresova et al Running head recto: Treatment cost of narcolepsy with cataplexy DOI: http://dx.doi.org/10.2147/TCRM.S119888",OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
Available from: http://www.sukl.cz /.,Non-OADS,/arxiv_data1/oa_pdf/61/a1/tcrm-12-1709.PMC5125720.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1721–1727Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1721ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12300 8 Protective effect of tartary buckwheat on renal   function in type 2 diabetics: a randomized  controlled trial Ju Qiu1 Zaigui li2 Yuchang Qin1 Yanfen Yue3 Yanping liu4 1institute of Food and nutrition  Development, Ministry of agriculture,   2College of Food science and  nutritional engineering, China  agricultural University, 3Department  of nutrition, Pinggu hospital of  Traditional Chinese Medicine, Pinggu,   4Department of nutrition, Peking  Union Medical College hospital,   Chinese academy of Medical sciences,   Beijing, ChinaAbstract:  Tartary buckwheat (TB) has been reported to be associated with a decreased risk  of type 2 diabetes mellitus (T2DM), and T2DM has had a major impact on the development  of diabetic kidney disease (DKD).",Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
"Management of hyperglycemia  and dyslipidemia is critical to prevent DKD for T2DM patients.1 A recent study  demonstrated the significant protective effect of flavonoids from buckwheat on renal Correspondence: Yanping liu Peking Union Medical College hospital  (east), number 1 shuaifuyuan Wangfujing,  Dongcheng, Beijing 100730, China Tel/fax +86 10 6915 9081 email liuyp1227@vip.sina.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Qiu et al Running head recto: Protective effect of tartary buckwheat on renal function DOI: http://dx.doi.org/10.2147/TCRM.S123008",Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
"Materials and methods subjects A parallel, randomized, open-label controlled, 4-week  dietary intervention trial was performed in Pinggu Hospital  of Traditional Chinese Medicine, Beijing, China (Trial  registration: chiCTR-IIR-15007600 at http://www.chictr.",Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/5a/tcrm-12-1721.PMC5125721.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/8f/tcrm-12-1729.PMC5125722.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1729–1748Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1729Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S11590 2 intestinal permeability in a patient with liver   cirrhosis Jonathan Manuel Aguirre  valadez1 Liliana Rivera-espinosa2 Osvely Méndez-Guerrero1 Juan Luis Chávez-Pacheco2 ignacio García Juárez1 Aldo T orre1 1Department of Gastroenterology,   instituto Nacional de Ciencias  Médicas y Nutrición”Salvador  Zubirán, 2Pharmacology Laboratory,   instituto Nacional de Pediatría,   Mexico City, MexicoAbstract:  Liver cirrhosis is a worldwide public health problem, and patients with this disease  are at high risk of developing complications, bacterial translocation from the intestinal lumen  to the mesenteric nodes, and systemic circulation, resulting in the development of severe  complications related to high mortality rate.",Non-OADS,/arxiv_data1/oa_pdf/a1/8f/tcrm-12-1729.PMC5125722.pdf
"In liver cirrhosis, bacterial translocation is a common denominator in the genesis  of several of its complications: upper gastrointestinal bleeding, HE, and SBP.Correspondence: Aldo T orre Gastroenterology Department, instituto  Nacional de Ciencias Médicas y Nutrición  Salvador Zubirán, Mexico City, Mexico email detoal@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Aguirre Valadez et al Running head recto: Intestinal permeability in the patient DOI: http://dx.doi.org/10.2147/TCRM.S115902",Non-OADS,/arxiv_data1/oa_pdf/a1/8f/tcrm-12-1729.PMC5125722.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a1/8f/tcrm-12-1729.PMC5125722.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/8f/tcrm-12-1729.PMC5125722.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.04.004 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
"System-dependent parameters ( e.g., tissue volume, blood ﬂow, glomerular ﬁltration rate, amount of microsomal protein/hepatocytes per gram of liver, plasma protein, enzyme, and transporter abundance) for human and preclinical species are available in the literature andhave been compiled in the commercial PBPK platforms, including GastroPlus ( www.simulations-plus.com ), PKSIM ( www.system sbiology.com/products/pk-sim.html ), Simcyp ( www.simcyp.com ), ADMEWORKS DDI Simulator ( http://www.fqs.pl/chemistry_ materials_life_science/products/ddi_simulator ), CLOEPK ( http:// www.cyprotex.com/insilico/ ), and many other modeling software.",OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
Available from: 〈http://www.fda.gov/downl oads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm292362.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
Available from: 〈http://www.ema.europa.eu/ docs/en_GB/document_library/Scienti ﬁc_guideline/2012/07/ WC500129606.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
Available from: 〈http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/51/main.PMC5125732.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/54/dd/ppa-10-2379.PMC5125755.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2379–2385Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2379OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11839 6 gender- and age-related treatment compliance  in patients with osteoporosis in germany Peyman hadji1 louis Jacob2 Karel Kostev3 1Department of Bone Oncology,   endocrinology and reproductive  Medicine, nordwest hospital,   Frankfurt, germany; 2Faculty of  Medicine, University of Paris, Paris,   France; 3epidemiology, iMs health  gmbh & co. Ohg, Darmstädter  landstraße, Frankfurt, germanyAim:  The purpose of this study was to analyze treatment compliance in osteoporotic patients  treated with osteoporosis medications in Germany.",Non-OADS,/arxiv_data1/oa_pdf/54/dd/ppa-10-2379.PMC5125755.pdf
"Keywords:  osteoporosis treatment, compliance, fracture, real-world data, Germany Introduction Osteoporosis affects around 200 million patients and causes more than 8.9 million  fractures worldwide every year.1 One in three women and one in five men over the age  of 50 years are estimated to experience osteoporotic fractures.1 A recently published  epidemiologic study reported that in 2009, around five million patients (6.3% of popu - lation) were diagnosed with osteoporosis in Germany, and that the fracture-associated  yearly cost exceeded 9 billion euros, underscoring the major impact of this chronic  disease on health economics nationwide.1 Medications prescribed to patients with osteoporosis usually need to be taken for  several years in order to achieve successful outcomes, in particular the prevention of  osteoporotic fractures.2–4 Unfortunately, one major problem associated with osteo - porosis and other chronic disorders is the lack of patient compliance, persistence, correspondence: Karel Kostev epidemiology, iMs health gmbh & co.  Ohg, Darmstädter landstraße 108, 60598  Frankfurt am Main, germany Tel +49 69 6604 4878 email kkostev@de.imshealth.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Hadji et al Running head recto: Compliance with osteoporosis treatments DOI: http://dx.doi.org/10.2147/PPA.S118396",Non-OADS,/arxiv_data1/oa_pdf/54/dd/ppa-10-2379.PMC5125755.pdf
"Available from:  https://www.iofbonehealth.org/facts-statistic s. Accessed July 18, 2016.",OADS,/arxiv_data1/oa_pdf/54/dd/ppa-10-2379.PMC5125755.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/54/dd/ppa-10-2379.PMC5125755.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fa/70/ijn-11-6229.PMC5125756.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6229–6238International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6229OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11283 5 synthetic high-density lipoproteins for delivery  of 10-hydroxycamptothecin Yue Yuan1,2 Jian Wen3 Jie Tang2 Qiming Kan1 rose ackermann2 Karl Olsen2 anna schwendeman2 1Department of Pharmaceutics, school  of Pharmacy, shenyang Pharmaceutical  University, shenyang, People’s  republic of china; 2Department of  Pharmaceutical sciences, Biointerfaces  Institute, college of Pharmacy,   University of Michigan, 3Department  of Internal Medicine, Division of  Molecular Medicine and genetics,   University of Michigan Medical school,   ann arbor, MI, UsaAbstract:  The purpose of this study was to develop a novel synthetic high-density lipoprotein  (sHDL) nanoparticle delivery system for 10-hydroxycamptothecin (HCPT) for treatment of  colon carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/fa/70/ijn-11-6229.PMC5125756.pdf
"Keywords:  apolipoprotein A-I mimic peptide, phospholipids, SR-BI receptor, colon carcinoma,  camptothecin, nanoparticle, nanodisc Introduction Cancer cells commonly over express the scavenger receptor B-I (SR-BI), primarily  found in the liver, in order to obtain extra cholesterol necessary for tumor growth.1  SR-BI recognizes high-density lipoproteins (HDLs), the natural nanoparticles  (8–10 nm) that remove excess cholesterol from peripheral tissues and shuttle it to the  liver for elimination in a process called reverse cholesterol transport (RCT).2 Several  synthetic HDL (sHDL) infusion products have reached the clinic as potential thera - pies to treat acute coronary syndrome patients by promoting RCT.3–5 Clinically tested  sHDLs are composed of protein, such as apolipoprotein A-I (ApoA-I), ApoA-I mutant,  or ApoA-I mimetic peptides, which is wrapped around with a lipid bilayer to form  a nanodisk.3–5 In the clinic, sHDL products have been dosed at 8–10 g lipid–protein  mixture per administration (eg, dosed weekly intravenously over 5–6 weeks) and are  known to have long circulating half-lives (8–24 h).3–5 Many hydrophobic drugs bind to HDL following administration, including pacli - taxel and camptothecins (CPTs).6,7 Several groups have utilized the ability of HDL  to retain hydrophobic anticancer drugs and selectively deliver chemotherapeutics to  tumors.1,7–11 A long circulation half-life and a very small particle size allow for sHDL to  effectively accumulate in a tumor region and to penetrate extracellular matrix.12 Y et the  clinical translation of this concept is lacking due to high cost and technical difficulty in correspondence: anna schwendeman Department of Pharmaceutical sciences,  Biointerfaces Institute, college of  Pharmacy, University of Michigan,  2800 Plymouth road, ann arbor,  MI 48109, Usa Tel +1 734 763 4056 Fax +1 734 615 6162 email annaschw@umich.ed uJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yuan et al Running head recto: Synthetic HDL for delivery of 10-hydroxycamptothecin DOI: http://dx.doi.org/10.2147/IJN.S112835",Non-OADS,/arxiv_data1/oa_pdf/fa/70/ijn-11-6229.PMC5125756.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fa/70/ijn-11-6229.PMC5125756.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/70/ijn-11-6229.PMC5125756.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2369–2377Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2369OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11686 0 Adverse events and patients’ perceived health- related quality of life at the end of multidrug- resistant tuberculosis treatment in namibia evans l sagwa,1 nunurai  ruswa,2 Farai Mavhunga,2  Timothy rennie,3 hubert gM  leufkens,1,4 Aukje K Mantel- T eeuwisse1 1Division of Pharmacoepidemiology and  clinical Pharmacology, Utrecht institute  for Pharmaceutical sciences, Utrecht  University, Utrecht, the netherlands;   2national T uberculosis and leprosy  Program, Ministry of health and social  services, Windhoek, namibia; 3Department  of Pharmacy Practice and Policy, University  of namibia school of Pharmacy, Windhoek,   namibia; 4Medicines evaluation Board,   Utrecht, the netherlandsPurpose:  The health-related quality of life (HRQoL) of patients completing multidrug-resistant  tuberculosis (MDR-TB) treatment in Namibia and whether the occur rence of adverse events  influenced patients’ rating of their HRQoL was evaluated.",Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
"Keywords:  drug safety, patient-reported health outcomes, SF-8™ questionnaire, second-line  tuberculosis drugs, Namibia Introduction Multidrug-resistant tuberculosis (MDR-TB) has become a major public health problem,  especially in developing countries, where the MDR-TB burden is the highest.1 Unlike  the treatment of drug-sensitive Mycobacterium tuberculosis , the treatment of MDR-TB  takes a long time, is complex and is frequently associated with the occurrence of  various adverse drug reactions.2–8 Some of these adverse drug reactions, such as  ototoxicity, nephrotoxicity, and hepatotoxicity, could severely diminish a person’s correspondence: evans l sagwa Utrecht institute for Pharmaceutical sciences,  Utrecht University, Universiteitsweg 99, 3584  cg Utrecht, PO Box 80082, 3508 TB Utrecht,  the netherlands Tel +264 81 352 1030 email esagwa@gmail.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sagwa et al Running head recto: Adverse events and HRQoL in MDR-TB treatment DOI: http://dx.doi.org/10.2147/PPA.S116860 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
Or use: http://youtu.be/8lrnFutJeV EVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
"Available from: https://www.optum.com/optum-outcomes/ what-we-do/health-surveys/sf-8-health-survey.htm l. Accessed  September 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6f/82/ppa-10-2369.PMC5125758.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/d5/ijn-11-6169.PMC5125759.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6169–6179International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6169OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11132 0 Monte carlo simulations guided by imaging to  predict the in vitro ranking of radiosensitizing  nanoparticles Paul retif1–3 aurélie reinhard2,3 héna Paquot2,3 Valérie Jouan-hureaux2,3 alicia chateau2,3 lucie sancey4 Muriel Barberi-heyob2,3 sophie Pinel2,3 Thierry Bastogne2,3,5 1Unité de Physique Médicale, chr  Metz-Thionville, ars-laquenexy,   2Université de lorraine, 3craN,   UMr 7039, cNrs, Vandoeuvre-lès- Nancy, 4Institut lumière Matière,   UMr 5306, cN rs, Villeurbanne,   5INrIa-BIgs & cra N, Université  de lorraine, Vandoeuvre-lès-Nancy  cedex, FranceAbstract:  This article addresses the in silico–in vitro prediction issue of organometallic  nanoparticles (NPs)-based radiosensitization enhancement.",Non-OADS,/arxiv_data1/oa_pdf/36/d5/ijn-11-6169.PMC5125759.pdf
"That is why in a recent comment,  McMahon et al15 have highlighted the fact that theoretical prediction scenarios and  values should be meaningful within a therapeutic context.correspondence: Paul retif Unité de Physique Médicale, hôpital de  Mercy, chr Metz-Thionville, 1 allée du  château, ars-laquenexy, 57530, France Tel +33 3 8755 3549 Fax +33 3 8755 3551 email p.retif@chr-metz-thionville.f r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Retif et al Running head recto: Numerical prediction of the in vitro ranking of radiosensitizing NPs DOI: http://dx.doi.org/10.2147/IJN.S111320",Non-OADS,/arxiv_data1/oa_pdf/36/d5/ijn-11-6169.PMC5125759.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/36/d5/ijn-11-6169.PMC5125759.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/d5/ijn-11-6169.PMC5125759.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/38/ijn-11-6239.PMC5125760.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6239–6250International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6239OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11968 0 Blockage of both the extrinsic and intrinsic  pathways of diazinon-induced apoptosis in  PaT u cells by magnesium oxide and selenium  nanoparticles Mahdi shiri1,2,* Mona Navaei-Nigjeh1,3,* Maryam Baeeri1 Mahban rahimifard1 hossein Mahboudi4 ahmad reza shahverdi5 abbas Kebriaeezadeh1 Mohammad abdollahi1,6,7 1Department of T oxicology and  Pharmacology, Faculty of Pharmacy  and Pharmaceutical sciences research  center, Tehran University of Medical  sciences, 2school of Medicine, artesh  University of Medical sciences,   3Department of Tissue engineering,   school of advanced T echnologies in  Medicine, Tehran University of Medical  sciences, T ehran, Iran; 4Department of  Biotechnology, Faculty of advanced  Technologies in Medicine, shahid  Beheshti University of Medical  sciences, T ehran, Iran; 5Department of  Biotechnology, Faculty of Pharmacy  and Biotechnology research center,   6T oxicology Interest group, UserN,   7endocrinology & Metabolism  research Institute, T ehran University  of Medical sciences, T ehran, Iran *These authors contributed equally  to this workAbstract:  Diazinon (DZ) is an organophosphorus insecticide that acts as an acetylcholinesterase  inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/e2/38/ijn-11-6239.PMC5125760.pdf
"When DZ enters the body, it can be oxidatively degenerated to  diazoxon in the liver microsomal enzyme system by using NADH and O2.1 Diazoxon,  an active oxygen metabolite of DZ, causes predictably higher levels of AChE inhibition  than the parent compound owing to the fact that the parent compound does not inhibit  AChE directly.2–4 In addition, studies have indicated that DZ could increase the genera - tion of reactive oxygen species (ROS), mitochondrial membrane damage, oxidative  stress, oxidative modifications, lipid peroxidation (LPO) and DNA fragmentation in  the genomic DNA content of the tissues/cells to induce cardiotoxicity, neurotoxicity,  genotoxicity or cytotoxicity, and apoptosis.5–9 RIN, HIT, MIN, INS-1, and beta-TC cells are insulin-producing cell lines that are  mostly used in in vitro studies.10 Although these pancreatic  cell lines could produce insulin, correspondence: Mohammad abdollahi Department of Toxicology and  Pharmacology, Faculty of Pharmacy  and Pharmaceutical sciences research  center, Tehran University of Medical  sciences, Poursina avenue, Tehran  1417614411, Iran email mohammad@tums.ac.i r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Shiri et al Running head recto: Interaction of MgO and Se NPs with the toxicity of diazinon in PaTu cells DOI: http://dx.doi.org/10.2147/IJN.S119680",Non-OADS,/arxiv_data1/oa_pdf/e2/38/ijn-11-6239.PMC5125760.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/38/ijn-11-6239.PMC5125760.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/38/ijn-11-6239.PMC5125760.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/9b/ijn-11-6135.PMC5125761.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6135–6148International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6135OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11742 5 celastrol nanomicelles attenuate cytokine  secretion in macrophages and inhibit macrophage- induced corneal neovascularization in rats Zhanrong li1,* Jingguo li1,* lei Zhu1 Ying Zhang1 Junjie Zhang1 lin Yao2 Dan liang2 liya Wang1 1henan eye Institute, henan eye  hospital, henan Provincial People’s  hospital and Zhengzhou University  People’s hospital, Zhengzhou, 2state  Key laboratory of Ophthalmology,   Zhongshan Ophthalmic center,   sun Yat-sen University, guangzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  The aim of the present study was to investigate the inhibitory effects of celastrol- loaded nanomicelles (CNMs) on activated macrophage-induced corneal neovascularization  (CNV) in rats and cytokine secretion in macrophages.",Non-OADS,/arxiv_data1/oa_pdf/ce/9b/ijn-11-6135.PMC5125761.pdf
"CNV is typically associated  with inflammation or hypoxic stress.1 The mechanisms of CNV have been investigated,  and several angiogenic and inflammatory molecules are involved in this process, such as  vascular endothelial growth factor (VEGF), basic fibroblast growth factor, tumor necrosis  factor-α (TNF-α), interleukin-6 (IL-6), and matrix metalloproteinases (MMPs).2–4 correspondence: liya Wang henan eye Institute, henan eye hospital,  henan Provincial People’s hospital and  Zhengzhou University People’s hospital,  Zhengzhou 450003, People’s republic  of china Tel +86 371 8733 0492 Fax +86 371 20 8733 4825 email wangliya_55@126.co m  Dan liang state Key laboratory of Ophthalmology,  Zhongshan Ophthalmic center, sun  Yat-sen University, 54 Xianlie south  road, guangzhou 510060, People’s  republic of china Tel +86 371 8733 0492 Fax +86 371 20 8733 4825 email liangd2@mail.sysu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Celastrol inhibit corneal neovascularization DOI: http://dx.doi.org/10.2147/IJN.S117425",Non-OADS,/arxiv_data1/oa_pdf/ce/9b/ijn-11-6135.PMC5125761.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ce/9b/ijn-11-6135.PMC5125761.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/9b/ijn-11-6135.PMC5125761.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/f9/ijn-11-6217.PMC5125762.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6217–6228International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6217OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11649 2 Macrophages participate in local and systemic  inflammation induced by amorphous silica  nanoparticles through intratracheal instillation Man Yang1,2 li Jing1,2 Ji Wang1,2 Yang Yu1,2 lige cao1,2 lianshuang Zhang1,2 Xianqing Zhou1,2 Zhiwei sun1,2 1School of Public Health, Capital  Medical University, Beijing, People’s  Republic of China; 2Beijing Key  Laboratory of Environmental  T oxicology, capital Medical University,   Beijing, People’s Republic of ChinaAbstract:  Silica nanoparticles (SiNPs) are amongst the most commonly used materials in the  field of nanomedicine and, therefore, their influence on organisms has drawn increasing atten - tion in recent years.",Non-OADS,/arxiv_data1/oa_pdf/e7/f9/ijn-11-6217.PMC5125762.pdf
"Further, some studies indi - cated cardiovascular toxicity of amorphous SiNPs.11,12 Nevertheless, the response of  other organs following inhalation of SiNPs remains poorly understood.correspondence: Zhiwei sun Department of Toxicology and hygienic  Chemistry, School of Public Health,  capital Medical University, No 10 Xi  Tou Tiao, You an Men, Beijing, 100069,  People’s Republic of China Tel +86 10 839 115 07 email zwsun@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ang et al Running head recto: Macrophages participate in local and systemic inflammation DOI: http://dx.doi.org/10.2147/IJN.S116492",Non-OADS,/arxiv_data1/oa_pdf/e7/f9/ijn-11-6217.PMC5125762.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e7/f9/ijn-11-6217.PMC5125762.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/f9/ijn-11-6217.PMC5125762.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 643–644Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 643 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S123032 Undergraduate hematology – a more integrated  approach Matteo A Di Carlofelice* Jack FT Cope* Faculty of Medicine, Imperial College  London, London, UK *These authors contributed equally to  this workDear editor As fellow medical students we read with great interest the article by Mandan et al1  proposing a dedicated hematology rotation.",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"5 Also, do the authors suggest Correspondence: Matteo A Di Carlofelice Faculty of Medicine, Imperial College London, Level 2, Faculty Building, South Kensington Campus, London SW7 2AZ, UKTel +44 77 1358 5731Email mad113@ic.ac.uk Jack FT Cope Faculty of Medicine, Imperial College London, Level 2, Faculty Building, South Kensington Campus, London SW7 2AZ, UKTel +44 79 1261 1228Email jack.cope13@ic.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Di Carlofelice and CopeRunning head recto: Undergraduate hematologyDOI: http://dx.doi.org/10.2147/AMEP .S123032",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK63506/.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
Available from: http://www.gmc-uk.org/doctors/register/ search_stats.asp.,Non-OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"Available from: https://en.wikipedia.org/wiki/ File:Pre-Clinical_Medicine_(A1)_UCAS_application_and_accpetances_statistics,_2007_-_2014.jpg.",OADS,/arxiv_data1/oa_pdf/b4/b0/amep-7-643.PMC5125763.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/da/87/ppa-10-2387.PMC5125764.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2387–2396Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2387OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11841 3 illness perceptions and stress: mediators between  disease severity and psychological well-being and  quality of life among patients with crohn’s disease Maochen Zhang1,* liwen hong1,* Tianyu Zhang1 Yun lin1 sichang Zheng1 Xiaolin Zhou1 rong Fan1 Zhengting Wang1 chenli Zhang2 Jie Zhong1 1Department of gastroenterology,   2exclusive Medical center, ruijin  hospital, school of Medicine, shanghai  Jiao Tong University, shanghai, People’s  republic of china *These authors contributed equally  to this workBackground:  Disease severity, illness perceptions, coping strategies, stress, psychological  well-being, and quality of life were reported to have close relationships.",Non-OADS,/arxiv_data1/oa_pdf/da/87/ppa-10-2387.PMC5125764.pdf
"Keywords:  Crohn’s disease, disease severity, illness perceptions, coping strategies, stress,  psychological well-being, quality of life Introduction Inflammatory bowel disease (IBD), including two major gastrointestinal disorders  namely Crohn’s disease (CD) and ulcerative colitis, affects nearly 28 million people correspondence: Jie Zhong Department of gastroenterology,  ruijin hospital, school of Medicine,  shanghai Jiao Tong University, 197 ruijin  er road, shanghai 200025, People’s  republic of china Tel +86 21 6437 0045 ext 600907 email jimmyzj64@hotmail.co m chenli Zhang exclusive Medical center, ruijin hospital,  school of Medicine, shanghai Jiao Tong  University, 197 ruijin er road, shanghai  200025, People’s republic of china Tel +86 21 6437 0045 ext 600907 email zhangchenli@medmail.com.c n Journal name: Patient Preference and Adherence  Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhang et al Running head recto: Factors associated with psychological health in Crohn’s disease patients DOI: http://dx.doi.org/10.2147/PPA.S118413",Non-OADS,/arxiv_data1/oa_pdf/da/87/ppa-10-2387.PMC5125764.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/da/87/ppa-10-2387.PMC5125764.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 401–408Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 401 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S119161 Intellijoint HIP®: a 3D mini-optical navigation tool  for improving intraoperative accuracy during total  hip arthroplasty Wayne G Paprosky1,2 Jeffrey M Muir3 1Department of Orthopedics, Section  of Adult Joint Reconstruction,   Department of Orthopedics, Rush University Medical Center, Rush–Presbyterian–St Luke’s Medical Center, Chicago,  2Central DuPage  Hospital, Winfield, IL, USA; 3Intellijoint  Surgical, Inc, Waterloo, ON, CanadaAbstract:  Total hip arthroplasty is an increasingly common procedure used to address degen- erative changes in the hip joint due to osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
"14 Similarly, inaccurate sizing of implants Correspondence: Wayne G Paprosky Central DuPage Hospital, Suite 505, 25 North, Winfield Road, Winfield, IL 60190, USA Tel +1 630 682 5653   Email wpaprosky@reagan.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Paprosky and MuirRunning head recto: Intellijoint HIP 3D mini-optical navigation tool for THADOI: http://dx.doi.org/10.2147/MDER.S119161 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
Or use: http://youtu.be/KCyGWJvxvLM,Non-OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/cf/0c/mder-9-401.PMC5125765.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/7f/ppa-10-2397.PMC5125766.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2397–2406Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2397Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9302 0 Polifeprosan 20, 3.85% carmustine slow release  wafer in malignant glioma: patient selection and  perspectives on a low-burden therapy Lawrence Kleinberg Department of Radiation Oncology  and Molecular Radiation Sciences,   Johns Hopkins University, Baltimore,   MD, USAAbstract:  Polifeprosan 20 with carmustine (GLIADEL®) polymer implant wafer is a biodegrad - able compound containing 3.85% carmustine (BCNU, bischloroethylnitrosourea) implanted in  the brain at the time of planned tumor surgery, which then slowly degrades to release the BCNU  chemotherapy directly into the brain thereby bypassing the blood–brain barrier.",Non-OADS,/arxiv_data1/oa_pdf/61/7f/ppa-10-2397.PMC5125766.pdf
"The blood–brain barrier appears to be an important obstacle to improving the thera - peutic outcome as it limits penetration of most drugs and creates an immune-privileged Correspondence: Lawrence Kleinberg Department of Radiation Oncology  and Molecular Radiation Sciences,  Johns Hopkins University, 401 North  Broadway, Suite 1440, Baltimore,  MD 21231, USA email kleinla@jhmi.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Kleinberg Running head recto: Carmustine wafer implantation DOI: http://dx.doi.org/10.2147/PPA.S93020",Non-OADS,/arxiv_data1/oa_pdf/61/7f/ppa-10-2397.PMC5125766.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/61/7f/ppa-10-2397.PMC5125766.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 223–229Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 223 Original researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S119997 hMMr antisense rna 1, a novel long noncoding  rna, regulates the progression of basal-like  breast cancer cells Wei liu Jun Ma Y ong Cheng hongbo ZhangWengguang luo hongyan Zhang Department of radiation Oncology,   anhui Provincial hospital, hefei,   People’s republic of ChinaAbstract: Recently, accumulating evidence has suggested that long noncoding RNAs (lncRNAs)  play crucial roles in carcinogenesis and cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
"Among these diversely expressed Correspondence: hongyan Zhang Department of radiation Oncology, anhui Provincial hospital, 17 lujiang road, hefei 230001, anhui, People’s republic of ChinaTel +86 551 6228 3535email hongyanzhang1602@163.comJournal name: Breast Cancer - Targets and Therapy Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Liu et alRunning head recto: HMMR-AS1 regulates progression of BLBC cellsDOI: http://dx.doi.org/10.2147/BCTT.S119997",Non-OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 229 hMMr-as1 regulates progression of BlBC cells,Non-OADS,/arxiv_data1/oa_pdf/ad/70/bctt-8-223.PMC5125767.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/28/ijn-11-6161.PMC5125768.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6161–6168International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6161OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11329 2 Pegylated and nanoparticle-conjugated sulfonium  salt photo triggers necrotic cell death alaa a Fadhel1 Xiling Yue1 ebrahim h ghazvini Zadeh1 Mykhailo V Bondar2 Kevin D Belfield3 1Department of chemistry, University  of central Florida, Orlando, Fl, Usa;   2Institute of Physics N asU, Kiev,   Ukraine; 3Department of chemistry  and environmental science, college of  science and liberal arts, New Jersey  Institute of Technology, University  heights, Newark, NJ, UsaAbstract:  Photodynamic therapy (PDT) processes involving the production of singlet  oxygen face the issue of oxygen concentration dependency.",Non-OADS,/arxiv_data1/oa_pdf/d0/28/ijn-11-6161.PMC5125768.pdf
"Therefore, the success of photodynamic therapeutics depends  largely on the photosensitizer concentration throughout the tissue, adequate intracellular Correspondence: Kevin D Belfield Department of chemistry and  environmental science, college of  science and liberal arts, New Jersey  Institute of Technology, University  heights, 323 Martin luther King Jr  Boulevard, Newark, NJ 07102, Usa Tel +1 973 596 3677 Fax +1 973 596 6063 email belfield@njit.ed uJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Fadhel et al Running head recto: Sulfonium salt nanoparticle PDT DOI: http://dx.doi.org/10.2147/IJN.S113292",Non-OADS,/arxiv_data1/oa_pdf/d0/28/ijn-11-6161.PMC5125768.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d0/28/ijn-11-6161.PMC5125768.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/28/ijn-11-6161.PMC5125768.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/ijn-11-6149.PMC5125769.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6149–6159International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6149OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11917 4 Incorporation of heparin-binding proteins into  preformed dextran sulfate-chitosan nanoparticles Paula Zaman1 Julia Wang1 adam Blau1 Weiping Wang2 Tina li1 Daniel s Kohane2 Joseph loscalzo1 Ying-Yi Zhang1 1Department of Medicine, Brigham  and Women’s hospital, 2Department  of anesthesiology, Boston children’s  hospital, harvard Medical school,   Boston, M a, UsaAbstract:  Incorporation of proteins into dextran sulfate (DS)-chitosan (CS) nanoparticles  (DSCS NPs) is commonly performed using entrapment procedures, in which protein molecules  are mixed with DS and CS until particle formation occurs.",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/ijn-11-6149.PMC5125769.pdf
"The most critical of  these limitations is the instability of the NPs in physiological saline (0.15 M NaCl), correspondence: Ying-Yi Zhang Department of Medicine, Brigham and  Women’s hospital, harvard Medical  school, 77 avenue louis Pasteur,  NrB 0630, Boston, Ma 02115, Usa Tel +1 617 525 4848 Fax +1 617 525 4830 email yyzhang@rics.bwh.harvard.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zaman et al Running head recto: Incorporation of heparin-binding proteins into DSCS NPs DOI: http://dx.doi.org/10.2147/IJN.S119174",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/ijn-11-6149.PMC5125769.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9e/a4/ijn-11-6149.PMC5125769.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/a4/ijn-11-6149.PMC5125769.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2407–2417Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2407OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11216 1 Men’s preferences for the treatment of lower  urinary tract symptoms associated with benign  prostatic hyperplasia: a discrete choice experiment colette Mankowski1 Divine ikenwilo2,† sebastian heidenreich2 Mandy ryan2 Jameel nazir1 cathy newman1 Verity Watson2 1health economics and Outcomes  research, Astellas Pharma europe  ltd., chertsey, 2health economics  research Unit, University of  Aberdeen, Aberdeen, UK †Dr ikenwilo passed away on  november 27, 2015Objective:  To explore and quantify men’s preferences and willingness to pay (WTP) for  attributes of medications for lower urinary tract symptoms associated with benign prostatic  hyperplasia using a discrete choice experiment.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"Keywords:  benign prostatic hyperplasia, discrete choice experiment, erectile dysfunction,  lower urinary tract symptoms, storage symptoms, urge incontinence Introduction Lower urinary tract symptoms (LUTS) are prevalent in aging men, with ~90% of men aged  50 to 80 years suffering from potentially bothersome symptoms.1 Presenting symptoms  include storage symptoms (ie, daytime urinary frequency, nocturia, urgency, urinary incon - tinence), voiding symptoms (ie, slow stream, splitting or spraying, intermittency, hesitancy,  straining, terminal dribble), and/or post-micturition symptoms (sensation of incomplete  emptying, post-micturition dribble).1 All three symptoms are found in ~one-third of men  with LUTS,2 but storage symptoms have been reported to be the most bothersome.1,3,4 The mechanisms leading to the development of LUTS are multifactorial.5 Benign  prostatic hyperplasia (BPH) is reported to be a common cause of LUTS6,7 and 25% to correspondence: colette Mankowski Astellas Pharma europe ltd., Astellas  Medical Affairs, eMeA, heOr, 2000  hillswood Drive, chertsey, surrey  KT16 0Ps, UK Tel +44 78 8194 0638 email colette.mankowski@astellas.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mankowski et al Running head recto: Preferences for the treatment of LUTS associated with BPH DOI: http://dx.doi.org/10.2147/PPA.S112161",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
References 1. https://www.nice.org.uk / [homepage on the internet].,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"Available from: http://uroweb.org/ wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS- Guidelines-2015-v2.pd f. Accessed August 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
18. http://www.fda.gov / [homepage on the internet].,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
Available from: http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance /GuidanceDocuments/UCM296379.,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
19. https://www.iqwig.de / [homepage on the internet].,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
20. http://www.ema.europa.eu/ema / [homepage on the internet].,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library /Report/2011/01/WC500101373.pd f. Accessed  August 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
53. https://www.ons.gov.uk / [homepage on the internet].,Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"Available from: http://www.ons.gov.uk/ons/ dcp171778_362910.pd f. Accessed August 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/ppa-10-2407.PMC5125770.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/18/ijn-11-6181.PMC5125772.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6181–6194International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6181OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10692 9 Fabrication and characterization of drug-loaded  nano-hydroxyapatite/polyamide 66 scaffolds  modified with carbon nanotubes and silk fibroin Meng-Zhu Yao1 Ming-Yi huang-Fu1 hui-Na liu1 Xia-rong Wang1 Xiaoxia sheng2 Jian-Qing gao1 1Institute of Pharmaceutics, college  of Pharmaceutical sciences, Zhejiang  University, 2hangzhou soliPharma  co., ltd, hangzhou, Zhejiang, People’s  republic of chinaAbstract:  Nano-hydroxyapatite/polyamide 66 (nHA/PA66) porous scaffolds were fabricated by  a phase inversion method.",Non-OADS,/arxiv_data1/oa_pdf/e2/18/ijn-11-6181.PMC5125772.pdf
"Due to advantages and disadvantages of single-type materials  mentioned above, composite scaffolds containing two or more different types of com - ponents have often been considered to exhibit improved characteristics by protruding correspondence: Jian-Qing gao Institute of Pharmaceutics, college  of Pharmaceutical sciences, Zhejiang  University, 866 Yuhangtang road,  hangzhou 310058, Zhejiang, People’s  republic of china Tel +86 571 8820 8436 Fax +86 571 8820 8436 email gaojianqing@zju.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ao et al Running head recto: Drug-loaded scaffolds DOI: http://dx.doi.org/10.2147/IJN.S106929",Non-OADS,/arxiv_data1/oa_pdf/e2/18/ijn-11-6181.PMC5125772.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/18/ijn-11-6181.PMC5125772.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/18/ijn-11-6181.PMC5125772.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: Catherine T Frenette, MD,  Scripps Center for Organ Transplantation, Scripps Clinic - Scripps Green Hospital,  10666 N. Torrey Pines Rd, Suite N200, La Jolla, CA 92037, United States.",Non-OADS,/arxiv_data1/oa_pdf/5b/fb/nihms-814142.PMC5125773.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/a9/ijn-11-6251.PMC5125786.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6251–6265International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6251OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11819 6 In vitro evaluation of folic acid-conjugated  redox-responsive mesoporous silica nanoparticles  for the delivery of cisplatin Merlis P alvarez-Berríos1 Juan l Vivero-escoto2,3 1Department of science and  T echnology, Inter american University  of Puerto rico, Ponce, Puerto rico,   2Department of chemistry, 3center  for Biomedical engineering and  science, University of North carolina  at charlotte, charlotte, N c, UsaAbstract:  The use of cisplatin(IV) prodrugs for the delivery of cisplatin have gained significant  attention, because of their low toxicity and reactivity.",Non-OADS,/arxiv_data1/oa_pdf/08/a9/ijn-11-6251.PMC5125786.pdf
"In addition, the two extra ligands provide a means to impart and fine-tune correspondence: Juan l Vivero-escoto Department of chemistry, University  of North carolina at charlotte,  9201 University city Boulevard,  charlotte, Nc 28223, Usa Tel +1 704 687 5239 Fax +1 704 687 0960 email jviveroe@uncc.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Alvarez-Berríos and Vivero-Escoto Running head recto: FA-conjugated MSNs for the delivery of cisplatin DOI: http://dx.doi.org/10.2147/IJN.S118196",Non-OADS,/arxiv_data1/oa_pdf/08/a9/ijn-11-6251.PMC5125786.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/08/a9/ijn-11-6251.PMC5125786.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/a9/ijn-11-6251.PMC5125786.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/ec/ott-9-7227.PMC5125790.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7227–7234OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7227Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12431 1 comparison of survival rates between 3D  conformal radiotherapy and intensity-modulated  radiotherapy in patients with stage iii non-small  cell lung cancer Moonkyoo Kong seong eon hong Department of radiation Oncology,   Kyung hee University Medical center,   Kyung hee University school of  Medicine, seoul, republic of KoreaPurpose:  Randomized trials showing a clear survival benefit of intensity-modulated  radiotherapy (IMRT) over 3-dimensional conformal radiotherapy (3D-CRT) in the treatment  of lung cancer are lacking.",Non-OADS,/arxiv_data1/oa_pdf/80/ec/ott-9-7227.PMC5125790.pdf
"In recent years, intensity-modulated RT (IMRT) has become widely  adopted for the treatment of lung cancer because of its ability to achieve a highly conformal  dose distribution.1–4 Several planning studies have demonstrated theoretical dosimetric  advantages of IMRT over 3-dimensional conformal RT (3D-CRT) in lung cancer.5–8 In  addition, several studies have reported that the use of IMRT significantly reduces the correspondence: Moonkyoo Kong Department of radiation Oncology,  Kyung hee University Medical center,  Kyung hee University school of Medicine,  23 Kyungheedae-gil, Dongdaemoon-gu,  seoul, 130-702, republic of Korea Tel +82 2 958 8661 Fax +82 2 958 9469 email kongmoonkyoo@khu.ac.k r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kong and Hong Running head recto: Intensity-modulated radiotherapy for non-small cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S124311",Non-OADS,/arxiv_data1/oa_pdf/80/ec/ott-9-7227.PMC5125790.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/80/ec/ott-9-7227.PMC5125790.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/ec/ott-9-7227.PMC5125790.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/92/ott-9-7169.PMC5125791.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7169–7175OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11229 0 effect of cyberKnife stereotactic body radiation  therapy for hepatocellular carcinoma on hepatic  toxicity Ping liang,1,* cheng  huang,2,* shi-Xiong   liang,2,3 Ye-Fei li,3   shang-Xiao huang,2   Zu-Ping lian,1 Jian-Min liu,1  Yang Tang,1 hai-Jie lu4 1Department of radiation Oncology,   ruikang hospital affiliated to guangxi  University of chinese Medicine,   2Department of radiation Oncology,   cancer hospital, guangxi Medical  University, nanning, 3Department  of radiation Oncology, shanghai  Pulmonary hospital, T ongji University  school of Medicine, shanghai,   4Department of radiation Oncology,   Zhongshan hospital of Xiamen  University, Xiamen, Fujian, People’s  republic of china *These authors contributed equally  to this workObjective:  To evaluate the safety of CyberKnife stereotactic body radiation therapy (SBRT)  for hepatocellular carcinoma (HCC) patients and identify the treatment-related risk factors of  hepatic toxicity.",Non-OADS,/arxiv_data1/oa_pdf/d3/92/ott-9-7169.PMC5125791.pdf
"Several  other modalities including percutaneous ethanol injection, transarterial chemoembo - lization (TACE), and sorafenib (an orally active multikinase inhibitor approved in the  European Union for the treatment of HCC) have been used as palliative treatments,  but the optimal treatment remains elusive.5–7correspondence: shi-Xiong liang  Department of radiation Oncology,  shanghai Pulmonary hospital, Tongji  University school of Medicine, 507,  Zhengmin road, shanghai, 200433,  People’s republic of china  Tel +86 139 1771 6605 Fax +86 21 6511 5006 email shixliang@vip.sina.co m hai-Jie lu  Department of radiation Oncology,  Zhongshan hospital of Xiamen  University, 209 hubin south road,  Xiamen, Fujian, 361004, People’s republic  of china Tel +86 133 6591 7208 Fax +86 59 2221 2328 email luhaijie1971@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liang et al Running head recto: Effect of CyberKnife for HCC on hepatic toxicity DOI: http://dx.doi.org/10.2147/OTT.S112290",Non-OADS,/arxiv_data1/oa_pdf/d3/92/ott-9-7169.PMC5125791.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/92/ott-9-7169.PMC5125791.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/92/ott-9-7169.PMC5125791.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/58/dddt-10-3827.PMC5125792.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3827–3835Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3827Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11232 2 Feasibility of sequential adjuvant chemotherapy  with a 3-month oxaliplatin-based regimen  followed by 3 months of capecitabine in patients  with stage iii and high-risk stage ii colorectal  cancer: JsWOg-c2 study atsushi Tsuruta,1,* Kazuki  Yamashita,2,* hiroaki Tanioka,3  akihito Tsuji,4,5 Michio inukai,6  T oshiki Yamakawa,7 T omoki  Yamatsuji,8 Masanori Y oshimitsu,9  Kazuhiro T oyota,10 Taketoshi  Yamano,11 Takeshi nagasaka,12  Masazumi Okajima13 On behalf of the Japan southwest  Oncology group (JsWOg) 1Department of Digestive surgery, Kawasaki  Medical school hospital, 2Department of  surgery, 3Department of Medical Oncology,   Okayama rosai hospital, Okayama,   4Department of Medical Oncology, Kobe  city Medical center general hospital, Kobe,   5Department of clinical Oncology, Faculty of  Medicine, Kagawa University hospital, Kagawa,   6Department of Medicine, Okayama saiseikai  general hospital, Okayama, 7Department  of surgery, Kagawa Prefectural central  hospital, Takamatsu, 8Department of general  surgery, Kawasaki Medical school, Okayama,   9Department of surgery, hiroshima city asa  hospital, hiroshima, 10Department of surgery,   national hospital Organization higashihirosima  Medical center, higashihiroshima,   11Department of surgery, Kurashiki Medical  center, 12Department of gastroenterological  surgery, Okayama University graduate school  of Medicine, Dentistry and Pharmaceutical  sciences, Okayama, 13Department of surgery,   hiroshima city hospital, hiroshima, Japan *These authors contributed equally to this workBackground:  Six months of oxaliplatin-based chemotherapy is the standard adjuvant  chemotherapy for completely resected stage III colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/04/58/dddt-10-3827.PMC5125792.pdf
"correspondence: atsushi Tsuruta Department of Digestive surgery, Kawasaki  Medical school hospital, Matsushima 577,  Kurashiki, Okayama 701-0192, Japan Tel +81 86 462 1111 Fax +81 86 462 1199 email atsuatsu@apost.plala.or.j p Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tsuruta et al Running head recto: Feasibility of sequential oxaliplatin-based adjuvant chemotherapy DOI: http://dx.doi.org/10.2147/DDDT.S112322",Non-OADS,/arxiv_data1/oa_pdf/04/58/dddt-10-3827.PMC5125792.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/04/58/dddt-10-3827.PMC5125792.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/58/dddt-10-3827.PMC5125792.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7133–7139OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7133Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11080 0 Meta-analysis of the impact of thioprine  S-methyltransferase polymorphisms on the  tolerable 6-mercaptopurine dose considering  initial dose and ethnic difference Myeong gyu Kim Minoh Ko in-Wha Kim Jung Mi Oh college of Pharmacy and research  institute of Pharmaceutical  sciences, seoul national University,   seoul, KoreaAbstract:  A meta-analysis was conducted to decide whether to reduce an initial 6-mercaptopurine  (6-MP) dose in TPMT  heterozygote in the case of an initial 6-MP dose of ,75 mg/m2/d and  to compare the tolerable 6-MP dose among different ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"According to the recommendation,  a homozygous wild-type starts 6-MP with a normal dose, the heterozygote starts as  30%–70% of the full dose (50 mg/m2/d), and the homozygous variant starts with an  extremely reduced dose.3,4 However, in most of Europe and Asia, the initial dose of correspondence: Jung Mi Oh college of Pharmacy and research  institute of Pharmaceutical sciences,  seoul national University, 1 gwanak-ro,  gwanak-gu, seoul 151–742, Korea Tel +82 2 8807 997 Fax +82 2 8809 560 email jmoh@snu.ac.k r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kim et al Running head recto: Tolerable 6-MP dose and TPMT polymorphism: a meta-analysis DOI: http://dx.doi.org/10.2147/OTT.S110800",Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
Available from: http://handbook.cochrane.or g   20.,OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"Available from: http://www.ohri.ca/programs/clinical_epi - demiology/oxford.as p. Accessed September 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"Available from: http://handbook.cochrane.org/ chapter_9/9_5_2_identifying_and_measuring_heterogeneity.ht m.  Accessed April 18, 2016.",OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/d7/ott-9-7133.PMC5125793.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2303–2309Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2303Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11880 9 Bleb related infections: clinical characteristics, risk  factors, and outcomes in an asian population Zhu li Yap1,2 Y ou Chuen Chin1 Judy Yu-Fen Ku1 Tat Keong Chan1,2 gillian T eh1,2 Monisha esther nongpiur2,3 Tin aung1,2 shamira a Perera1–3 1singapore national eye Centre,   singapore; 2singapore eye research  institute, singapore; 3Duke nUs  graduate Medical school, singaporePurpose:  Comparison of the demographic, ocular, systemic and microbiological characteristics  of eyes with bleb related infection (BRI) and bleb related endophthalmitis (BRE).",Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
"While nearly all studies agree  that diabetes, inferior bleb position, bleb leak and bleb manipulation are strong risk  factors for BRI, dispute exists over others, such as age and gender.6,8,9,11–13 It is therefore  pertinent that our study examines the risk factors in our population and their impact  on the development of BRI.Correspondence: shamira a Perera singapore national eye Centre, 11 Third  hospital avenue, singapore 168751 Tel +65 6322 4584 Fax +65 6323 1903 email shamira.perera@snec.com.s g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y ap et al Running head recto: Bleb related infections in an Asian population DOI: http://dx.doi.org/10.2147/OPTH.S118809",Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
"The abstract was  published in Investigative Ophthalmology & Visual Science,  April 2014, Vol 55, 4316 ( http://iovs.arvojournals.org/article.",Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/d3/opth-10-2303.PMC5125794.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/45/dddt-10-3873.PMC5125795.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3873–3878Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3873Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12341 1 Physicochemical stability of ternary admixtures  of butorphanol, ketamine, and droperidol in  polyolefin bags for patient-controlled analgesia use Baoxia Fang1 linhai Wang2 Junfeng gu3 Fuchao chen1 Xiao-ya Shi1 1Department of Pharmacy, Dongfeng  hospital, 2Department of Pharmacy,   3Department of anesthesiology,   renmin hospital, hubei University  of Medicine, hubei, People’s republic  of chinaBackground:  Delivery of drug admixtures by intravenous patient-controlled analgesia is a  common practice for the management of postoperative pain; however, analytical confirmation  of the compatibility and stability of butorphanol tartrate, ketamine hydrochloride, and droperidol  combined in ternary admixtures is not available.",Non-OADS,/arxiv_data1/oa_pdf/8c/45/dddt-10-3873.PMC5125795.pdf
"Hence, subanesthetic dose of ketamine is used as  an adjuvant to opioids PCA for postoperative pain control.4,5 Recently, a triple-component solution containing butorphanol tartrate, ketamine  hydrochloride, and droperidol with PCA was reported to give satisfactory analgesic  effects and decrease the incidence of nausea and vomiting in patients after upper limbs  surgery.6 In addition, the ternary analgesic admixture has sometimes been used for Correspondence: Xiao-ya Shi Department of Pharmacy, Dongfeng  hospital, hubei University of Medicine,  no 16 Daling road, shiyan, hubei,  442008, People’s republic of china email dfyyshixiaoya@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Fang et al Running head recto: Compatibility of butorphanol tartrate solutions DOI: http://dx.doi.org/10.2147/DDDT.S123411",Non-OADS,/arxiv_data1/oa_pdf/8c/45/dddt-10-3873.PMC5125795.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8c/45/dddt-10-3873.PMC5125795.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/45/dddt-10-3873.PMC5125795.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/2b/opth-10-2329.PMC5125796.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2329–2336Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2329Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12184 9 a retrospective analysis of intraocular pressure   changes after cataract surgery with the use of  prednisolone acetate 1% versus difluprednate 0.05% Yael Kusne1 Paul Kang1 robert e Fintelmann1,2 1University of arizona College of  Medicine–Phoenix, 2Barnet Dulaney  Perkins eye Center, Phoenix, aZ, UsaPurpose:  To compare the effect of topical prednisolone acetate 1% (PA) used after routine  cataract surgery to the effect of difluprednate 0.05% (DFBA) used for the same indication on  intraocular pressure (IOP).",Non-OADS,/arxiv_data1/oa_pdf/67/2b/opth-10-2329.PMC5125796.pdf
"Steroids inhibit the production  of leukotrienes and prostaglandins post-surgery, thereby reducing potentially hazardous  ocular inflammation.1 Although steroids help in decreasing inflammation by speeding  up recovery and improving visual outcomes, they are known to have significant side  effects, whether topically or systemically administered.2,3 One of the common side effects of topical steroids include increased intraocular  pressure (IOP).3–5 Interestingly, use of systemic steroids may also result in increased  IOP in a set of patients.6 Patients with a tendency to experience corticosteroid- induced significantly increased IOP have been referred to as “steroid responders” Correspondence: robert e Fintelmann Barnet Dulaney Perkins eye Center,  4800 north 22nd street, Phoenix,  AZ 85015, USA Tel +1 602 254 7255 email rofint@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kusne et al Running head recto: Difluprednate use post-cataract surgery increases IOP DOI: http://dx.doi.org/10.2147/OPTH.S121849",Non-OADS,/arxiv_data1/oa_pdf/67/2b/opth-10-2329.PMC5125796.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/2b/opth-10-2329.PMC5125796.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/2b/opth-10-2329.PMC5125796.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7207–7218OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7207Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11256 6 Monitoring the effects of doxorubicin on  3D-spheroid tumor cells in real-time namhuk Baek1,* Ok Won seo1,* Minsung Kim1 John hulme2 seong soo a an2 1Department of r & D, nanoentek  inc., seoul, republic of Korea;   2Department of Bio nano Technology  gachon University, gyeonggi-do,   republic of Korea *These authors contributed equally  to this workAbstract:  Recently, increasing numbers of cell culture experiments with 3D spheroids pre - sented better correlating results in vivo than traditional 2D cell culture systems.",Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
"Keywords:  doxorubicin, 3D spheroid, cytotoxicity Introduction Traditionally, monolayer cell cultures were used to monitor behavior and identify  effective anti-tumor activities.1 Initial work using extracted nerve cells from the  notochord of frogs highlighted the challenges of growing 3D cellular structures  in vivo.2,3 In 1951, the HeLa cell line was established by Master and Lucey et al,  which jump-started the full-scale research with animal cells.4,5 Since then, various correspondence: John hulme;   seong soo a an  Department of Bionano Technology,  gachon Medical research institute,  gachon University, (461-701)  1342 sungnam Daero, sungnamsi,  republic of Korea Tel +82 31 750 8550 Fax +82 31 750 8755 email flp15@gachon.ac.k r;  seongaan@gachon.ac.k r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Baek et al Running head recto: Monitoring the effects of DXR on 3D-spheroid tumor cells DOI: http://dx.doi.org/10.2147/OTT.S112566 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
Or use: http://youtu.be/qWheGbchEt AVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/1e/ott-9-7207.PMC5125797.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/ott-9-6987.PMC5125798.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6987–6998OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6987Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11098 5 The relationship between the expression of  UsP22, BMi1, and eZh2 in hepatocellular  carcinoma and their impacts on prognosis run Zhai1,2,* Fang Tang3,* Jianhua gong1,2,* Jing Zhang1,2 Biao lei1,2 Bo li2 Yangchao Wei1,2 Xingsi liang1 Bo Tang1,2 songqing he1,2 1laboratory of liver injury and repair  Molecular Medicine, guilin Medical  University, guilin, guangxi, People’s  republic of china; 2Department  of hepatobiliary surgery, affiliated  hospital, guilin Medical University,   guilin, guangxi, People’s republic  of china; 3Pathology Department,   affiliated hospital, guilin Medical  University, guilin, guangxi, People’s  republic of china *These authors contributed equally  to this workAbstract:  Recent studies have shown that deubiquitination plays a key role in tumor progression,  metastasis, resistance to chemotherapy drugs, and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/ott-9-6987.PMC5125798.pdf
"BMI1 is a member of the polycomb group (PcG) of proteins.2 BMI1 inhibits  CDKN2A  (a gene encoding the tumor suppressors p16INK4a and p19Arf), and induces  telomerase activity to regulate cell-cycle progression, apoptosis, senescence, and  immortalization.3,4 A large number of studies have shown that BMI1 is overexpressed  in many human malignancies, including breast cancer,5 pancreatic cancer,6 and HCC.7–9 correspondence: Bo Tang; songqing he Department of hepatobiliary surgery,   Affiliated Hospital, Guilin Medical   University, 95 lequn road, Xiufeng,   guilin, guangxi 541001, People’s   republic of china Tel +86 773 280 9503 Fax +86 773 282 2703 email dytangbo@163.co m;   dr_hesongqing@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhai et al Running head recto: USP22, BMI1, and EZH2 in HCC DOI: http://dx.doi.org/10.2147/OTT.S110985",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/ott-9-6987.PMC5125798.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/ott-9-6987.PMC5125798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/bd/ott-9-6987.PMC5125798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2989–2996Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2989OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12229 6 Prevalence of alcohol use disorders and  associated factors among people with epilepsy  attending amanuel Mental specialized hospital,  addis ababa, ethiopia Tsegereda Waja1 Jemal ebrahim2 Zegeye Y ohannis1 asres Bedaso2 1Department of Psychiatry, amanuel  Mental specialized hospital, addis  ababa, 2school of Nursing and  Midwifery, college of Medicine and  health sciences, hawassa University,   hawassa, sNNP r, ethiopiaIntroduction:  Alcohol use disorders represent one of the leading causes of preventable  death, illness, and injury in many societies throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
"Keywords:  alcohol use disorder, epilepsy, Amanuel Mental Specialized Hospital, sub-Saharan  Africa, stress relief Introduction Epilepsy is a common chronic neurological disorder that affects nearly 70 million  people worldwide.1 More than 85% of people with epilepsy are living in low- and  middle-income countries including sub-Saharan Africa.2,3 Meta-analysis studies on  the estimation of burden of epilepsy showed that the median lifetime prevalence for correspondence: asres Bedaso school of Nursing and Midwifery,  college of Medicine and health sciences,  hawassa University, PO Box 1560,  hawassa, sNNPr, ethiopia Tel +251 91 180 1195 email asresbedaso@gmail.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Waja et al Running head recto: Prevalence of alcohol use disorders and associated factors DOI: http://dx.doi.org/10.2147/NDT.S122296",Non-OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
Available from: http://www.who.int/ iris/handle/10665/4449 9.,OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/a4/ndt-12-2989.PMC5125799.pdf
